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Abstract 
Duplication of the proteolipid protein (PLP1) gene, which encodes the most 
abundant protein of central nervous system (CNS) myelin, is the most common 
cause of Pelizaeus Merzbacher disease (PMD). Various animal models have been 
generated to study the effect of Plp1 gene overexpression on oligodendrocyte 
and myelin sheath integrity. The #72 line harbours 3 additional copies of the 
murine Plp1 gene per haploidic chromosomal set. Homozygous #72 mice appear 
phenotypically normal until three months of age, after which they develop 
seizures leading to premature death at around 4 months of age. An earlier study 
examining the optic nerve showed a progressive demyelination accompanied by 
marked microglial and astrocytic responses. Using electron microscopy and 
immunohistochemistry, I demonstrated that initial myelination of the #72 corpus 
callosum was followed by a progressive demyelination, probably mediated by a 
distal “dying back” phenomenon of the myelin sheath. No evidence of effective 
remyelination was observed despite the presence and proliferation of 
oligodendrocyte progenitor cells (OPCs). A marked increase in density and 
reactivity of microglia/macrophages and astrocytes, and the occurrence of 
axonal swellings, accompanied the demyelination. In situ and in vitro evaluation 
of adult #72 OPCs provided evidence of impaired OPC differentiation. 
Transplantation of neurospheres (NS) into adult #72 mouse corpus callosum 
confirmed that axons were capable of undergoing remyelination. Furthermore, 
NS transplanted into neonatal CNS integrated into the parenchyma and survived 
up to 120 days, demonstrating the potential of early cell replacement therapy. 
Taking advantage of the spatially distinct pathologies between the retinal and 
chiasmal region of the #72 optic nerve, I evaluated the capability of diffusion 
weighted MRI to identify lesion type. I found significant differences between #72 
and wild type optic nerves, as well as between the two distinct pathological 
regions within the #72 optic nerve. These results confirm the potential of the 
#72 mouse to serve as a model to study chronic demyelination. The study also 
demonstrates the utility of the #72 mouse to evaluate cell transplant strategies 
for the treatment of chronic CNS white matter lesions and PMD. Additionally, DW 
MRI has potential as a modality capable of diagnosing myelin-related white 
matter changes, and may be applicable to the clinical setting. 
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1 Introduction 
 
1.1 Background 
 
Central nervous system (CNS) myelin is a lipid rich structure synthesised by 
oligodendrocytes and wrapped around axons in order to reduce transfibre 
capacitance and enable saltatory conduction of the electrical potential. This 
results in a much higher speed of electrical impulse transmission in myelinated 
compared to non myelinated axons (Frankenhaeuser, 1952). The importance of 
myelin is illustrated by the devastating consequences of diseases that affect it. 
The genetic developmental disorders of myelin, such as the leukodystrophies, 
are progressive and invariably untreatable debilitating diseases (reviewed in Biffi 
et al., 2011;Schiffmann and Boespflug-Tanguy, 2001;Schiffmann and van der 
Knaap, 2004). Pelizaeus-Merzbacher disease (PMD), as a specific example of a 
leukodystrophy, is caused by a mutation in the PLP1 gene and spans a wide 
spectrum of clinical severity, ranging from severe, connatal forms which are 
incompatible with life, to relatively mild forms with a late onset and a normal 
life expectancy (reviewed in (Seitelberger, 1995;Yool et al., 2000;Hudson et al., 
2004). In the severe connatal form of PMD there is a failure to form normal 
myelin (dysmyelination), whereas in classical PMD there is a failure to maintain 
myelin (demyelination). 
 
Multiple sclerosis (MS), the archetypical demyelinating disease, is relatively 
common, especially among Caucasians (reviewed in Noseworthy et al., 2000). 
Progressive demyelination leads to chronic disability and, in some cases, to 
premature death. In general, changes in myelin affect the myelin sheath 
integrity and lead to neurological dysfunction including motor dysfunction, 
cognitive dysfunction, seizures, mental health impairment and death, depending 
on the extent of, and the CNS region affected by, the demyelination. 
 
In MS the histopathological changes are not only restricted to the myelin sheath 
but also involve the axon. Axonal changes may occur concomitant with 
inflammatory demyelination or later, possibly as a consequence of chronic 
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demyelination (Bjartmar et al., 2003;Bjartmar and Trapp, 2003;Dutta and Trapp, 
2011). Axonal changes may even occur in some primarily dysmyelinating 
disorders without demyelination (Edgar et al., 2004b;Griffiths et al., 1998; 
reviewed in Edgar and Garbern, 2004;Nave, 2010a;Nave, 2010b). The 
involvement of the axon in disorders primarily affecting the myelin sheath 
highlights the importance of a normal functioning axonal-glial interaction in 
order to maintain axonal integrity (reviewed in Nave, 2010a;Nave, 
2010b;Gruenenfelder et al., 2011). 
 
Remarkable progress has been made in the diagnosis and monitoring of myelin 
disorders following the development of magnetic resonance imaging (MRI). The 
non-invasive nature, superior soft tissue resolution and high sensitivity for 
detecting pathological changes in soft tissues, compared to other imaging 
modalities, makes MRI a useful tool to investigate white matter changes and 
progression in vivo (reviewed in Ciumas et al., 2008). However the specificity for 
determining the lesion type is not high with standard MRI sequences and it is 
currently not possible to distinguish between acute and chronic demyelination 
(Bitsch et al., 2001). Diffusion tensor imaging (DTI), which measures the 
directionality of water diffusion in tissue, is influenced by tissue ultrastructure 
and allows detection of microstructural changes in white matter tracts. If acute 
inflammatory demyelination could be distinguished from chronic silent 
demyelination, it would provide the research and clinical community with 
invaluable information about disease development and therapy response. Only 
recently a study by (Xie et al., 2010) has attempted to investigate if DTI detects 
differences between active demyelination with inflammation and chronic silent 
demyelination, the two hallmarks of MS lesions. 
 
1.2 The central nervous system (CNS) 
 
The white and grey matter of the CNS differs substantially in cell architecture 
and function. Astroglia, oligodendroglia, oligodendroglial precursor cells (OPCs) 
and microglia are distributed throughout the grey and white matter, while 
neuronal cell bodies with dendrites are predominantly located in the grey matter 
and axons are largely arranged in parallel bundles in the white matter. In the 
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brain, the grey matter is macroscopically identified as the cortex or, in deeper 
structures, as nuclei. The white matter is macroscopically present below the 
cortex or in between the nuclei. 
 
A magnitude of precisely timed neuronal-neuronal interactions are necessary for 
normal function of the CNS. To maintain the demand for fast and precise 
communication between neurons, highly organised and rapid propagation of 
electrical signals along axons is crucial. The rate of propagation of the electrical 
potential is dependent on both axonal diameter and myelination status. The 
larger the axonal diameter, the lower its resistance, and the faster electrical 
impulses are propagated. The evolution of myelin serves to maximise fast 
conduction of electrical impulses while minimising the amount of space, which is 
required to contain the millions of nerve fibres that constitute the vertebrate 
CNS (Rushton, 1951). With myelination of axons, the necessity for large axonal 
diameters to enable fast electrical potential transmission is overcome. Saltatory 
conduction is also highly energy efficient, since action potentials need only be 
generated at the node of Ranvier, and not constitutively as in non myelinated 
nerves (reviewed in Rosenbluth et al., 1994). 
 
1.2.1 The neuron 
 
The neuron consists of the cell body, dendrites and one or more axons. The 
neuronal cell body processes signal inputs and generates the electrical potential 
at the level of the axonal hillock for signal output. The dendrites conduct inputs 
to the neuronal cell body and the axons conduct outputs from the cell body to 
other neurons or (in the peripheral nervous system [PNS]) effecter organs. Most 
of the neurons in the CNS are multipolar; in which multiple dendrites and 
multiple axons are present in one neuron. Communication between neurons is 
mediated at synapses, a specialised region where the electrical signal is 
converted into a chemical signal, affecting the post synaptic/effector neuron. 
The chemical signal binds to receptors on the postsynaptic membrane, which 
then produce either an excitatory or inhibitory signal in the target neuron. In 
some cases direct transmission of the electrical signal between the neurons can 
occur (Blumenfeld, 2002). 
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1.2.2 The axon 
 
The axon is the long extension of the neuronal cell body that allows information 
to be transferred over long distances. Axons of projection neurons can extend 
for up to several feet. Axonal diameter varies between axons, with the average 
diameter in the CNS being around 1µm. In general, the diameter is constant 
along the entire axon (Friede and Samorajski, 1970), except at nodal regions. 
The electrical compound potential generated at the axonal hillock is conducted 
along the axon to the presynaptic membrane (reviewed in Hildebrand et al., 
1993; Blumenfeld, 2002). Most CNS axons have a diameter larger than 0.2µm and 
are myelinated (reviewed in Hildebrand et al., 1993). 
 
The axolemma, or axonal membrane is a lipid bilayer and maintains the resting 
potential of the axon (reviewed in Hildebrand et al., 1993). The molecules in the 
axolemma are also responsible for action potential generation and propagation. 
In the myelinated axon there is an accumulation of electron microscopy (EM) 
dense structures in the axolemma of the axonal hillock and at the level of the 
node of Ranvier, which are related to ion channels (Rosenbluth, 2009). Actin 
filaments located beneath provide support to the axolemma. In the cytosol, 
there is a dense network of neurofilaments and microtubules (Amos and Amos, 
1987). The neurofilaments, which are 10 nm thick unbranched fibres, give the 
axon structure and stability (Brady et al., 1999). Neurofilaments become 
phosphorylated during the myelination process and this increases filament 
spacing, concomitantly increasing axonal diameter. Microtubules are 25nm thick 
unbranched tubes, consisting of heterodimers of α – and β tubulin (Brady et al., 
1999). Microtubules are utilised by molecular motor proteins for the anterograde 
and retrograde transport of organelles. This is an important transport mechanism 
since most of the transcriptional entities of the neuron are located in the cell 
body or synapses. The axons itself is dependent on the synthesis and transport of 
cellular products from the cell body. In the cytosol, mitochondria are found 
along the entire axon and are also transported in both directions on the 
microtubular system to supply the axon with adenosine triphosphate (ATP). 
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1.2.3 The oligodendrocyte 
 
The oligodendrocyte is a multiprocess–bearing cell that forms the CNS myelin 
sheath. Oligodendrocytes are located in the grey and white matter, with the 
highest density in the white matter ranging between 350 – 1000/mm2, depending 
on the white matter tract and the thickness of the tissue section in which 
density is measured (see Chapter 5 and Al-Saktawi et al., 2003). The 
oligodendrocyte is metabolically highly active during myelination, and a single 
oligodendrocyte can synthesise up to 50,000µm2 of membrane per day (reviewed 
in Pfeiffer et al., 1993). One single oligodendrocyte can produce and maintain 
up to 60 individual myelin sheaths (reviewed in Hildebrand et al., 1993). The 
advantage of myelination is clear (see above). The disadvantage is the 
vulnerability of the complex myelin sheath to injury (reviewed in Hildebrand et 
al., 1993).  
 
1.2.4 The myelin sheath and its adjacent structures 
 
The myelin sheath is not a continuous structure and multiple myelin sheaths 
align along one axon. Individual oligodendrocyte processes wrap multiple times 
around an axonal segment; in some cases up to 160 times (Hildebrand et al., 
1993), to form the compact myelin sheath. The lateral and longitudinal 
dimensions of the myelin sheath segment are directly coupled to the axon 
diameter. In general this results in a ratio between axon diameter and fibre 
diameter (G-ratio) of approximately 0.6; the optimal ratio for maximal 
conduction velocity (Hildebrand and Hahn, 1978). Between each myelin sheath 
segment there is a gap of 0.8 – 0.9µm, which is referred to as the node of 
Ranvier (Hildebrand and Waxman, 1984). There are four distinct regions which 
can be distinguished along a myelinated axonal segment: the internodal 
segment, the node or Ranvier, the paranode and the juxtaparanode. 
 
The internodal segment is the unit between the lateral edges of each myelin 
sheath. The length of an internodal segment varies in the CNS but increases in 
general with larger diameters and ranges between 100 to 1700µm (Hildebrand et 
al., 1993).  
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The node of Ranvier, which is not covered by the myelin sheath, contains various 
voltage gated sodium channels. The node is mainly responsible for the 
generation of the action potential for the saltatory conduction but also interact 
with oligodendrocytes and OPCs (reviewed in Salzer, 2003). 
 
The paranode, which is adjacent to the node, constitutes of non-compact myelin 
loops, which interact with the axolemma. The axolemmal cis complex, which is 
composed of caspr and contactin, interacts with the glial expressed NF155 and is 
believed to regulate junction development and stabilisation (reviewed in Salzer, 
2003;Nave, 2010a). The interaction between caspr/contactin and NF155 is also 
believed to influence axon-glial communication (reviewed in Salzer, 2003;Nave, 
2010a).  
 
The juxtaparanode mainly harbours voltage gated Kv 1.1/1.2 potassium channels 
and Caspr2 expressed on the axolemma. The glial expressed Tag-1 protein forms 
a cis complex with Caspr2. The function of the juxtaparanode is believed to 
prevent hyperexcitation and backfiring of action potentials (reviewed in Salzer, 
2003;Nave, 2010a). 
 
1.2.4.1 Myelin ultrastructure 
 
The concentric layers of the oligodendrocyte process as it wraps around the axon 
gives myelin an ordered structure. Between the cytoplasmic surfaces of each 
wrap, the major dense line forms when cytoplasm is extruded and the myelin 
sheath compacts. Between the extracellular surfaces of consecutive wraps of 
compact myelin lies a 2 nm thick space, called the intraperiod line or space. The 
distance between two adjacent major dense lines is defined as one myelin 
period and, in CNS tissue processed for EM, measures 15.65nm (Agrawal et al., 
2009;Hildebrand et al., 1993;Edgar and Griffiths, 2009). The outermost rim of 
the oligodendrocyte process is a cytoplasm-filled channel that forms the inner 
and outer tongues and the paranodal loops of each myelin sheath segment. 
Together, these constitute non-compact myelin. At the paranode, the myelin 
sheath is attached by transverse bands to the axolemma (reviewed in Edgar and 
Griffiths, 2009). Finally, the radial component which appears as a dense 
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thickening in consecutive intraperiod lines in electron micrographs, spans the 
whole or part of the compact myelin, and represents the tight junctions 
(Hildebrand and Mohseni, 2005;Kosaras and Kirschner, 1990). 
 
1.2.4.2 Biochemical composition of myelin 
 
Biochemical and histochemical analysis of the myelin sheath have identified 
multiple proteins and lipids. Proteins account for about 30% of the myelin dry 
mass. The most abundant protein is proteolipid protein (PLP) and its isoform 
DM20, followed by myelin basic protein (MBP). Less abundant proteins include 
myelin associated oligodendrocytic basic protein (MOBP), 2’-3’-cyclic nucleotide-
3’-phosphodiesterase (CNP), myelin associated glycoprotein (MAG) and Claudin 
11. Small amounts of myelin/oligodendrocyte protein (MOG) and oligodendrocyte 
myelin glycoprotein (OMpg) are also present. Recently a large number of myelin 
proteins were identified using mass spectrometry (Jahn et al., 2009). 
 
Lipids account for approximately 70% of the dry mass of myelin (Norton, 1984). 
Four main classes are histochemically identifiable including galactosphingolipids 
(cerebrosides and their sulphated derivates, sulfatides); sterols, mainly 
cholesterol; phospholipids; and plasmalogens (Bosio et al., 1998;Saher et al., 
2011). 
 
1.2.4.2.1 Myelin Proteins 
 
1.2.4.2.1.1 Proteolipid Protein/DM20 (PLP/DM20) 
 
PLP and its isoform DM20 is the major myelin protein in the CNS. Recent 
proteomics studies suggest that together, PLP/DM20 account for around 17% of 
all myelin protein (Jahn et al., 2009). PLP and DM20 are predicted to be 
tetraspan proteins. DM20 differs from PLP in that it lacks 35 amino acids in the 
second intracellular loop. Prior to myelination, DM20 is the predominant isoform 
in the CNS. Once myelination is initiated, PLP becomes the predominant form. 
The role of PLP/DM20 in CNS myelin is still not fully understood, but it has been 
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shown to be important for formation and maintenance of the intraperiod line of 
compact CNS myelin (Klugmann et al., 1997) and for the transport of other 
proteins into compact myelin (Werner et al., 2007). More detail about the 
proteolipid protein gene structure and function are found in 1.5.2.1 The 
proteolipid protein gene in the CNS: normal structure, function and the role in 
the aetiology of Pelizaeus-Merzbacher disease. 
 
1.2.4.2.1.2 Myelin basic protein (MBP) 
 
MBP is the second most abundant myelin protein. Its relative contribution to the 
total myelin protein content is about 8% (Jahn et al., 2009). MBP is a 
cytoplasmic protein mainly located in the major dense line. There are at least 
five isoforms which become upregulated during myelination (reviewed in 
Campagnoni and Skoff, 2001). It has been demonstrated that the Mbp gene is 
part of a larger gene complex, the gene of oligodendrocyte lineage (Golli-Mbp 
gene). GOLLI-MBP proteins are only expressed at a low level in the CNS. However 
GOLLI-MBP products have been found in T-cells and macrophages in the thymus 
and are believed to play a role in the induction of experimental autoimmune 
encephalitis (EAE) (reviewed in (Campagnoni and Skoff, 2001). In the CNS, MBP is 
responsible for the fusion of the two cytoplasmic myelin sheath membrane 
surfaces, forming the major dense line. MBP has also been demonstrated to 
stabilise microtubules in differentiating oligodendrocytes (Galiano et al., 2006). 
Lack of MBP function in the naturally occurring shiverer mutant mouse and the 
Long Evans shaker rat (O'connor et al., 1999;Readhead and Hood, 1990) causes 
severe hypomyelination of the CNS. 
 
1.2.4.2.1.3 Claudin 11/OSP 
 
Claudin 11 also referred to oligodendrocyte specific protein (OSP) is the third 
most abundant myelin protein and accounts for about 7% of the total myelin 
proteins (Bronstein et al., 1997). It is a tetraspan protein and its structure is 
similar to PLP/DM20. Claudin11 is located between the extracellular surfaces 
and is detectable as the radial component of the CNS myelin. It is believed that 
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Claudin11 forms tight junctions and is thought to play a structural role in myelin 
formation and maintenance (Gow et al., 1999). However, Claudin11 deficient 
mice, like PLP/DM20 null mice, morphologically develop a relatively normal 
myelin sheath. However, Claudin11*PLP/DM20 double knockout mice have a 
severe deficiency in myelin compaction leading to neurological deficits, 
suggesting an interaction between PLP/DM20 and Claudin11 for myelin 
compaction (Chow et al., 2005). 
 
1.2.4.2.1.4 2’-3’-cyclic nucleotide-3’-phosphodiesterase (CNP) 
 
CNP constitutes about 4% of total myelin protein (Jahn et al., 2009). CNP is an 
enzyme which is expressed in oligodendrocytes from very early in the 
myelination process. CNP is located in the non-compact myelin, such as the 
inner and outer tongue, the paranodal loops and, in the PNS, in the Schmitt-
Lantermann incisures. However the substrate of CNP has not been found in the 
CNS and the function of CNP in oligodendrocytes is not clear. Overexpression of 
CNP impairs distal oligodendrocyte process extension (Gravel et al., 1996). CNP 
can bind to RNA and suppress translation, indicating that it may be involved in 
trafficking RNA to the distal oligodendrocyte process (Gravel et al., 2009). Cnp1 
null mice form almost completely normal myelin except for swelling of the inner 
tongue process of some oligodendrocytes, but develop an early-onset 
axonopathy (Edgar et al., 2009 and Lappe-Siefke et al., 2003). 
1.2.4.2.1.5 Myelin associated glycoprotein (MAG) 
 
MAG accounts for approximately 1% of total myelin protein (reviewed in Schnaar 
and Lopez, 2009). MAG is a transmembranous glycosylated protein located in the 
periaxonal membrane of the oligodendrocyte. MAG is believed to interact with 
the axon through gangliosides and through the Nogo and p75 receptor on the 
axolemma. The main function of MAG seems to be in the support of the axono-
glial stabilisation and mediates neurofilament phosphorylation (reviewed in 
(Schnaar and Lopez, 2009). Although MAG is not essential for myelination, a late 
onset axonopathy has been observed in MAG deficient mice (Fruttiger et al., 
1995). Recently MAG was shown to play a role in the molecular organisation of 
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the node of Ranvier (Marcus et al., 2002). It also inhibits axonal growth after 
injury (McKerracher et al., 1994). However the role of MAG in axonal 
regeneration is not fully understood (reviewed in Schnaar and Lopez, 2009). 
 
1.2.4.2.2 Myelin lipids 
 
Of the four main classes of myelin lipids, galactocerebrosides and cholesterol, 
have been the focus of in depth investigation and will be briefly presented. 
 
1.2.4.2.2.1 Cerebrosides and sulfatides 
 
Twenty seven percent of myelin lipids originate from the galactocerebrosides 
and their sulphated derivatives, the sulfatides (Norton and Cammer, 1984). 
Galactocerebrosides (GalC) are expressed from the early stages of 
oligodendrocyte development (reviewed in Pfeiffer et al., 1993). It has been 
shown that application of antibodies against (GalC) results in a Ca++ influx 
mediated re-arrangement of microtubules in oligodendrocytes (Dyer and 
Benjamins, 1988;Dyer and Benjamins, 1990) and inhibit the myelination process 
in vitro and in vivo (Fry et al., 1974;Rosenbluth et al., 1994). Mouse models 
lacking GalC showed that myelin formation takes place without GalC, but the 
myelin has impaired insulation properties and lacks long term stability (Coetzee 
et al., 1996). 
 
1.2.4.2.2.2 Cholesterol 
 
Cholesterol is an important structural lipid in the cell membrane of vertebrates. 
It contributes to the semi-permeability of cell membranes and influences cell 
membrane fluidity (Ikonen, 2008). In myelin, cholesterol constitutes about 28% 
of the lipid content and it is locally synthesised in oligodendrocytes (Morell and 
Jurevics, 1996;Saher et al., 2005). Mice deficient in cholesterol synthesis in 
oligodendrocytes manifest hypomyelination of the CNS during post-natal 
development, leading to tremor, ataxia and in some cases premature death. 
However, in surviving animals, the phenotype stabilises with age and 
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myelination returns to more normal levels. The recovery is related to the supply 
of cholesterol by astrocytes (Saher et al., 2005). Recently the role of cholesterol 
in lipid raft formation and its interaction with myelin proteins such as PLP has 
initiated an increased interest in the role of cholesterol in myelin. Lipid rafts are 
highly motile regions in the cell membrane that are believed to function as 
platforms for protein interaction and signal transduction (Simons and Ikonen, 
1997). These rafts have also been shown to associate with PLP integration into 
the membrane (Simons et al., 2000). On the other hand, overexpression of the 
Plp1 gene results in a sequestration of cholesterol to endosomes/lysosomes and 
autophagosomes inducing storage disease-like changes (Saher et al., 2011;Simons 
et al., 2002;Karim et al., 2010). 
 
1.2.5 The oligodendrocyte precursor cell 
 
OPCs represent the undifferentiated multipotent cell pool, which develop into 
myelinating cells during post natal development (Kessaris et al., 2006).  In adult 
CNS, OPCs are the cells that differentiate into new myelin sheath forming 
oligodendrocytes after demyelination (2006;Zawadzka et al., 2010). OPCs are 
dispersed over the entire CNS and constitute, in the rat, approximately 8 - 9% of 
the glial cell population in white matter and approximately 2 – 3% of the glial 
cells in grey matter (Dawson et al., 2003). OPCs derive from different regions in 
the developing CNS. In the spinal cord they originate from the ventral 
neuroepithelial tube and migrate from there into other spinal cord areas. A 
recent study showed that the situation in the forebrain is different. Here OPCs 
populate the forebrain in waves. The first wave originates from the medial 
ganglionic eminence and the anterior entopeduncular area, the second wave 
originates from lateral and caudal ganglionic eminence and the third wave from 
the postnatal neocortex. Only the OPCs originating from the second and third 
wave persist and supply the region with myelinating oligodendrocytes (Kessaris 
et al., 2006).  
 
The morphology of OPCs in the CNS differs during post natal maturation. In 
vitro, at an early stage of development, the cells appear bipolar and are 
identified by the expression of A2B5 and PDGFRα. In the adult in vivo, OPCs are 
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cells with multiple processes, which express PDGFRα and the chondroitin 
sulphate proteoglycan NG2. At this stage the OPCs are multipotent and can 
develop either into oligodendrocytes, astrocytes or neurons (reviewed in Levine 
et al., 2001;Miron et al., 2011). During myelination OPCs exit the cell cycle and 
differentiate into oligodendrocytes (Miller, 2002). In adults after chemically 
induced demyelination, OPCs proliferate, repopulate the demyelinated area and 
differentiate into myelin forming oligodendrocytes (Zawadzka et al., 2010). 
Remyelination by OPCs after chemical demyelination is in general very 
successful but in diseases such as MS, failure of the repair process is commonly 
observed, and leads to chronic and permanent neuronal dysfunction. 
 
OPCs are not only responsible for (re)myelination. They influence neuronal 
activity at the node of Ranvier (Butt et al., 1999). OPC processes have also been 
detected in close proximity to synapses, where they may contribute to synapse 
remodelling (reviewed in Frohlich et al., 2011). Recently a glutamate mediated 
interaction between yet unmyelinated axons and NG2+ cells was demonstrated 
and is believed to facilitate rapid axono-glial communication initiating 
myelination (Ziskin et al., 2007). NG2+ cells are also capable of differentiating 
into astrocytes, highlighting their stem cell like multipotency (Zhu et al., 
2008a).  
 
1.2.6 The astrocyte 
 
Astrocytes are characterised by their star shaped appearance and generally, by 
expression of glial fibrillary acidic protein (GFAP) (Eng et al., 1971). They can be 
divided into two main groups; fibrous astrocytes of the white matter and the 
protoplasmic astrocytes of the grey matter (reviewed in Figley and Stroman, 
2011). The function of astrocytes in the CNS is multifaceted. They are involved 
in electrolyte homoeostasis (reviewed in Sofroniew and Vinters, 2010), in the 
maintenance and function of the blood brain barrier (reviewed in Abbott, 2002), 
in regulating local blood flow (reviewed in Figley and Stroman, 2011), 
influencing the generation of synapses and modifying synaptic transmission 
(Ullian et al., 2001), influencing myelination dynamics (reviewed in Nash et al., 
2011) and maintaining an active astrocyte-astrocyte and astrocyte-neuronal 
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signalling network (reviewed in (Sofroniew and Vinters, 2010;Rusakov et al., 
2011). In the white matter astrocytes interact with the oligodendroglia via gap 
junctions (Nagy et al., 2001) and extend processes to the node of Ranvier (Butt 
et al., 1994). Astrocytes respond to any kind of tissue damage including 
demyelination by proliferating and changing morphology, turning into reactive 
astrocytes (reviewed in Norton et al., 1992). 
 
1.2.7 Microglia  
 
The microglial cells are the resident macrophages of the CNS and are considered 
to constitute the innate immune system of the CNS. They originate from myeloid 
precursor cells and populate the CNS during late embryonic development. 
Approximately 12% of CNS glial cells can be attributed to microglia (reviewed in 
Walter and Neumann, 2009). In the normal CNS, microglia monitor their 
environment by continuously scanning to detect pathological changes, without 
disturbing the cellular network (reviewed in Hanisch and Kettenmann, 2007). As 
soon as there are abnormal changes in the CNS tissue, such as invasion by 
microorganism, production of inflammatory cytokines, accumulation of 
intracellular substances or protein aggregates, microglia change their activity 
from a surveillance mode to a reactive mode, depending on the severity and 
duration of the insult. In general, when microglia become ‘activated’ they 
change their morphology from small cell bodies with fine processes to swollen 
cell bodies with shortened and thicker processes. Activation is mainly mediated 
through activation of Toll-like receptors, through lack of inhibition of receptors 
or through neurotransmitters, making them respond to known and unknown 
changes. ‘Activated’ microglia can interact with other immune cells such as 
macrophages and T-cells, can exhibit phagocytic activity, for example removing 
myelin debris after demyelination, secrete pro- or anti-inflammatory substances 
and can support adult oligodendrogliogenesis and neurogenesis. In general 
microglia maintain and restore optimal conditions for normal CNS function 
(reviewed in Hanisch and Kettenmann, 2007). However microglial activation can 
also exacerbate and aggravate the disease process.  
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This exacerbation and aggravation of the disease process has been shown in 
different models of demyelination where suppression of microglial/macrophage 
activation led to amelioration of the disease process (Ip et al., 2007;Popovic et 
al., 2002;Kondo et al., 2011) and highlights the bivalent role of microglia in 
white matter pathology.   
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Figure 1. White matter at a glance. 
Illustration of the architecture of major white matter tracts (A) composed of axons and their 
myelin sheath (B, C, and D), microglia (E), astroglia (F) and oligodendrocyte precursor cells (G). 
PLP (blue) and MBP (orange), the two most abundant proteins of CNS myelin, are located in 
compact myelin. CNP (red) and Sirtuin2 (green) are associated with non-compact myelin. MAG 
(purple) traverse the periaxonal space and binds to receptors (blue) in the axolemma (MDL: 
major dense line, IPL: intraperiod line, modified from Gruenenfelder et al., 2011). 
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1.3 Myelination of the CNS 
 
Myelination of the mouse CNS mainly occurs during post natal development with 
peak myelination around P20. The myelination process is largely complete 
around P60 (Edgar and Griffiths, 2009). However there are some regions, such as 
the corpus callosum, where on-going myelination into late adulthood is present 
(see Chapter 3). The process of myelination is tightly controlled and involves in 
general all axons larger than 0.2µm in diameter (reviewed in Hildebrand et al., 
1993). 
 
The process of myelination, from OPC proliferation to differentiation and 
formation of the myelin sheath is orchestrated by a precise temporal and spatial 
interaction of inhibitory and promoting cell intrinsic and extrinsic factors 
(reviewed in Franklin and ffrench-Constant, 2008;Emery, 2010a). Most of the 
known OPC extrinsic factors and molecules are expressed on axons and act 
through axonal glial communication. They are, in general, inhibitors of OPC 
differentiation and the down-regulation or inactivation of these ligands such as 
Jagged, PSA-NCAM, NRG1-III or LINGO-1 results in decreased inhibition of OPC 
differentiation (Charles et al., 2000;Mi et al., 2005;Wang et al., 1998;Emery, 
2010a;Flores et al., 2008). Neuronal activity has additionally been identified to 
induce OPC differentiation and myelination (Barres and Raff, 1993). The 
influence of neuronal activity on myelination highlights the plasticity of the 
white matter, which is preserved into adulthood and can be stimulated with 
specific training (Scholz et al., 2009). 
 
Activation of the canonical Wnt pathway in OPCs is required for OPC 
proliferation but needs to be downregulated to induce OPC differentiation. 
Prolonged activation of the Wnt pathway leads to delayed myelination and also 
delayed remyelination (Fancy et al., 2009). 
 
Cell intrinsic factors involved in the regulation of OPC differentiation include 
translational, posttranslational and epigenetic mechanisms (Emery, 
2010a;Franklin and ffrench-Constant, 2008). For OPC development, normal 
function of the transcriptional factor Olig2 is crucial and disruption thereof leads 
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to absence of OPCs in the CNS (Lu et al., 2002 and reviewed in Emery, 2010b). 
During OPC differentiation other transcription factors such as Olig1, Sox10 and 
Nkx 2.2 become more important and any disruption thereof impairs the 
differentiation of OPC into myelin synthesising oligodendrocytes (Emery, 2010b). 
Recently microRNA has been shown to control OPC differentiation. The 
transgenically mediated inhibition of the microRNA processing enzyme Dicer1 in 
cells from the oligodendrocyte lineage, leads to a dysmyelinating phenotype 
with an elevated OPC pool. OPC differentiation and myelination was reinduced 
by overexpression of miR-291 and miR-338 which act through silencing the 
inhibitory factors Sox6 and Hes5 (Zhao et al., 2010). 
 
Finally epigenetic control mechanism involving, for example, histone 
deacetylases (HDAC1 and 2) influence myelination as well as remyelination. It 
has been shown that HDACs block Wnt pathway activity believed to inhibit OPC 
differentiation (Ye et al., 2009).  
 
In contrast to the PNS, where myelination is mainly governed by axonal signals, 
the myelination process in the CNS is more complex and some of the cell 
intrinsic and cell extrinsic influences on myelination have been identified. 
Understanding the molecular changes involved in normal myelination during 
development could help to investigate the mechanism involved in remyelination 
and remyelination failure.    
 
1.4 The regenerative capacity of the white matter 
 
It has been shown that extensive repair can occur after a pathological insult to 
the myelin sheath where the demyelinated axons become remyelinated (Duncan 
et al., 2009). The remyelination process in the CNS can be very effective and 
extensive, leading to a full recovery of the whole demyelinated area.  Recently 
it has been observed that demyelinated regions become repopulated by a 
specific multipotent cell type, the OPCs. However remyelination often fails 
especially in MS despite of OPCs being abundantly present in the demyelinated 
regions (Chang et al., 2002;Goldschmidt et al., 2009;Kuhlmann et al., 2008). 
These regions often stay demyelinated and secondary axonal changes develop, 
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possibly as a consequence of failed remyelination. Why the default 
remyelination process fails with disease chronicity is not understood and 
research using animal models of demyelination is focusing on this phenomenon in 
order to understand the development of remyelination failure and to potentially 
find ways to enhance the regenerative process. 
 
1.4.1 Demyelination and remyelination of the CNS 
 
Demyelination is the process whereby the myelin sheath breaks down. 
Demyelination of the CNS occurs in two ways:  
 
a) Primary demyelination, where pathology mainly affects the myelin sheath, 
causing a demyelination  
 
b) Wallerian degeneration, where the breakdown of the myelin sheath follows 
axonal degeneration. 
 
Primary demyelination of the white matter is a common pathology in humans 
and two major disease groups affect the CNS myelin sheath: inflammation 
induced primary demyelination, with MS being the most common aetiology, and 
much less common, demyelination mediated through a genetic defect, such as 
the leukodystrophies, for example, PMD or Krabbe’s disease.  
 
In general, the regeneration potential of the CNS is limited. However, with 
regard to regeneration of the myelin sheath, it has been shown that 
remyelination is a highly effective and dynamic process following a 
demyelinating insult (Blakemore, 1974;Coman et al., 2005;Woodruff and 
Franklin, 1999;Kuhlmann et al., 2008;Franklin and ffrench-Constant, 
2008;Duncan et al., 2009;Miron et al., 2011). It has been demonstrated that 
OPCs are responsible for remyelination in the adult CNS (Zawadzka et al., 2010). 
This regenerative capacity of the OPC is believed to be maintained throughout 
life (reviewed in Franklin and ffrench-Constant, 2008). 
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This regenerative capacity has also been observed in patients suffering from MS, 
in that virtually complete restoration of myelin can occur after an acute event 
(Kuhlmann et al., 2008). However there appears to be a different situation in 
chronically demyelinated lesions, where the remyelination capacity of OPCs 
becomes diminished (Goldschmidt et al., 2009). 
 
Chronic remyelination failure is leading to permanent demyelination as seen in 
chronic MS. The reasons for remyelination failure are not fully understood. 
However the consequence of this failure is that axonal loss, which is believed to 
lead to permanent disability and which can be caused by inflammation-mediated 
demyelination, is also recognised in association with remyelination failure 
(reviewed in Trapp and Nave, 2008). Consequently, more attention has been 
given to investigating the axonal glial interaction, and it has been suggested that 
the axonal loss evident in chronic demyelinated regions is due to the long term 
loss of trophic factors derived from the myelin sheath (Pohl et al., 2011; 
reviewed in Bjartmar et al., 2003;Nave, 2010a;Nave, 2010b). Evidence for the 
trophic supporting role of the myelin sheath has been provided from the study of 
various genetically modified mouse models (reviewed in Edgar and Garbern, 
2004), such as the Plp1 (Griffiths et al., 1998;Garbern et al., 2002) and Cnp1 
knock out (Lappe-Siefke et al., 2003;Edgar et al., 2009) mice in which axonal 
degeneration occurs over time despite an abundance of relatively normal 
myelin. This suggests that biochemically abnormal myelin may even be more 
detrimental to axonal health, than no myelin (Edgar et al., 2010; reviewed in 
(Nave, 2010a). 
 
1.4.2 Successful remyelination is dependent on a finely tuned 
interaction between oligodendrocyte precursor cell intrinsic and 
cell extrinsic changes 
 
It has been postulated that for effective remyelination to take place, cell 
intrinsic and extrinsic factors must interact in a precise spatial and temporal 
manner (reviewed in Franklin and ffrench-Constant, 2008). Briefly, the initial 
step after demyelination involves clearance of the affected region of myelin 
debris by local microglia/macrophages. Normal microglial/macrophage 
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phagocytic function is an important prerequisite for successful remyelination 
(Kotter et al., 2001;Pohl et al., 2011). This is followed by OPC migration into the 
demyelinated area and OPC proliferation, leading to OPC repopulation of the 
demyelinated area. OPCs must then differentiate into early oligodendrocytes in 
order to initiate remyelination. Cell processes of the newly formed 
oligodendrocytes then contact the demyelinated axons, resulting in upregulation 
of the expression of myelin-related genes (reviewed in Franklin and ffrench-
Constant, 2008). Finally, successful restoration of the myelin sheath leads to 
functional recovery (Duncan et al., 2009). 
 
Given the complexity of the repair process, minimal interference with the 
process could result in perturbation of the remyelination process, which in the 
worst case could end in failure of remyelination. 
To understand the role of intracellular and extracellular compartments during 
demyelination and remyelination it is necessary to address the structural and 
molecular changes within the differentiating OPC intrinsic and extrinsic 
environment including the astroglia, the microglia and the extracellular matrix. 
Successful remyelination is mediated by OPCs (Zawadzka et al., 2010). However 
the mere presence of OPCs within and around the demyelinated lesion is not 
always sufficient for successful remyelination. This situation has been observed 
in chronic MS lesions where, despite the presence of OPCs, there is no evidence 
of remyelination, suggesting that there is a block in OPC differentiation 
(Kuhlmann et al., 2008). The transition of the OPC from a proliferating to 
differentiating cell is thought to be a critical point during the remyelination 
process (reviewed in Fancy et al., 2010;Franklin and ffrench-Constant, 2008).   
 
1.4.3 The role of OPC intrinsic factors in successful (re)myelination 
 
1.4.3.1 Intrinsic control of the cell cycle is crucial for OPC differentiation 
 
As previously stated, a crucial factor in initiating (re)myelination is the 
differentiation of OPCs to young oligodendrocytes. This starts with the OPCs 
exiting the cell cycle. Depending on the dominance of cell cycle promoters or 
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inhibitors, the OPC will either continue to proliferate and go through another 
cell cycle, or will exit the cell cycle and start to differentiate into a non-dividing 
oligodendrocyte. Cell cycle arrest in OPCs depends on a decrease in cyclin-
dependent kinase (CDK), with mainly CDK2 and p27Kip-1, which is part of the 
retinoblastoma (Rb) pathway, as the main regulator (reviewed in Casaccia-
Bonnefil and Liu, 2003). Additionally, the p53 pathway influences the cell cycle, 
especially during the differentiation step. The NH2-terminus of p53 appears to be 
important for the development of the cytoskeleton during differentiation, 
whereas the COOH-terminus of p53 affects exit from the cell cycle (reviewed in 
Casaccia-Bonnefil and Liu, 2003). 
 
1.4.3.1.1 Wnt pathway activity interacts with the timing of OPC 
proliferation and differentiation  
 
As described in Section (1.3 Myelination of the CNS), the Wnt pathway plays a 
regulatory role in the induction of OPC differentiation during development 
(Fancy et al., 2009), but also during remyelination (Fancy et al., 2009). 
Constitutive activation of the Wnt pathway in mice led to delayed but normal 
myelination during development and delayed remyelination after chemical 
demyelination (Fancy et al., 2009). It has been suggested that delayed 
differentiation, during myelin repair, may lead to incomplete or failed 
remyelination by missing the narrow time window for the proliferating OPC’s to 
respond to parameters favouring remyelination (Fancy et al., 2009). Further 
evidence for a regulatory role for the Wnt pathway came from a study showing 
that suppression of the Wnt pathway, mediated through Axin2 stabilisation, a 
negative feedback regulator of the Wnt pathway, resulted in enhanced 
remyelination capacity of OPCs in mice (Fancy et al., 2011). 
 
1.4.3.1.2 The Notch pathway and remyelination 
 
The role of the Notch pathway in remyelination is controversial. It has been 
postulated that Notch1 signalling is involved in the precise timing of the 
myelination process during development. The effect appears to depend on the 
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involvement of either the canonical or non-canonical pathway. Blocking of 
Notch1 receptor stimulation may therefore contribute to remyelination failure in 
MS (Blaschuk and ffrench-Constant, 1998). However, blocking the canonical 
Notch1 pathway in young and adult mice did not influence the remyelination 
rate after chemically induced demyelination in mice (Stidworthy et al., 2004). 
However, remyelination failure in chronically demyelinated MS lesions, in which 
Notch1 receptors were saturated with Contactin and therefore activated, was 
not attributed to Notch pathway activation, but rather to a failure of nuclear 
translocation of the intracellular non-canonical Notch1 domain (Nakahara et al., 
2009). On the other hand, during white matter development and myelination, 
inhibition of Notch1 through the canonical pathway resulted in impaired OPC 
differentiation, leading to an increase in prematurely differentiated immature 
oligodendrocytes (Genoud et al., 2002). 
 
Together, these data show that the Notch signalling pathway can act as an 
inhibitor or promoter depending on activation pathway, suggesting that Notch 
signalling plays a regulating role in remyelination kinetics and is not just an 
inhibitor of OPC differentiation during remyelination (Fancy et al., 2010). 
 
1.4.3.1.3 The activation of Neuregulin1/ErbB signalling in remyelination 
is important but not crucial 
 
In the PNS axonal expressed Neuregulin1-III (NRG1-III) ligands control almost the 
entire myelination process by binding to glial ErbB2/ErbB3 receptors, which 
upregulate myelin gene expression through a phosphatidylinositol-3-kinase (PI3K) 
mediated activation of Akt1/mTor (Michailov et al., 2004). In contrast, in the 
CNS the role of axonal NRG1-III ligands is not crucial for successful myelination 
(Brinkmann et al., 2008;Flores et al., 2008). However, transgenic mice with 
continuous activation of the Akt1 pathway develop a hypermyelination of the 
CNS (Flores et al., 2008;Brinkmann et al., 2008). Although the Akt1/mTor 
pathway is involved in myelin gene upregulation and formation of the myelin 
sheath, the importance of this pathway for successful remyelination is not clear. 
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1.4.3.1.4 The spatial and temporal interaction between transcription 
factors is crucial for successful remyelination 
 
Recently, the role of transcription factors in the remyelination process has 
gained increased attention. As previously discussed, during developmental 
myelination, oligodendrocyte specific transcription factors such as Olig1, Olig2, 
Nkx 2.2 and Sox10 are responsible for OPC development, differentiation, 
myelination and survival.  It has also been shown that in adult CNS transcription 
factors are involved in OPC proliferation and differentiation mandatory for 
successful remyelination (Kuspert et al., 2011).  
Accurate subcellular localisation of the basic helix-loop-helix (bHLH) 
transcription factor Olig1 is crucial for (re)myelination. In normal mice, transient 
intranuclear translocation of transcription factor Olig1 occurs during 
remyelination following chemically induced demyelination. In the Olig1 knock 
out mouse, in which developmental myelination occurs normally, remyelination 
is severely impaired after chemical demyelination (Arnett et al., 2004). In 
contrast, overexpression of Olig1 in transgenic mice had no enhancing effect on 
developmental myelination (Maire et al., 2010). However the influence of Olig1 
overexpression during remyelination has not been examined. Another bHLH 
transcription factor, Olig2 regulates OPC and motoneuron specification during 
embryonic development (Lu et al., 2002). Olig2 knock-out mice display a severe 
reduction of OPCs and motoneurons and do not survive post-natally making it 
impossible to evaluate the influence of absent Olig2 in myelination and 
remyelination (Lu et al., 2002). Furthermore, transplantation of transfection 
induced Olig2 overexpressing human stem cells into shiverer mouse brain 
resulted in increased differentiation and MBP expression by transplanted OPCs 
(Maire et al., 2009;Maire et al., 2010). This suggests that increasing Olig2 
expression increases OPC proliferation and differentiation and that manipulating 
Olig2 levels could potentially enhance remyelination. 
 
However, Olig2 does not function in isolation. During remyelination, increased 
Olig2 expression is always linked to Nkx 2.2 expression in differentiating OPCs. A 
delay in co-expression leads to a reduced remyelination, indicating that the 
combination of Olig2/Nkx 2.2 expression is critical for the remyelination process 
(Fancy et al., 2004;Kitada and Rowitch, 2006;Othman et al., 2011). 
24 
Furthermore, Olig2 regulates Sox10 expression, ensuring OPC survival and acting 
as a direct promoter of myelin gene expression (Stolt et al., 2002;Finzsch et al., 
2008;Kuspert et al., 2011).  
 
In summary, the temporally and spatially regulated action of transcription 
factors is crucial for (re)myelination and only minor disruption can have severe 
consequences for the repair process. 
 
1.4.3.2 Epigenetic influences on (re)myelination 
 
The deacetylation of histones by HDAC, an important intracellular epigenetic 
control mechanism of gene expression, modulates the remyelination capacity of 
the white matter. In the case of OPCs, the HDACs positively influence 
remyelination by blocking the function of molecules such as Tcf4, Sox2, Hes5 
and Id4, which are thought to inhibit OPC differentiation (Shen and Casaccia-
Bonnefil, 2008). The reduction of HDAC in mice, especially HDAC1 and HDAC2, 
causes the level of the intracellular inhibitory molecules for OPC differentiation 
to be elevated. The negative effect on remyelination capacity in the absence of 
HDAC1/2 is mediated through the absence of a competing interaction with Tcf4 
function, which is plays a central part of the Wnt pathway. 
 
Briefly multiple intracellular signalling pathways involved in changing cell status 
from a proliferating one to a differentiating one play a pivotal role during 
myelination and remyelination and knowledge of specific cell intrinsic 
interactions provides an opportunity to manipulate these factors in favour of the 
remyelination process. 
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1.4.4 Factors in the OPC extrinsic compartment that can disrupt the 
remyelination process leading to remyelination failure 
 
1.4.4.1 Mitogens and differentiation factors act through specific cell 
receptors on OPCs 
 
Although OPC intrinsic factors are mandatory for successful (re)myelination, a 
permissive environment for OPC differentiation and myelin sheath formation is 
of equal importance. A variety of OPC extrinsic factors can have a stimulatory or 
inhibitory effect on either proliferation or differentiation. 
 
Mitogens such as PDGF, basic FGF, BDNF and NT3 are responsible for OPC 
proliferation (reviewed in Casaccia-Bonnefil and Liu, 2003) and for increasing 
the number of OPCs. In order to differentiate into new, non-dividing 
oligodendrocytes, OPCs must exit the cell cycle. Extracellular factors such as 
TGF-β, cAMP and thyroid hormone enhance OPC differentiation (reviewed in 
Casaccia-Bonnefil and Liu, 2003). However, it is not only mitogens and 
differentiating inducing molecules that are important, mandatory receptors on 
the OPC membrane such as the Erb family, and integrins are required for 
successful (re)myelination (reviewed in Casaccia-Bonnefil and Liu, 2003;Taveggia 
et al., 2010). 
 
1.4.4.2 The influence of the extracellular matrix on the remyelination 
process 
 
The composition of the extracellular matrix substantially influences the 
generation of new oligodendrocytes (reviewed in Franklin and ffrench-Constant, 
2008). For example hyaluronan, a glycosaminoglycan composed of glucuronic 
acid and N-acetylglucosamine, impairs OPC differentiation (Back et al., 2005). 
The accumulation of high molecular weight (HMW) hyaluronan has been found to 
negatively impact the activation and differentiation of OPCs in chemically 
induced and demyelinated lesions in vitro in a model of chronic demyelination 
and in chronic MS biopsy samples (Back et al., 2005). Recently it was 
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demonstrated that the blocking mechanism of hyaluronan on OPC differentiation 
is mediated by binding of low molecular weight (LMW) hyaluronan to Toll-like 
receptor 2 (TLR2) on OPCs. Hyaluronidase, expressed on OPCs, locally breaks 
down the HMW to LMW hyaluronan and is responsible for the accumulation of 
LMW hyaluronan (Sloane et al., 2010). 
 
Another inhibitory molecule that accumulates in chronic MS lesions is 
Semaphorin 3A (Williams et al., 2007a). Semaphorin 3A is synthesised by 
microglia, astroglia and/or a subset of cells belonging to the oligodendroglial 
lineage (Williams et al., 2007a). The receptor NP-1, to which Semaphorin 3A 
binds, is expressed on OPCs. Recent in vitro and in vivo work showed that 
Semaphorin 3A acts as an inhibitor of OPC differentiation (Syed et al., 2011). 
 
1.4.4.3 Inhibition of the initial axonal glial contact impairs the remyelination 
process 
 
Initiation of myelination is dependent on glia-axonal interaction and it has been 
suggested that polysialation of the neural cell adhesion molecule (PSA NCAM) on 
axons may play a role in inhibiting remyelination after demyelination (Charles et 
al., 2002). PSA NCAM is present on astrocytes and axons during CNS development 
and is involved in O-2A cell migration in vitro (Wang et al., 1996) and axonal 
growth in vitro (Doherty et al., 1990). In the mature CNS, PSA NCAM is no longer 
expressed on axons (Charles et al., 2002), but it is re-expressed in chronic MS 
lesions, possibly impairing remyelination (Charles et al., 2002). The contact-
mediated inhibitory effect of PSA NCAM results in OPC differentiation failure and 
a lack of myelin forming oligodendrocytes (Taveggia et al., 2010). 
 
Structural integrity of the axon is also likely to be crucial for remyelination. Of 
interest, there is evidence that the length of time axons remain demyelinated 
does not impact on the remyelination potential of the demyelinated axons 
(Setzu et al., 2004). 
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1.4.4.4 Astroglia, microglia/macrophages and inflammation influence 
remyelination  
 
The important role of macrophages in remyelination was demonstrated by 
experimental depletion of macrophages, using clodronate-liposome, after 
demyelination in experimental animals. This led to reduced levels of growth 
factors, insulin growth factor 1 (IGF-1) and transforming growth factor β1 (TGFβ-
1), and had a negative impact on OPC recruitment into the demyelinated region 
(Kotter et al., 2001;Kotter et al., 2005). 
 
The important role of the phagocytic activity of macrophages is demonstrated by 
the observation that the accumulation of myelin debris products impairs 
remyelination by inhibiting OPC differentiation (Kotter et al., 2006;Syed et al., 
2008).  
 
1.4.4.4.1 Microglial activation and inflammation can stimulate or inhibit 
the remyelination process 
 
The role of inflammation during the remyelination process is controversial. In 
rodents, zymosan, a TLR2 binding glycan, induces an acute inflammation which 
causes transplanted OPC to myelinate retinal axons more efficiently (Setzu et 
al., 2006). It has also been shown that a saline mediated acute inflammation 
induced after transplantation of OPCs into the chronically demyelinated dorsal 
columns of taiep rats had a beneficial effect on transplanted OPCs to effectively 
remyelinate the chronically demyelinated regions (Foote and Blakemore, 2005a). 
 
On the other hand, minocycline induced suppression of microglial activation in 
Long Evans shaker rats leads to enhanced function and survival of transplanted 
OPCs. This observation suggests that fully activated microglia, characterised by 
expressing MHCII and iNOS and by secretion of cytokines and active phagocytosis, 
may contribute to the non-permissiveness for remyelination by making the 
environment detrimental for transplanted OPCs (Zhang et al., 2003). 
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Furthermore, studies using genetically induced models of demyelination and 
experimental autoimmune encephalitis showed that suppressing microglial 
activation ameliorates progressive demyelination (Ip et al., 2007;Popovic et al., 
2002). 
 
1.4.4.4.2 Astrocytes – promoter or inhibitor? 
 
Astroglia also have an ambiguous role during (re)myelination. Remyelination, 
induced by injection of OPCs and Schwann cells into a chemically and radiation 
induced astroglia-free demyelinated lesions in vivo, was more effective than 
remyelination after transplantation into a demyelinated area containing 
astrocytes. This implies a negative influence of the endogenous astroglia on the 
remyelination capacity (Blakemore et al., 2003). Reactive astrocytes secrete 
hyaluronan, which inhibit OPC differentiation (Back et al., 2005;Sloane et al., 
2010) (see section 1.4.4.2 The influence of the extracellular matrix on the 
remyelination process). On the other hand, using an EAE model, it was 
demonstrated that astrocytes in the demyelinated lesions secrete substances 
such as insulin-like growth factor binding protein 2 (IGFBP-2) which helps to 
target insulin-like growth factor 1 (IGF-1) to insulin-like growth factor receptor 1 
(IGFR-1) expressing oligodendrocytes, essentially having a promoting effect on 
the newly formed oligodendrocytes to remyelinate (Liu et al., 1994). 
Furthermore a bivalent role during the remyelination process has been 
postulated since astrocytes may amplify the damage caused by inflammation 
mediated through TNF-α. This may lead to repulsion and apoptosis of OPCs. On 
the other hand the astrocytes facilitated debris clearance, attracted OPCs to the 
demyelinated region and promoted OPC differentiation by secretion of IL-6 
related cytokines (reviewed in Williams et al., 2007b)    
 
1.4.4.5 Thyroid hormone 
 
Thyroid hormone is known for its positive effect on cell metabolism. Various 
experimental studies focussing on myelin repair and on functional recovery after 
spinal cord injury have shown the positive effect of T3, the biologically active 
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form of thyroid hormone. Acute and also chronic illness has been shown to cause 
the phenomenon of a non-thyroidal illness syndrome (NTIS) (reviewed in 
Papanicolaou, 2000). To date the NTIS is believed to be elicited by a 
combination of systemically suppressive effects on thyroid hormone synthesis 
and locally on thyroid hormone metabolism and transport. Of interest in the 
complex aetiology of NTIS are for example tanycytes, which are located on the 
floor of the third ventricle. The tanycytes respond to acute and chronic illness 
with local upregulation of deiodinase 2 (D2) which controls the secretory activity 
of thyroid releasing hormone (TRH) producing cells in the periventricular nuclei 
(reviewed in Herwig et al., 2008). The upregulation of D2, which is responsible 
for converting T4 to T3, causes a local hyperthyroidism inhibiting TRH secretion 
and elicits a centrally mediated systemic hypothyroidism. 
 
An effective local regulator of active thyroid hormone levels in tissue is the 
deiodinase 3 (D3), which inactivates T4 and T3, locally depriving the tissue of 
active T3, despite thyroid levels being normal (reviewed in Visser et al., 2011). 
D3 is expressed on neutrophilic granulocytes and macrophages and is believed to 
be involved in the development of NTIS in inflammatory diseases (Boelen et al., 
2005). Finally T3 has to be actively transported into the cell by active 
transporters such as monocarboxylase transporters (MTC). In the CNS, MTC8 is 
the major intracellular transporter for T3 and abnormal function and distribution 
has been reported to cause PMD like disease development (Vaurs-Barriere et al., 
2009). All of these components have been described to be involved in the 
development of NTIS. The positive effect on remyelination activity observed 
after application of high T3 doses in different models of EAE may be explained 
by overriding a potential local tissue hypothyroidism mediated through 
inflammation, by saturating the D3 activity and by optimising the impaired 
intracellular transport by artificially elevating the T3 concentration in tissue. 
 
1.4.4.6 Age as an ubiquitous negative factor for remyelination capacity 
 
Increasing age negatively influences both remyelination promoting cell intrinsic 
and cell extrinsic factors. Simultaneous expression of Nkx2.2/Olig2, which is 
important for OPC differentiation and remyelination, diminishes with age (Fancy 
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et al., 2004). Also the HDAC1 and 2 activity becomes reduced with age, leading 
to reduced suppression of myelin suppressing pathways, thereby slowing down 
the remyelination process (Shen et al., 2008;Ye et al., 2009).  Aging also affects 
phagocytic activity, delaying myelin clearance and consequently leading to 
inefficient remyelination (Kotter et al., 2005; reviewed in Neumann et al., 
2009). 
 
1.5 Diseases affecting the myelin sheath 
 
The myelin sheath in the CNS can be affected by various diseases leading to two 
main forms of pathology: 
 
1.) Dysmyelination, in which myelin formation and/or structure is perturbed 
2.)  Demyelination, in which there is destruction of the myelin sheath. 
 
The archetypal disease of white matter in humans is MS, which classically leads 
to widespread formation of demyelinated patches in the white matter. Some 
demyelinated lesions remyelinate and some develop into chronically 
demyelinated lesions (reviewed by Agrawal and Yong, 2007;Noseworthy et al., 
2000). Another group, where an initial dysmyelination may be followed by 
demyelination, has a genetically determined background such as in Pelizaeus 
Merzbacher diseases (Hudson et al., 2004;Garbern, 2007), Krabbe’s disease 
(Duffner et al., 2009), adrenoleukodystrophy (Moser et al., 2005), 
metachromatic leukodystrophy (Gieselmann, 2008) and Alexander’s disease 
(Johnson and Brenner, 2003). Other reasons, such as metabolic disturbances, 
toxins, radiation, vascular events or chemotherapy induced demyelination, have 
been also been described (reviewed in Schmahmann et al., 2008). 
 
In acute diseases affecting the white matter, remyelination with complete 
restoration of neurophysiological function may occur. However in MS or in 
genetically induced demyelination, the repair process often fails and, with time, 
an accumulation of chronically demyelinated regions eventually leads to 
permanent neurological dysfunction (Kuhlmann et al., 2008). The reason why 
remyelination fails, and the regenerative process stops, is a major research 
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area. Classically, the experimentally induced autoimmune encephalitis (EAE) 
model has been used to study the immunological component of demyelination 
(Swanborg, 1995). In contrast, the regenerative capacity of white matter, is 
often studied using chemically induced demyelination. Genetically determined 
models can also be used to investigate remyelination failure in the absence of an 
overt immune component. 
 
1.5.1 Models of myelin pathology 
 
In vitro and in vivo models of demyelination are routinely used to investigate 
remyelination biology and pathology (Fressinaud, 2005;Thomson et al., 
2006;Woodruff and Franklin, 1999;Zhang et al., 2011). In vitro and ex-vivo 
models such as cell and tissue culture are useful in the study of remyelination 
biology with respect to the fact that they are easily manipulated, imaged and 
assessed. The main disadvantage is that they never reflect the in situ situation 
properly. For example, they are generally generated from embryonic or early 
post-natal tissue and, due to their limited lifespan, cannot be used to reproduce 
chronic demyelination. Ideally remyelination should be studied in situ, either in 
an animal model or in humans. For studying white matter biology and pathology 
in situ, a prominent white matter tract without neuronal cell bodies is 
preferred. The long dorsal columns of spinal cord, the optic nerve and the 
corpus callosum fulfil these criteria. The advantage of the corpus callosum is 
that it is a large but anatomically confined myelinated white matter tract in the 
CNS that is readily accessible in vivo and in which manipulation does not usually 
result in substantial clinical deficits. 
 
There are three pathologically distinct groups of animal models that have 
become useful in investigating myelin pathology: 
 
1.) Inflammatory mediated models of demyelination such as the experimental 
allergic encephalitis (EAE) or the Theiler’s murine encephalomyelitis virus 
(TMEV) models (reviewed in Dal Canto et al., 1995;Swanborg, 1995). EAE, 
which can be induced in a wide spectrum of experimental animals such as 
rodents (Swanborg, 1995), pigs (Feng et al., 2009) and non-human 
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primates (D'Intino et al., 2011), has provided valuable insight into the 
aetiology of immune mediated demyelination and proved to be invaluable 
for the development and evaluation of effective immune modulatory 
drugs that have been used in the treatment of MS (reviewed in Lublin, 
2005;Agrawal and Yong, 2007;Korniychuk et al., 2007) 
 
2.) Genetically modified models of dysmyelination and demyelination such as 
the Plp1 gene related models of the leukodystrophies (reviewed in Yool et 
al., 2000), the Mbp related shiverer (Readhead and Hood, 1990) or the 
newer models of genetically inducible demyelination (Pohl et al., 2011) 
have highlighted the importance of normal axonal glial interaction 
(Anderson et al., 1998;Edgar et al., 2002;Edgar et al., 2004b;Edgar et al., 
2009;Edgar et al., 2010;Griffiths et al., 1998;Lappe-Siefke et al., 2003; 
reviewed in Gruenenfelder et al., 2011) and the influence of myelin 
proteins on myelin sheath integrity (reviewed in Griffiths et al., 1995b), 
demyelination (Anderson et al., 1999;Inoue et al., 1996b;Mastronardi et 
al., 1993;Readhead et al., 1994;Kagawa et al., 1994) and remyelination 
impairment (Ma et al., 2006). 
 
3.) The third group consists of chemically induced models of demyelination 
such as focal injection of ethidium bromide (Blakemore, 1982) or 
lysolecithin (Hall, 1972) or systemic application of cuprizone (Blakemore, 
1974). Chemically induced models, especially the focally demyelinated 
models, have been extremely helpful in identifying and analysing the 
endogenous remyelination process in the CNS (Woodruff and Franklin, 
1999). 
  
The focus of this study is the homozygous Plp1 gene overexpressing mouse 
model, line #72, a mouse model of Pelizaeus-Merzbacher disease. Previous 
studies have demonstrated changes in the myelin development in spinal cord and 
optic nerve (Anderson et al., 1998;Edgar et al., 2010) and recently, using a 
combination of DTI measures and histopathology have provided evidence for 
widespread hypomyelination in the adult brain (Ruest et al., 2011). However, a 
complete characterisation of the temporal progression of myelin pathology and 
associated changes has not been undertaken other than in the optic nerve. 
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1.5.2 The Leukodystrophies  
 
The leukodystrophies represent are a relatively rare group of diseases affecting 
the white matter. So far, more than 40 leukodystrophies with various genetic 
causes have been identified and only a few will be mentioned. The most 
common leukodystrophy is the X-linked adrenoleukodystrophy in which an 
accumulation of very long chain fatty acids is associated with neuroinflammation 
and demyelination (Schiffmann and van der Knaap, 2004). Other 
leukodystrophies include metachromatic leukodystrophy, in which deficiency in 
arylsulfatase A leads to a slowly progressive demyelination (reviewed in 
Gieselmann, 2008;Kohler, 2010) and globoid cell leukodystrophy (Krabbe’s 
disease), which is caused by a deficiency in the enzyme galactosylceramide 
beta-galactosidase leading to a demyelination (Kohler, 2010). Haematopoietic 
stem cells transplantation in X-ALD (Cartier et al., 2009) and Krabbe’s disease 
has led to post natal improvement in treated children. However reports of rapid 
deterioration in older children and adolescents with Krabbe’s disease has raised 
questions about the long term efficacy of the treatment (Duffner et al., 2009). 
Finally, Pelizaeus Merzbacher disease (PMD) and the allelic disorder Spastic 
Paraplegia type 2 (SPG2), in which the genetic defect lies in the PLP1 gene, 
(reviewed in Yool et al., 2000) will be described in more detail.  
 
1.5.2.1 The proteolipid protein gene in the CNS: normal structure, function 
and the role in the aetiology of Pelizaeus-Merzbacher disease 
 
1.5.2.1.1 The PLP1 gene  
 
The PLP1 gene encodes the major tetraspan transmembranous proteolipid 
protein and its isoform DM20. The gene is X-linked and is located on a single 
locus at Xq21.33-22 in man (Mattei et al., 1986). The PLP1 gene is expressed in 
mature oligodendrocytes, but other CNS cells such as specific neurons in the 
olfactory bulb, hippocampus and cerebellum may also express PLP1/Plp1 
(Bongarzone et al., 1999). Outside the CNS PLP1/Plp1 gene expression is also 
found in Schwann cells, lymphoid tissue, spleen and cardiac myocytes (Puckett 
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et al., 1987;Campagnoni et al., 1992;Voskuhl, 1998). The size of the PLP1 gene 
is approximately 17 kb and contains eight exons and seven introns (Diehl et al., 
1986;Macklin et al., 1987;Bongarzone et al., 1999). The gene contains three 
polyadenylated sites and two translation initiation codons (Griffiths et al., 
1995a). Exon 1 contains the major translation initiation codon (Yool, 2000). The 
second translation initiation codon lies on exon 1.1 (Bongarzone et al., 1999). 
Exon 7 encodes the carboxy terminus and the entire 3’UTR (Macklin et al., 
1987;Yool, 2000). Two major protein isoforms (PLP [30 kDa] and DM20 [26.5 
kDa]) and two minor isoforms (srPLP and srDM20; in mice) are generated through 
alternate splicing of the primary transcript (Figure 2). Recently two exons in 
intron1 were identified on the human PLP1 gene, possibly leading to the 
expression of three more isoforms (Sarret et al., 2010). Between species there is 
a high level of sequence conservation. Comparing the protein coding region 
between man and rodents the identity reaches 100%. The non-coding and 
regulatory regions are also highly conserved, with the upstream regulatory and 
the 5’ non-coding region of the mouse gene having a 92% homology with the 
human gene (Macklin et al., 1987). The high level of conversation within the 
protein coding region point to strict regulatory control is vital for normal gene 
function (Yool, 2000). 
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Figure 2. Organisation of the murine Plp1 gene and its major transcription 
products.  
Chromosomal arrangement of the Plp1 gene (a). Four major products are generated from the 
Plp1 gene, the two most abundant transcripts Plp and Dm20, followed by the two less frequently 
transcribed srPlp and srDm20 (b) (Yool, 2000). 
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1.5.2.1.2 Regulation of the Plp1 gene expression 
 
Expression of the Plp1 gene is controlled mainly at the level of gene 
transcription and the protein production mirrors transcription levels (Cook et al., 
1992). Promoter and enhancer regions have been identified on intron 1 and as 
little as 225bp of the promoter region is sufficient to induce oligodendrocytic 
specific Plp1 expression (Cambi and Kamholz, 1994).  Interestingly the Plp1 gene 
transcripts are expressed parallel to the Mbp gene transcripts, which indicates 
that these two genes share a common controlling pathway (Cook et al., 1992). 
  
1.5.2.1.3 Posttranscriptional modification and regulation  
 
Both Plp and Dm20 share the same pre-mRNA and are produced through 
alternate splicing of the pre-mRNA. Dm20 mRNA differs from the Plp-mRNA by 
the exclusion of exon 3b (Nave et al., 1987b). The expression pattern of the two 
isoforms is spatially and temporally distinct (Levine et al., 1990). Dm20 
dominates premyelination, but by the time of maximal Plp1 gene expression, Plp 
supersedes Dm20 and becomes the predominant form in the oligodendrocyte. 
 
The two minor isoforms, srPlp and srDm20 show a similar splice site within exon 
3 but additionally retain exon 1.1 (Bongarzone et al., 1999). More Plp isoforms 
have been detected recently but the role of these isoforms has not yet been 
clarified (Jahn et al., 2009;Sarret et al., 2010). 
 
1.5.2.1.4 Plp1 gene expression during development 
 
In the mouse Plp expression can first be detected post-natally between P0 and 
P2. The myelination pattern of the CNS follows that of Plp upregulation, starting 
at the medulla and progressing rostrally to the cerebrum and caudally to the 
spinal cord (Verity and Campagnoni, 1988). At peak myelination, which is around 
22 days post natal in the mouse, Plp expression is at its highest level and then 
drops to approximately 60% (Sorg et al., 1987). Dm20 transcripts on the other 
hand can be first detected at day 9.5 of embryonic development and DM20 
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protein is first detected at E12 in the basal plate of the diencephalon and caudal 
hypothalamus (Spassky et al., 1998). From there, these cells populate the major 
white matter tracts. DM20 expressing cells belong to the oligodendrocyte 
precursor population and later develop into myelin synthesising oligodendrocytes 
(Dickinson et al., 1996). Post-natally Dm20 expression is observed in close 
relation to Plp expression and maximally reaches 50% of the Plp mRNA level 
(Nave et al., 1987b). 
 
1.5.2.1.5 The PLP/DM20 protein 
 
PLP is a transmembranous hydrophobic tetraspan myelin protein, which is 
composed of 276 amino acids. PLP is located in the lipid bilayer of the myelin 
sheath membrane. DM20, which contains 35 amino acids less than PLP, has a 
similar location in the cell membrane. The Plp and Dm20 mRNA are translated in 
the rough endoplasmatic reticulum and the proteins are transported through the 
secretory pathway to the myelin sheath membrane where they become 
integrated into the lipid bilayer (Gow et al., 1994). There are only two post-
translational modifications of the protein; removal of the amino terminal 
located methionine and acylation, reviewed in (Yool, 2000). 
 
The six cysteine residues of the PLP protein (four in DM20) are acetylated with 
long chain fatty acids, mainly palmitic, oleic, palmitoleic and stearic acids 
(Bizzozero and Lees, 1999). The acylation of PLP renders the protein more 
hydrophobic and influences the protein conformation. 
 
1.5.2.1.6 The function of PLP and DM20 in the CNS 
 
To date the precise function of PLP/DM20 has still not been fully elucidated. The 
abundance and transmembranous configuration of PLP in the myelin sheath 
membrane suggests that PLP has a structural function and provides the 
compaction and stability to the myelin sheath (Boison et al., 1995). Plp1 gene 
mutants often show a hypomyelination and an altered myelin periodicity, 
especially as condensed intraperiod lines (Duncan et al., 1987;Yool, 2000). 
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Furthermore PLP/DM20 mediates the provision of trophic support for axons. Mice 
containing a Plp1 null allele myelinate relatively normally but develop a late 
onset axonal pathology, suggesting a supportive role of glial cells for axonal 
integrity (Griffiths et al., 1998). The PLP protein structure also shows similarities 
to ion channel proteins and in vitro data suggests that PLP isoforms may act as 
ionophores (Diaz et al., 1990;Mobius et al., 2008). 
 
DM20 is expressed during embryonic development and also during myelination. 
The presence of Dm20 transcripts in a subset of OPCs during embryonic 
development suggests that DM20 is involved in embryonic oligodendrocyte 
development (Dickinson et al., 1996). However, Plp1 knockout mice are not 
deficient in oligodendrocytes. 
 
1.5.2.2 Pelizaeus-Merzbacher disease 
 
PMD (OMIM 312080) and the allelic form SPG2 (OMIM 312920) are X-linked, 
recessive leukodystrophies caused by mutations in the PLP1 gene. The severity 
of the disease is to some extent dependent on the precise mutation (Cailloux et 
al., 2000;Garbern, 2007).  So far over 100 different mutations in the PLP1 gene 
have been identified, including duplication of the gene, null mutation and 
various missense mutations (Hudson et al., 2004). The clinical signs include 
nystagmus, psychomotor developmental retardance, stridor, spasticity, 
cerebellar symptoms, mental deterioration, seizures and optical atrophy 
(Seitelberger, 1995). The marked spectrum of clinical severity of the disease has 
led to the classification of the PMD into three main categories (Seitelberger, 
1995): 
 
1.) Type I, which is the connatal form with early onset and rapid progression 
leading to death within the first two years of life 
 
2.) Type II, which is the classical form with an early onset and slow 
progression with a survival rate up to 40 + years 
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3.) Type III, which is an intermediate form between Type I and II, with 
survival rates up to early adolescence  
 
The variety of mutations in the PLP1 gene causing PMD may explain, in part, the 
clinical spectrum of disease severity, ranging from severe lethal to mild, late 
onset forms (reviewed in Koeppen and Robitaille, 2002). 
 
The pathology of PMD consists of a generalised, symmetric hypomyelination of 
the CNS with reduced numbers of oligodendrocytes and a dense fibrillary 
astrocytosis. Regions with myelin patches are sometimes present and 
macroscopically visible. Neuronal architecture appears normal. Ultrastructurally 
the compaction and lamellar order of the myelin sheath may appear abnormal. 
The PNS is unaffected and myelinates normally. In the acute connatal form the 
CNS is severely hypomyelinated (Seitelberger, 1995). 
 
Due to the X-linked mode of inheritance, males are predominantly affected and 
females act, in general, as unaffected carriers. However juvenile (Hodes et al., 
1995) and adult (Hodes et al., 1997) PMD has also been observed in females. Due 
to random X-inactivation in females, female carriers are chimeric at the PLP1 
locus. Most females do not develop clinical disease despite 50% of 
oligodendrocytes potentially being affected by the mutation. The observation 
made in jimpy mice, where the genetically altered oligodendrocytes die during 
post natal development (Kagawa et al., 1994) and are replaced by the 
oligodendrocytes expressing the wild type Plp1 gene, may provide an 
explanation. Whether the situation is similar in humans is unknown, but 
assuming so the survival of individual cells most likely depends on the nature of 
the mutation (Koeppen and Robitaille, 2002), since cells harbouring a mild 
mutation are more likely to survive than those with a severe mutation (Edgar et 
al., 2002). 
 
1.5.2.2.1 Genetic basis of PLP1 gene related disorders in man 
 
The first PLP1 gene abnormalities leading to PMD to be identified were point 
mutations (Gencic et al., 1989;Hudson et al., 1989;Trofatter et al., 1989). To 
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date more than 100 point mutations causing PMD have been identified (reviewed 
in Woodward, 2008;Garbern et al., 1999). Recently, PLP1 deletion or loss of 
function (Raskind et al., 1991) and PLP1 gene duplication (Inoue et al., 1999) has 
been linked to PMD (Inoue et al., 1996a). PLP1 gene duplication accounts for 60 – 
70% of PMD cases (Sistermans et al., 1998). Duplication (or occasionally, 
triplication) of the PLP1 gene is probably caused by unequivocal sister chromatid 
exchange during meiosis in the male (Inoue et al., 1999;Mimault et al., 
1999;Yool et al., 2000). 
 
From the disease severity point of view the missense mutations, which result in 
non-conservative amino acid substitution, often cause the most severe form of 
PMD, whereas PLP1 gene duplication in general causes a moderate form and in 
the case of PLP1 gene deletion or loss of function mutations, a mild form of PMD 
(reviewed in Woodward, 2008). The effect of PLP1 gene overexpression or 
deletion further suggests that altered gene regulation plays a role in the PMD 
pathogenesis. In short, gain of function or cytotoxic effects of PLP are believed 
to be largely responsible for early, more severe forms with dysmyelination, 
whereas loss of function is seen in relation with the later milder forms, where 
mainly CNS and PNS demyelination is observed (reviewed in Woodward, 2008). 
 
Presumptive diagnosis of PMD is made based on clinical signs and white matter 
changes detected on MRI. Final diagnosis can often be achieved with specific 
genetic tests. Since most of the cases are caused by PLP1 gene overexpression, 
interface fluorescence in situ hybridisation (FISH) technique (Woodward et al., 
1998) is the first choice to apply on suspected PMD cases. If FISH turns out to be 
normal, PLP1 gene sequencing is used to identify mutations (reviewed in 
(Woodward, 2008). However in about 20% of all suspected PMD cases no 
abnormalities are detected, which suggests that either changes in regulatory 
sequences or other loci can cause PMD (reviewed in Woodward, 2008). 
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1.5.2.3 Plp1 gene related disease in animals 
 
1.5.2.3.1 Plp1 gene mutation in animals 
 
Plp1 gene mutations has been described in various species such as the mouse 
(Plpjp (Nave et al., 1987a), Plpjp-4 (Pearsall et al., 1997), Plpjp-msd (Gencic and 
Hudson, 1990), Plpjp-rsh (Schneider et al., 1992)), the rat (Plpmd (Boison and 
Stoffel, 1989;Duncan et al., 1987)), the dog (Plpsh Nadon et al., 1990) and the 
rabbit (Plppt (Tosic et al., 1994), Table 1). 
 
The jimpy mouse harbours a point mutation in intron 4 of the Plp1 gene leading 
to aberrant RNA processing by disrupting the 3’ acceptor splice site, which leads 
to a deletion of exon 5. This produces a truncated protein with a novel cysteine 
rich carboxy terminus (Nave et al., 1987a). The other mutants harbour Plp1 gene 
point mutations, which lead to amino acid substitutions.  
 
Most of these mutants develop a severe hypomyelination of the CNS, often 
accompanied by a loss of oligodendrocytes, microglial proliferation (Vela et al., 
1996) and astrocytic hypertrophy (Billings-Gagliardi et al., 1995;Harsan et al., 
2007). Clinically, the affected animals develop tremors, ataxia and seizures and 
in general die prematurely (Thomson et al., 1997). However, rumpshaker mice 
show a mild phenotype with a normal life span (Griffiths et al., 1990;Thomson et 
al., 1997;Edgar et al., 2004a). Nevertheless, the clinical course depends on the 
genetic background of the mouse (Al-Saktawi et al., 2003). 
 
Although profoundly hypomyelinated, some axons still contain a myelin sheath. 
The ultrastructure of these myelin sheaths in mutants is often abnormal, 
apparent as thin and loosely compacted sheaths. In the md rat for example, the 
intraperiod line becomes condensed, which leads to a measurable reduction in 
the periodicity from 11 nm in the wild type to 9 nm in the md rat (Duncan et al., 
1987). 
 
The reason for the hypomyelination in the jimpy mouse, the msd mouse or the 
md rat is considered to be the result of an increased apoptosis of mature 
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oligodendrocytes, although the numbers of immature oligodendrocytes is normal 
(Gow et al., 1998;Nadon and Duncan, 1995;Skoff, 1995;Cerghet et al., 2001). 
The situation in the shaking pup dog appears to be different, where the 
oligodendrocytes remain immature and fail to myelinate (Nadon and Duncan, 
1996). 
 
Different studies have focused on the intracellular effects of abnormal Plp1 gene 
function due to point mutations (Gow et al., 1998;Southwood et al., 
2002;McLaughlin et al., 2007; reviewed in Woodward, 2008). In the variants 
caused by missense mutations of the Plp1 mouse/rat gene the mutant PLP 
appears to accumulate in rough endoplasmatic reticulum and Golgi vesicles 
causing endoplasmic reticulum stress, which activates the unfolded protein 
response (UPR) and eventually leads to oligodendrocytic death (Cerghet et al., 
2001; reviewed in Woodward, 2008). Mutated PLP protein appears to be poorly 
tolerated by the oligodendrocyte and apoptosis appears to be the main 
mechanism preventing the synthesis of a potentially abnormal myelin sheath. 
 
1.5.2.3.2 Transgenic animals  
 
1.5.2.3.3  Plp1 gene deletion, null alleles and knock out models 
 
In models with Plp1 gene deletion or loss of function, myelin development 
initially appears normal. However, with age a progressive axonopathy develops. 
The late onset of axonal degeneration is believed to be caused by disrupted 
axonal glial interaction resulting from a lack of PLP/DM20 (Griffiths et al., 
1998;Yool, 2000). 
 
These observations further highlight the multifaceted effects of Plp1 gene 
mutations and that PLP does not only play a structural role in myelin sheath, but 
is also involved in axono-glial interactions and oligodendrocyte-mediated axonal 
support. 
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1.5.2.3.4 Plp1 gene overexpressing animals 
 
PLP1 gene duplication is considered to be the major cause of PMD (Sistermans et 
al., 1998) and is characterised by a dysmyelination of the CNS (Seitelberger, 
1995). So far, no spontaneous model with Plp1 gene overexpression has been 
described. There are three transgenic engineered mouse models overexpressing 
the entire Plp1 gene, the 4e (Kagawa et al., 1994) the #66 and the #72 
(Readhead et al., 1994) mouse model, each with different numbers of extra 
copies of the Plp1 gene (Table 1). The extra copies, including all the exonic 
sequences linked to 5’ and 3’ gene flanking sequences of the murine Plp1 gene, 
were inserted by pronuclear microinjection and randomly integrated into the 
genome (Readhead et al., 1994;Kagawa et al., 1994). The 4e contain 2 (Kagawa 
et al., 1994), the #72 contain 3 (Readhead et al., 1994) and the #66 contain 7 
extra Plp1 gene copies (Readhead et al., 1994) per haploid genome. All three 
homozygote models develop hypomyelination with associated tremors and 
seizures (Inoue et al., 1996b;Readhead et al., 1994;Anderson et al., 
1999;Kagawa et al., 1994). However the severity of the phenotype is markedly 
different; the homozygous 4e and #66 develop early clinical signs and die around 
60 days of age whereas the homozygous #72 shows a slower disease progression 
in which clinical signs appear later and die around 120 days of age. The mRNA 
level in these animal models does not correlate with the number of Plp1 gene 
copies and some of these transgenes are probably less effectively transcribed 
than others (Kagawa et al., 1994;Inoue et al., 1996b;Readhead et al., 1994). 
 
Hemizygotes from all three lines, on the other hand, appear to develop normally 
and produce similar levels of myelin compared to the wild type. With age, a 
progressive demyelination of the CNS becomes apparent in the hemizygotes 
(Inoue et al., 1996b;Anderson et al., 1998;Ma et al., 2006). The demyelination is 
accompanied by axonal changes such as axonal swellings, which are mainly 
present in tracts with small diameter fibres. 
Transgenic animals, which overexpress only Dm20 have also been generated 
(Johnson et al., 1995;Mastronardi et al., 1993). These mice also develop a late 
onset demyelination with age and the disease severity is dependent on the level 
of Dm20 overexpression. There appears to be no correlation between the level 
of Dm20 overexpression and DM20 protein levels (Johnson et al., 1995).  
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Line Source 
Structural gene 
unit 
Haploid copy 
number 
Reference 
#66 Mouse 7 exons / 6 introns 7 
(Readhead et al., 
1994) 
#72 Mouse 7 exons / 6 introns 3 
(Readhead et al., 
1994) 
4e Mouse 7 exons / 6 introns 3 
(Kagawa et al., 
1994) 
PlpTg1 Human Plp – cDNA 30 
(Nadon et al., 
1994) 
Dm20Tg2 Human Dm20 – cDNA ? 
(Nadon et al., 
1994) 
ND3a Human Dm20 – cDNA 17 
(Mastronardi et al., 
1993) 
ND4 Human Dm20 – cDNA 70 
(Johnson et al., 
1995) 
 
Table 1. Transgenic animals overexpressing Plp genomic transgenes and 
human cDNA transgenes (Yool, 2000). 
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1.5.2.3.5 Pathogenesis in Plp1 gene overexpression  
 
The situation in Plp1 overexpressing mouse models is different to that in the 
point mutations. With low Plp1 gene copy numbers, relatively normal 
myelination takes place during post natal development and the formed myelin 
appears ultra-structurally normal. However with increasing numbers of copies of 
the Plp1 gene, the CNS pathology becomes more severe, with marked 
dysmyelination occurring during post natal development (Kagawa et al., 
1994;Anderson et al., 1998;Anderson et al., 1999;Readhead et al., 1994). The 
homozygous #72 mouse, which is the subject of this PhD thesis, with 3 extra 
copies of Plp1 gene per haploid, has a relatively mild degree of dysmyelination 
in development that is followed by progressive demyelination, at least in the 
optic nerve (Anderson et al., 1998;Anderson et al., 1999;Edgar et al., 2010;Inoue 
et al., 1996b). The effect on disease severity of Plp1 gene overexpression is not 
only dependent on the numbers of Plp1 gene extra copies but most likely also on 
modifying loci (Inoue et al., 1999). A prominent astrogliosis and microglial 
response have also been described in relation to Plp1 gene overexpression (Ma et 
al., 2006;Tatar et al., 2010) and has been suggested to contribute to the 
progression and severity of the demyelination process (Ip et al., 2007;Ip et al., 
2006). 
 
1.5.2.3.6 Biochemical changes related to Plp1 gene overexpression 
 
 A study investigating the biochemical effect of Plp1 gene overexpression in cell 
lines has shown substantial disruption in myelin protein transport and 
distribution (Simons et al., 2002). The overexpression of Plp1 leads to 
accumulation of PLP and cholesterol in late endosomes and lysosomes (Simons et 
al., 2002). In PLP overexpressing cells, sphingolipids become missorted from 
their normal location in the Golgi apparatus (Simons et al., 2002).  
 
Using spinal cord and brain from a Plp1 gene overexpressing mouse model (line 
#66), Karim et al. showed that PLP/DM20 accumulates in the cell body and is 
reduced in myelin (Karim et al., 2007). This study also reported that the 
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overexpression of the Plp1 gene significantly reduced MBP steady state levels in 
myelin, emphasizing that overexpression of the Plp1 gene causes an imbalance 
in the assembly of myelin components (Karim et al., 2007). Further in vitro and 
in vivo investigation of oligodendrocytes from homozygous #66 and #72 mice 
confirmed the perturbed trafficking and assembly of PLP/DM20 into myelin and 
lipid rafts. Ultra structural investigation showed an increase of autophagosomes, 
which are thought to function as a storage vehicle for over synthesised 
PLP/DM20, in oligodendrocytes. The severity of the ultra-structural changes in 
the oligodendrocyte cell body was gene dose dependent (Karim et al, 2010).  
 
The biochemical changes in myelin in the Plp1 gene overexpressing mouse 
models are believed to result in disturbed myelin formation, leading to 
perturbation of myelin and oligodendrocyte development (Readhead et al., 
1994;Kagawa et al., 1994;Inoue et al., 1996; Simons et al., 2002:Karim et al., 
2007, Karim et al, 2010). The different biochemical and morphological changes 
that are evident suggest that disruption of normal protein distribution leads to 
impaired cell function and results in abnormal morphological development. 
 
1.5.3 Demyelination in Plp1 overexpressing mice 
 
Plp1 overexpression has an adverse effect on normal myelin maintenance, which 
over time leads to instability of the myelin sheath, progressive demyelination, 
an inflammatory response and axonal changes (Inoue et al., 1996b;Kagawa et 
al., 1994;Anderson et al., 1999;Edgar et al., 2010;Readhead et al., 1994). The 
findings of some studies using transgenic models with a low number of Plp1 gene 
extra copies or just overexpression of Dm20 gene, suggest that these mouse 
models may mimic chronic MS demyelinated lesions and might provide new 
insights into the development of remyelination failure (Ma et al., 
2006;Mastronardi et al., 1993). So far no detailed description of the temporal 
and spatial pathological development and progressive demyelination in Plp1 
gene overexpressing mouse models has been published, except in the optic nerve 
(Edgar et al., 2010), although other studies have shown that the spinal cord is 
demyelinated in older mice (Inoue et al., 1996b;Kagawa et al., 1994;Anderson et 
al., 1998;Readhead et al., 1994). The spontaneous demyelination and the 
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development of chronic demyelinated regions are of high interest. Major 
intracranial white matter tract, such as the corpus callosum, have been shown 
to have reduced myelin content in the adult #72 mouse (Ruest et al., 2011) and 
hemizygote 4e model (Ma et al., 2006), but the development of the pathological 
process in these two models has not been described to date. Considering the 
myelin phenotype in these animals, the relative clinical normality of the #72 
mice up to 90 days is remarkable. After 90 days the mice show a subtle tremor 
and generalised mild ataxia with seizures, which eventually leads to premature 
death. The relatively late development of clinical deficits suggests that post 
natal development is largely normal but is followed by apparently progressive 
clinical signs, suspicious of a progressive demyelination, presumably without 
repair. 
 
1.6 Use of MRI in diagnosing white matter changes 
 
One of the difficulties in monitoring the progression of white matter lesions in 
vivo (including the effect of any intervening therapy) has been visualising the 
CNS. In the past the full distribution and extent of the pathology was only 
evident at the point of necropsy. With the advent of advanced imaging 
modalities including magnetic resonance imaging (MRI), the diagnosis and 
monitoring of white matter lesions in vivo has become possible. In the case of 
multiple sclerosis, MRI has resulted in improved accuracy of diagnosis, 
localisation and monitoring of the course of white matter pathology (Ciumas et 
al., 2008;Fox, 2008). Repeated MRI allows mapping of lesion distribution and 
provides the ability to compare temporal changes in lesion size and location. 
One major disadvantage of conventional MRI sequences in the characterisation 
of white matter pathology is the inability to distinguish between different 
pathological changes, in particular between areas of acute active inflammation 
with ongoing demyelination and inactive, chronically demyelinated areas (Fox, 
2008;Inglese et al., 2005b;Inglese et al., 2005a). A modality capable of 
distinguishing these two different stages of white matter pathology would have a 
major impact on monitoring disease development, treatment regime and 
accurate prognosis for the affected patient and would also allow better 
monitoring of experimental models of demyelination. 
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Advanced MRI techniques such as magnetisation transfer imaging (MTI), magnetic 
resonance spectroscopy (MRS) and diffusion weighted MRI (DW MRI) are being 
used to detect pathological changes in relation to the myelin sheath (reviewed 
in Zivadinov and Cox, 2007). The most commonly used technique in clinical 
settings is MTI, which is based on the interaction between unbound free protons 
in water and protein bound molecules (reviewed in Horsfield, 2005). MTI has 
proven useful in evaluating lesion type in MS and EAE and correlations have been 
found with regard to lesion development (reviewed in Horsfield, 2005;Zivadinov 
and Cox, 2007). However, not only myelin, but also inflammation, is responsible 
for protein-proton interaction and the value of MTI in distinguishing inflamed 
from non-inflamed demyelinating lesions is therefore still speculative. 
 
Magnetic resonance spectroscopy has mainly been used in neurodegenerative 
disorders (reviewed in Zivadinov and Cox, 2007). MRS in MS has not yet been 
used extensively, but it has been demonstrated that inflammation correlates 
with increased choline, lactate and lipid peaks, whereas axonal damage 
correlates with an increased N-acteylaspartate (NAA) peak. MRS is considered to 
be helpful in detecting axonal damage and could become valuable in specifically 
detecting progressive axonal degeneration (reviewed in Zivadinov and Cox, 
2007).  
 
The DW MRI technique utilises the movement of molecular water within the 
tissue. The motion of water molecules is caused by the natural phenomenon of 
random thermal motion of molecules, also referred to as Brownian motion 
(reviewed in Mori and Zhang, 2006;Zivadinov and Cox, 2007). In pure water, the 
water molecules can move around freely. Water molecules in tissue, however, 
are restricted in movement, with this restriction depending on the composition 
of the surrounding tissue. Cell type, cell number, cell integrity and extracellular 
composition all contribute to the water diffusivity. White matter is a complex 
network composed of axons, myelin sheaths and the associated supporting cell 
populations of oligodendrocytes, astrocytes, microglia, trafficking immune cells 
and OPCs. All these cells could potentially influence the Brownian motion of 
water molecules. In normal tissue axons have the most pronounced effect on 
water diffusivity (Basser and Pierpaoli, 1996;Beaulieu and Allen, 1994;Beaulieu, 
2009;Zivadinov and Cox, 2007), but myelin and, in all probability, the density of 
49 
the supporting cell population also contribute substantially to the direction of 
water diffusivity. Since axons in specific tracts are arranged in a parallel 
fashion, DTI becomes useful for fibre tract examination and tracking. In these 
white matter tracts, the parallel nature of the nerve fibres leads to a net 
movement of water molecules parallel to the axonal alignment and this can be 
detected and measured by DTI sequences (Alexander et al., 2007). The high 
sensitivity of the sequence for water molecule diffusion may also be used to 
identify pathological states of white matter or pathological process interfering 
with the normal course of water diffusion along axons (Laule et al., 2007). 
However, distinguishing between chronic demyelination and active inflammation 
with ongoing demyelination has not been fully elucidated. 
 
1.6.1 The homozygote #72 optic nerve as a model to evaluate the 
ability of MRI techniques to detect specific white matter 
pathological states 
 
Ideally a mouse model in which an inflamed demyelinated and a chronic non-
inflamed “silent” demyelination exists simultaneously along one major white 
matter tract would be used to evaluate the sensitivity of novel MRI techniques to 
detect different white matter lesion types. The adult #72 homozygote optic 
nerve, with spatially distinct regions of active and complete demyelination 
(Edgar et al., 2010), is as an ideal model to evaluate MTI, MRS or DW MRI. 
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1.7 Aim of the thesis 
 
The study aims are 
 
1.) To describe the temporal histological changes in white matter elements in 
the corpus callosum in the #72 mouse model in order to understand the 
nature and progression of the pathology that leads to profound 
hypomyelination in this model. 
 
2.) To evaluate changes in OPC intrinsic and extrinsic factors in relation to 
the reduced myelin content using in vivo and in vitro strategies. 
 
3.) To use the optic nerve of the #72 mouse model of PMD to test if DW MRI 
techniques can distinguish between specific white matter lesion types. 
 
The results of these three chapters will be critically assessed and future 
areas, where the findings can be integrated and which could induce new 
work, will be discussed in the final discussion of the thesis. 
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2 Material and Methods 
 
2.1 Miscellaneous 
 
All experiments were carried out according to the guidelines laid out in the 
Animals Scientific Procedures Act under a project license from the UK Home 
Office, and were approved by the local Ethics and Welfare review panel of the 
Faculty of Veterinary Medicine, University of Glasgow. 
 
Inorganic chemicals were of molecular biology grade and were sourced from 
Sigma or VWR. Solutions were sterilised as appropriate. Bulk solutions were 
autoclaved using a stovetop steam autoclave (Prestige classic steam autoclave 
2100, Prestige Medical UK). Small volumes and fluids that could not be 
autoclaved were either filter sterilised through a 0.2µm filter (Minisart Plus 
filter, Sigma Aldrich 17823K) in a sterile laminar flow hood (Biogen) or UV 
sterilised, where each sample was placed in a UV steriliser for twelve minutes. 
Gloves, eye protection and protective clothing were worn when appropriate. 
Fixatives, volatile liquids and toxic powders were prepared in a specifically 
designated fume cupboard. 
 
Details of the preparation of fixatives, stains, buffers, staining and processing 
protocols can be found in the Appendix and are cross referenced by page number 
in this section. 
 
2.2 Mouse breeding 
 
2.2.1 Animal breeding facilities 
 
Mice were bred in designated animal breeding facilities, Biological Services, 
Faculty of Veterinary Medicine, University of Glasgow. Picorna virus and murine 
hepatitis virus infections have occurred in the past within the unit and both are 
known to be associated with neurological disease in mice (Fujiwara, 1994;Lipton 
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et al., 1994). During the period of the study, there was no evidence of clinical 
disease. The wild type mice did not show the phenotype and pathology seen in 
the transgenic mice. 
 
2.2.2 Transgenic mouse lines 
 
2.2.2.1 The Plp1 transgenic overexpressing #72 transgenic mouse line 
 
72 transgenic mice were generated by (Readhead et al., 1994). A rat Plp1 cDNA 
probe was used to isolate the murine Plp1 gene from a cosmid library. The 
isolated murine Plp1 gene was used to generate a purified 26.6 kb Cla1 fragment 
that contains the transgene construct including 3.5 kb of the PLP 5’ regulatory 
region and a transgene unique T7 promoter at the PLP 3’ region. To generate 
transgenic mice, pronuclear microinjection into BDF2-fertilized ova of the 
transgene cassette was performed. Two transgenic lines were produced 
containing intact Plp1 transgenes, the 66 and the 72 line. These two lines 
were assessed by southern blotting, estimating seven copies in the 66 line and 
three copies in the 72 line per haploid genome. The transgene cosegregated in 
subsequent generations in an autosomal inheritance pattern suggestive of 
tandem integration at autosomal sites (Readhead et al., 1994). In our study we 
only used the 72 line on a C57BL/6N (Charles River) background, containing 6 
extra copies of the Plp1 gene in the homozygote mouse (Figure 3). 
 
2.2.2.2 The Plp1 transgenic and cyan fluorescing protein (Thy-1 CFP) 
expressing mouse line 
 
Mice expressing cyan fluorescence protein (CFP) under the Thy1 reporter gene 
(B6.Cg-Tg(Thy1-CFP)23Jrs ⁄J) produced by (Feng et al., 2000) were introduced 
into the Plp1 transgenic 72 mouse line on a C57BL/6N background and bred for 
more than six generations. In the CNS, Thy1 is mainly expressed in neurons. The 
CFP gene has been inserted into the Thy1.2 gene excluding part of exon 2 and 4, 
completely excluding exon 3 and the flanking introns of exon 3 (Caroni, 
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1997;Feng et al., 2000). The product was introduced by pronuclear 
microinjection into fertilised oocytes obtained from mating C57BL/6J with CBA 
hybrids (Feng et al., 2000). Although Thy1 is expressed in most neurons (Kollias 
et al., 1987;Vidal et al., 1990), it has been observed that in the transgenic Thy1 
CFP mice generated by Feng et al., the CFP expression is limited to a certain 
subset of neuronal cells. About 25 different founder lines have been described so 
far (Feng et al., 2000). The reason for the variable expression pattern in the 
different lines is not clear but is thought to most likely be due to genetic, 
epigenetic and stochastic components on transgene expression in relation to the 
insertion site of the CFP transgene copies (Feng et al., 2000). However, the CFP 
expression from a specific line does not vary in the following generations (Feng 
et al., 2000). In our Thy 1-CFP expressing mouse line, only a subset of motor and 
sensory neurons express CFP. Therefore not all axons in the corpus callosum 
express CFP. CFP is located unbound in the cytoplasm and is distributed in 
neuronal cell bodies, axons and dendrites (Feng et al., 2000). The fluroescing 
protein tends to accumulate in axonal swellings, which are early changes in 
axonal pathology. Therefore, CFP expressed in axons can be used as a sensitive 
marker for early axonal changes. 
 
The newly created mouse line carries the Plp1 transgene and the Thy1-CFP 
transgene (CFP+/Plp1+). Only CFP positive male mice were used in the current 
study. The group of neurons expressing CFP can be readily detected under 
epifluorescence microscopy without further processing. Due to the fluorescence 
microscope filters used in the Olympus IX-70, CFP appears green instead of blue. 
To increase the probability of producing homozygous Plp1 overexpressing and 
CFP positive samples for transplantation studies the CFP+/Plp1+ line was mated 
with a homozygote #72 mouse (Figure 4). 
 
2.2.2.3 The green fluorescent protein (β-actin GFP) expressing mouse line 
 
The GFP expressing mouse line containing the reporter gene GFP, was generated 
by (Ikawa et al., 1995). The GFP transgene was linked to the chicken β-actin 
promoter possessing a cytomegaly virus enhancer (Ikawa et al., 1995). The GFP 
construct was introduced by microinjection into male pronuclei of B6C3F1 
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fertilized oocytes. The resulting offspring expressed GFP under a β-actin 
promoter. In the cell, GFP is located unbound in the cytoplasm  (Ikawa et al., 
1995) and is detected under UV light without additional processing. In vivo GFP 
positive pups can be detected easily by exposing them to ultraviolet (UV) light, 
where the pups display green fluorescence (Figure 4).  
 
2.2.2.4 The Plp1-LacZ fusion protein transgenic mouse line 
 
Mice harbouring a Plp1-LacZ fusion gene were generated by (Wight et al., 1993). 
The Plp1-LacZ transgene contains the proximal 2.4 kb of 5’-flanking Plp DNA, 
exon1, intron 1 and the first 37bp of exon 2 ligated to a trpS-LacZ fusion gene 
and SV-40 polyadenylation signal. The transgene was introduced by pronuclear 
microinjection into BDF2 fertilised mouse oocytes (Wight et al., 1993). The 
resulting transgene product is a protein where β-galactosidase is fused to 13 
amino acids from the NH2-terminal of PLP and is only expressed when PLP 
expression occurs. The fusion of β-galactosidase with the thirteen amino acids 
from the NH2-terminal of PLP is sufficient for the transgene product to be 
integrated into the myelin sheath (Wight et al., 1993) and is a marker of myelin 
sheaths (Figure 5). 
2.2.3 Maintenance of transgenic lines of mice 
 
The Plp1 overexpressing #72, Thy-1 CFP/Plp1, β-actin GFP and Plp1- LacZ lines 
of transgenic mice were maintained by creating colonies of transgene positive 
animals with a C57BL/6N background. 
 
2.2.3.1 Maintenance of the #72 mouse line 
 
For the histopathological evaluation of the #72 corpus callosum and the MRI 
study, non-litter mate 72 hemizygote mice on a C57BL/6N (Charles River) 
background were bred to generate homozygote, hemizygote and wild type 
offspring. Only homozygote and wild type mice were used for the experiments.  
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For the cell intrinsic and cell extrinsic pathway evaluation experiments, cell 
culture experiment and the transplant study, homozygote Plp1 gene 
overexpressing #72 males were mated with homozygote Plp1 gene 
overexpressing #72 females to generate homozygote samples and wild type 
males were mated with wild type females to generate wild type samples.  
 
To identify homozygote #72 mice at an early stage (P30) to establish the specific 
homozygote #72 lineage, genotyping using quantitative real time PCR to 
ascertain gene copy number and therefore identification of homozygote animals 
was outsourced to Embark Scientific. To confirm that the line contained the Plp1 
transgene, amplification by PCR was performed as described below. At regular 
intervals, breeding mice from this line were killed by a schedule 1 method and 
the optic nerves were dissected and examined to confirm that the line was 
homozygous for the transgene. The optic nerve of homozygous mice appears 
relatively transparent compared to the nerve of wild type or hemizygous mice 
 
2.2.3.2 Maintenance of the CFP+/Plp1+ mouse line  
 
For histopathological evaluation of the axons in the #72 mouse during 
demyelination and after transplantation of neurospheres, the CFP Thy-1 mice 
were crossed with transgene positive 72 mice with a CL57BL/6N background 
(Charles River) for at least six generations. The newly created mouse line was a 
carrier of the Plp1 transgene and the Thy1-CFP transgene (CFP+/Plp1+). For the 
transplant study, the CFP+/Plp1+ line was always mated with a known 
homozygote #72 mouse in order to increase the probability of producing 
homozygote Plp1 overexpressing and CFP fluorescing samples. Only CFP and Plp1 
transgene positive male mice were used for this specific study. 
2.2.3.3 Maintenance of the GFP expressing mouse line 
 
For generation of a GFP expressing mouse line, a male mouse expressing the 
reporter gene GFP was crossed with a wild type female from the #72 line with a 
C57BL/6N (Charles River) background. For generation of GFP expressing 
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neurospheres and GFP expressing OPCs only GFP+ #72 wild type male pups were 
used. 
 
2.2.3.4 Maintenance of the LacZ expressing mouse line 
 
In order to generate neurospheres, expressing β-galactosidase under the Plp1 
promoter, P1 pups from -homozygous Plp1-LacZ mice on a C57BL/6 background 
were used. 
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Figure 3. Schematic representation of the Plp1 #72 transgene. 
a) Genomic organization of the transgene construct. The Plp1 exons are depicted as numbered 
cylinders, dark grey regions represent the coding regions. The transgene specific T7 promoter is 
shown as a green cylinder  
b) Endogenous Plp1 allele of a wild type mouse lacking the transgene specific T7 promoter. The 
Plp primer (red arrow) binds to the Plp1 gene. However as the T7 promoter is absent, the 
reverse T7 primer cannot bind to the DNA, accordingly no PCR product can be amplified.  
c) The 3/ end of Plp1 transgene with the T7 promoter. The Plp1 primer (red arrow) and the T7 
primer (green arrow) will generate a PCR product of approximately 400bp readily detectable by 
ethidium bromide gel electrophoresis (modified from Yool, 2000). 
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Figure 4. Schematic representation of CFP and GFP transgene constructs. 
a) Schematic representation of CFP Thy1 transgene. Exons are numbered and are coloured in 
dark grey and the CFP gene in turquoise. The CFP gene was inserted into the Thy1.2 gene as a 
construct comprising part of exon 2 and full length exon 4 (Caroni, 1997;Feng et al., 2000).  
b) Schematic representation of GFP β-actin transgene. Expression of the GFP β-actin transgene is 
driven by a combination of two regulatory elements comprising a cytomegaly virus (CMV-IE, light 
grey cylinder) enhancer and a chicken – β- actin promoter (dark cylinder).  A rabbit β-globin 
polyadenylation signal (dark grey) is inserted in the 3/ end of the GFP transgene (Ikawa et al., 
1995).     
 
 
Figure 5. Schematic representation of the LacZ transgene construct. 
The construct contains exon 1, intron 1 and the first 37bp of exon 2 followed by the LacZ gene 
linked to a SV40 polyadenylation signal (Wight et al., 1993). Coding regions are in dark grey, 
LacZ transgene in blue and the SV40 polyA signal in green (modified from Yool, 2000). 
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2.3 Isolation of nucleic acid 
 
2.3.1 Tissue biopsy procedure 
 
Ear biopsies for DNA extraction were taken using an ear punch, transferred into 
an Eppendorf tube and stored at -20ºC. In the case of CFP expressing animals, 
fresh ear biopsies were used for CFP evaluation. Tissue from tail biopsies were 
place in an Eppendorf tube, stored at -20ºC and later used for DNA extraction. 
The ear biopsies were performed in a systematic manner so that the location of 
the ear punch was also used for animal identification (Figure 5). 
 
2.3.2 Extraction of genomic DNA from tissue 
 
DNA was extracted from ear or tail biopsies using 100µl of 50mM sodium 
hydroxide (Fisher, 1310-73-2). The tissue was lysed on PHC-3 thermal cycler 
(Techne) for 90 minutes at 95ºC, then cooled to 4ºC and neutralised using 10µl 
Tris buffer, pH 5.0 per sample (Truett et al., 2000).  
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2.4 PCR Genotyping 
 
2.4.1 PCR core programme 
 
Amplifications for genotyping were performed on a Perkin Elmer DNA thermal 
cycler 
 
1) Initial cycle  denaturing temperature  94ºC  3min 
annealing temperature  58ºC  1min 
extension temperature  72ºC  2min 
 
2) Step cycle  denaturing temperature  93ºC  40sec  
(35 cycles)  annealing temperature  58ºC  1min 
extension temperature  72ºC  30sec 
 
3) Final cycle  denaturing temperature  93ºC  40sec  
   annealing temperature  58ºC  1min 
extension temperature  72ºC  2min 
 
2.4.2 Genomic PCR 
 
All plastic ware was UV treated prior to use and the work surface was wiped 
with 70% ethanol. A commercially available polymerase chain reaction assay 
(RedTaq, Sigma, R2523) was used to amplify the transgene specific product in 
the 72 mouse. 25 µl PCR reactions were carried out in 0.1 ml PCR tubes 
containing 12.5 µl RedTaq with MgCl2, 0.5 µl Plp1 primer (concentration:300nM 
in sterile  pure H2O), 0.5 µl T7 primer (concentration:300nM in sterile  pure 
H2O), 10.5 µl sterile pure H2O and 1 µl of lysed tissue solution. The transgene 
specific marker, the T7 promoter, is attached at the 3’ end of the transgenic 
cassette.  The T7 primer (αT7 5’ GCA-TAA-TAC-GAC-TCA-CTA-TAG-GGA-TC 3’) 
recognising the T7 promoter region and the Plp1 primer (PLP 5’ CAG-GTG-TTG-
AGT-CTG-ATC-TAC-ACA-AG 3’) recognising a specific region at the 5’ end of the 
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murine Plp1-gene produce a PCR product of approximately 400bp from the 
transgene (Readhead, 1994).  
 
2.4.3 DNA electrophoresis 
 
Routine analysis of PCR products was performed on a 2% agarose gel in tris 
acetate ethylene-di-amine-tetra-acetate (TAE) buffer. Gels were made from 
ultra-pure, electrophoresis grade agarose (Invitrogen, 15510-027) dissolved by 
heating in 1x TAE buffer. Ethidium bromide (from a stock of 5mg/ml) was added 
to the cooling gel to give a final concentration of 0.5µg/ml. 10µl of the PCR 
product was loaded in each well. A one kb DNA ladder (Invitrogen, 15615-016) 
was used as a control for the PCR product size. In each gel a positive, a negative 
and a H2O control sample were run. PCR products were run for 25 minutes at 70 
volt.  The PCR product of approximately 400bp was visible under UV light (Figure 
6). The test was qualitative and only detected the presence or absence of the 
Plp1-transgene. Gels were viewed with an ultraviolet trans illuminator (Fotoprep 
I, Fotodyne Inc.). Gels were recorded using a digital Camera (Kaiser RA1 CCD) 
and a video graphic thermal printer (Sony UP-890CE). For colour photographs a 
Canon G4 Powershot digital camera was used and the images were stored 
digitally (Figure 6). 
 
2.4.4 Identification of CFP expression in Thy-1 CFP mice 
 
CFP positive mice were identified by evaluation of fresh ear biopsies under 
fluorescence microscopy (Olympus IX70). The filter available was a FITC filter, 
which excites at 450nm and makes the CFP appear green. Samples containing 
green fluorescing axons in the pinna were regarded as a positive. Questionable 
and non-fluorescing tissue was regarded as negative (Figure 7). 
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2.4.5 Identification of GFP expression in β-actin GFP mice 
 
GFP positive mice were identified by exposing the new born litter to a handheld 
UV lamp in a dark room. GFP positive pups could readily be identified by green 
fluorescence of their skin. 
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Figure 6. Representative image of a gel after electrophoresis with twelve 
PCR products, each from an individual mouse ear sample.  
A 1 kb DNA ladder (asterisk) was used to confirm the correct size of the PCR product (400bp). 
One positive sample (+), one negative sample (-) and a water sample (H2O), were used as 
controls.  Lanes 1-7 and 8-12 contain test samples. Transgene positive samples are identified by 
the presence of a fluorescent band at the level around 400bp. Transgene negative samples have 
complete absence of a band. 
  
64 
 
 
 
Figure 7. Identification of CFP expression was made on fresh ear biopsies. 
Image of a pinna from a CFP expressing mouse as seen under epifluorescent microscopy (Olympus 
IX-70, x10). The axons in the pinna of a CFP expressing mouse are visible as green fine lines 
running across the pinna (arrows). 
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2.5 Experimental procedures 
 
2.5.1 Intraperitoneal injection of 5-bromo-2-deoxyuridine (BrdU) as a 
marker for cell proliferation 
 
To evaluate cell proliferation a single intraperitoneal injection of 50µg/gram 
body weight 5-bromo-2-deoxyuridine (BrdU) (Sigma, B5002) was performed one 
hour prior to euthanasia. 
 
2.5.2 Cell culture 
 
2.5.2.1 Isolation of adult OPCs from corpus callosum for culture 
 
For each OPC co-culture experiment, OPCs were isolated from two adult wild 
type GFP expressing corpus callosa and from two adult #72 homozygote corpus 
callosa. The isolated wild type OPCs were mixed with the isolated homozygote 
#72 OPCs at the same density immediately before plating down on poly-L-lysine 
coated glass coverslips. 
 
To isolate adult OPCs, P120 homozygote #72 and wild type GFP expressing mice 
were killed using CO2. Decapitation and collection of the head into a sterile Petri 
dish was performed after spraying the head with 70% ethanol. Using sterile 
instruments, the brain was removed from the skull cavity and placed into a 
sterile Petri dish containing 500µl of cold Leibovitz’s L15 with L-glutamine and 
without phenol red (L15, Gibco, 21083-027). The meninges were carefully 
removed before isolating the corpus callosum from each brain. Two dissected 
corpus callosa where placed on a sterile Petri dish and cut into 1mm3 pieces. The 
cut tissue was transferred into a small sterile bijou filled with 3ml HBSS (Sigma, 
H-4891) solution containing 0.125% trypsin (Sigma, T-3924). 30µl of DNAse 
(50mg/ml, Sigma, DN25-100mg) was finally added to 3ml of HBSS/Trypsin 
solution and incubated for 90 minutes in 5% CO2 at 37°C 
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After 90 minutes the tissue digestion was stopped by adding 100µl of heat 
inactivated foetal bovine serum (HIFBS) (Invitrogen, 10082147) per 1ml solution. 
The cell emulsion was then transferred into a 15ml tube using a curved, flame 
polished glass pipette and filled with L15 containing 10% HIFBS and centrifuged 
at 1000 rpm for 10 minutes at room temperature. The supernatant was removed 
and the remaining pellet was resuspended in 2ml of L15 containing 10% HIFBS 
and triturated at least 6 times or until no tissue chunks were visible through a 
flame polished, bent glass pipette on ice. 
 
After trituration, the cell suspension was diluted to a total volume of 6.5ml using 
L15 containing 10% HIFBS in which 65µl of DNAse (50mg/ml) was added. A 90% 
Percoll® (Sigma, 4937) solution was obtained by adding an appropriate volume 
of 10x Dulbecco’s phosphate buffered saline (Gibco, 14200-067) to Percoll®.  
3ml of the 90% Percoll® solution was added to the cell suspension and gently 
mixed. The solution was then transferred into an Oakridge tube and centrifuged 
at 30000g at 4°C for 30 minutes. After the centrifugation the myelin layer sitting 
on top of the gradient and some of the Percoll® gradient were removed until 
approximately 1 – 1.5cm above the red blood cell layer. The OPCs were then 
harvested immediately above the red blood cell layer. The OPC suspension was 
then diluted in a minimum of 5ml of L15 containing 10% HIFBS before 
centrifugation at 1000rpm for 10 minutes at room temperature. The excess fluid 
was removed and the pellet was resuspended in 100µl of L15 containing 10% 
HIFBS. 10µl of the cell suspension was mixed with 10µl trypan blue and placed 
into a haemocytometer for cell counting. Following the cell count the remaining 
suspension was diluted to a concentration of 105 cells/100µl. The high cell count 
was chosen because test runs demonstrated that adult OPCs appeared to have a 
high rate of cell death in vitro. Before plating the OPCs on poly-L-lysine coated 
12mm diameter glass coverslips, Plp1 transgenic and GFP wild type OPCs were 
mixed together in equal numbers for co-culture and plated down at a 
concentration of 105 cells/coverslip. Three coverslips were contained in one 
Petri dish of 3cm diameter. 
 
Purification of P5 old OPCs was performed using the same technique as for the 
purification of adult OPCs. However, since young OPCs can be expected to be 
more robust in relation to the isolation process, less cell death can be expected 
67 
during the in vitro experiment, the number of cells plated down in young 
animals was reduced to 30,000 to 40,000 cells/coverslip.    
 
2.5.2.2 Maintenance of the OPC culture  
 
The OPC cell culture was maintained in 5% CO2 at 37°C for seven days. 
Differentiation medium (7.5 Media for cell culture) was used to feed the cells 
during the experiment. Every second day, 480µl of media was removed from the 
Petri dish containing the three coverslips and replaced by 520µl of fresh 
differentiation media.  
 
2.5.3 Generation of Plp1 Lac-Z expressing neurospheres and generation 
of β-actin GFP expressing neurospheres 
 
Neurospheres carrying the LacZ reporter gene under the control of Plp1 gene 
promoter (Wight et al., 1993) or the GFP reporter gene under the β-actin 
promoter (Okabe et al., 1997) were generated from LacZ or GFP expressing 
mice. These mice were wild type at the Plp1 locus.  
 
Post-natal day 0 or 1 (P0 and P1) animals were sacrificed using isofluorane. The 
brain was removed from the calvarium and transferred into a Petri dish 
containing neurosphere (NS) medium (7.5 Media for cell culture). The brain was 
cut in half in the sagittal plane. The meninges, the ependymal intraventricular 
layer, brainstem, midbrain and olfactory bulb were removed. The striatum was 
then isolated, transferred into a separate Petri dish containing NS medium and 
cut into small pieces. The tissue was triturated with a bent, flame-polished glass 
pipette using an automatic pipette until a single cell suspension was achieved. 
The single cell suspension was then transferred into a T25 flask containing 5ml of 
NS medium. The cells were triturated twice to achieve even dispersion 
throughout the medium. One microliter of epidermal growth factor (EGF, stock 
concentration 20ng/ml, Gibco, 13247-010) per 5ml NS medium was added to the 
flask and incubated at 37°C in 5% CO2. 
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Every second day, depending on cell growth, 2 - 4ml of medium was removed 
and replaced by 5 – 10ml fresh NS medium. For every 5ml of fresh NS media, 1μl 
(stock concentration 20ng/ml) of EGF was added to the flask. Each week the 
neurospheres were passaged into a new flask. The flask size used during NS 
culture was dependent on cell proliferation, but in general the cell suspension 
was put into a T75 flask after one week in culture, containing a minimum of 
20ml of NS media. Neurospheres were removed for transplantation between the 
second and the fourth passage, depending on the neurosphere density in the 
flask.  
 
2.5.3.1 Preparation of neurosphere for transplantation into homozygote #72 
mice 
 
On the day of transplantation 10 - 20ml of neurosphere medium containing LacZ 
expressing neurospheres and 10 – 20ml of neurosphere medium containing GFP 
expressing neurospheres (the volume was dependent on the actual neurosphere 
density in the flask, based on a required density of approximately 50,000 
cells/ml) were mixed together and centrifuged at 1000r.p.m. for 5 minutes. The 
supernatant was then removed and the cell pellet was resuspended in 1ml 1x 
L15 and placed in an Eppendorf tube. The cell suspension was then triturated 
with a flame polished glass pipette until no cell clusters were visible to the 
naked eye. 
 
At this stage 10µl of cell suspension was removed and mixed with 10µl trypan 
blue to evaluate the viability of the cells and perform an approximate cell 
count. The remaining cell suspension was centrifuged at 1000r.p.m. for five 
minutes, the supernatant removed and finally resuspended in 20 – 30µl ice cold 
L15, forming a visible, dense neurosphere cell mass, which corresponded to at 
least 50000 cells/µl. The Eppendorf tube containing the cell suspension was then 
stored on ice until immediately before intraparenchymal injection.  
 
To evaluate the viability and potency of the neurospheres, neurospheres that 
were surplus to requirements following transplantation where diluted in plating  
medium at the end of the transplantation procedure, plated down on poly-l-
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lysine covered coverslips and cultured for three days in the differentiation media 
used for oligodendrocyte precursor cell culture.    
 
2.5.4 Identification of stereotactic coordinates for corpus callosum cell 
transplantation 
 
Two areas of the corpus callosum were selected for transplantation based on the 
results from the histopathological study of the homozygote #72 corpus callosum. 
The areas of interest chosen were 0.5mm parasagittal to the midline, at the 
level at which the fimbria hippocampi merged with the corpus callosum (Figure 
8). The selected regions were stereotactically accessible and could safely be 
used for the intraparenchymal injections cells. The stereotactic coordinates for 
the selected regions of the corpus callosum were then determined from a 
stereotactic atlas of the mouse brain (Paxinos and Franklin, 2001). The 
coordinates of the first injection site were -0.58mm caudal to the Bregma point 
0, 0.5mm lateral to the midline suture and 1.5mm ventrally to the brain surface. 
The second injection site coordinates are -1.34mm caudal to Bregma point 0, 
0.5mm lateral to the midline suture and 1.5mm ventrally from the brain surface. 
To avoid extensive haemorrhage the injection site was adjusted intra-
operatively to avoid large meningeal vessels. The accuracy of the coordinates 
was confirmed prior to the start of the study on the basis of test injections with 
toluidine blue into freshly euthanized animals.  
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Figure 8. Identification of the corpus callosal region for histopathological 
characterisation and potential external modulation. 
Parasagittal view of a mouse brain. The corpus callosum is delineated with dotted lines. The 
area of interest is where the fimbria merges with the corpus callosum (square) and the two 
potential injection sites are marked with a black and a white star. (R: rostral, C: caudal, Ceb: 
Cerebrum, Hip: Hippocampus, Fim: Fimbria, Mid: Midbrain, Bs: Brainstem, Cbl: Cerebellum. Nissl 
stain. Image taken from http://brainmaps.org/HBP-JPG/8/m17b.jpg).  
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2.5.4.1 Identification of injection sites for homozygote #72 P1 neonates 
 
Four injection sites were chosen to allow even distribution over the two cerebral 
hemispheres. Two injections were made into the rostral part of the cerebrum, 
immediately right lateral and left lateral to Bregma point 0. Two injections were 
made into the caudal part of the cerebrum, immediately right and left lateral to 
where the midline suture crosses the caudal suture line. A waterproof mark was 
set 1.5mm proximal to the needle tip in order to have a constant injection depth 
in each mouse brain. 
 
2.5.5 Surgical procedure and injection of neurospheres into adult 
homozygote #72 corpus callosum 
 
Anaesthesia was induced with isoflurane and maintained at 2% isoflurane, 30% O2 
and 70% NO2 during the whole procedure. The anaesthetised animal was fixed in 
a rodent stereotactic frame with a mouse face mask and non-traumatic ear bars. 
Presurgical subcutaneous injection of 0.3ml carprofen (Rimadyl® large animal 
injection solution, Pfizer; diluted in 1:100 sterile H2O to a concentration of 
0.5mg/ml) was administered to each mouse for pain management. Longitudinal 
incision of the skin was performed from the rostral aspect of the frontal bone to 
the caudal aspect of C1. The skull was exposed and prepared for the 
craniectomy. 
 
The margins of the craniectomy window were made along the following 
anatomical hallmarks: The starting point was at Bregma point 0. A rostro-lateral 
drill line was continued along the rostral suture line for approximately 5mm. A 
medial drill line was continued along the midline suture for approximately 
7.5mm, terminating just rostral to the occipital protuberance. The midline 
suture line was included in the drill line. A caudo-lateral drill line was continued 
till 5mm lateral to the end point of the medial drill line. The craniectomy was 
completed by connecting the rostro-lateral and the caudo-lateral points, forming 
a square shaped bone flap. During drilling, sterile NaCl was used to cool the drill 
bit and the bone. 
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Once the bone had been thinned along the entire drill line, the skull bone was 
penetrated along the drill lines using a fine dental hook. The bone flap was 
removed, exposing the right lateral cerebral hemisphere and the intact dorsal 
sagittal sinus. A glass capillary was connected to a microinfusion pump (CellTram 
Oil manual piston pump, Eppendorf). The air in the capillary was removed 
completely and L15 was drawn up to form a barrier between the oil from the 
microinjection system and the cell suspension. At least 2µl of neurosphere 
suspension with a minimum density of 50,000 cells/µl was transferred into the 
glass capillary. The glass capillary containing the neurospheres was placed at 
Bregma 0, touching the brain in order to calculate the stereotactic coordinates 
for the two previously defined injection sites. At each injection site the dura 
was pierced with a sharp, bent 25G needle tip before advancing the glass 
capillary into the parenchyma. Once the capillary reached the injection site, the 
glass capillary was advanced for another 0.5mm, left in place for 1 minute and 
then retracted to the calculated injection site where the injection of the cell 
suspension commenced (Figure 8). The total volume injected at each site was 
1μl with an injection rate of 0.1μl/min. After the injection was finished, the 
needle was left in place for 5 minutes, then slowly retracted and removed from 
the brain. 
 
After finishing the two injections, the surgical site was moistened and closed by 
suturing the skin using 5-0 absorbable Vicryl (Ethicon) with a cutting needle. 
 
Before recovering the mouse from anaesthesia, a subcutaneous injection of 
0.5ml 0.85% NaCl was given. 
 
For continuous pain management, Rimadyl® was added to the drinking water to 
a concentration of 0.05mg/ml for three days.  
 
2.5.5.1 Injection of neurospheres into neonate homozygote #72 mice 
 
The entire litter was removed from the mother prior to surgery to minimise the 
risk of rejection, afterwards. Anaesthesia was induced by putting the pups into a 
box containing 5% isoflurane and O2 for approximately 30 – 45 seconds. The pups 
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were then placed under the operating microscope. The head was manually fixed 
and a 5µl Hamilton syringe (Hamilton 65RN, 7633-01) was used to inject the 
neurospheres. At each injection site, after advancing the needle through the 
skin and soft skull into the brain parenchyma to a depth of 1.5mm, 0.5µl of the 
neurosphere cell suspension was injected slowly. A total of 2µl of neurosphere 
suspension was injected into each pup. The injections were made free handed 
under visual control. After injection, the pups were left to recover in a heated 
recovery box before returning them to their mother. 
 
2.6 Tissue sampling and processing  
 
2.6.1 Fixatives 
 
2.6.1.1 Periodate – lysine – paraformaldehyde (PLP) fixative 
 
PLP fixative (McLean and Nakane, 1974; 7.1.1 Periodate lysine 
paraformaldehyde) was used for preservation of all the tissue used in the 
descriptive histopathological study of the corpus callosum and in the in situ 
evaluation of the cell intrinsic and cell extrinsic compartments in remyelination 
failure.  
 
2.6.1.2 4% paraformaldehyde in PBS     
 
4% paraformaldehyde in PBS (7.1.2 4% Paraformaldehyde in PBS) was used for 
preservation of the tissue used for the MRI experiment. All cell culture and cell 
transplantation samples were also preserved in 4% paraformaldehyde before 
immunohistochemical evaluation. Tissue where PSA-NCAM and hyaluronan 
markers were used, were also fixed in 4% paraformaldehyde. All CFP positive 
mice were preserved in 4% paraformaldehyde.  
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2.6.1.3 Karnovsky’s modified fixative (paraformaldehyde / glutaraldehyde 
4%/5%) 
 
Karnovsky’s modified fixative (7.1.3 Karnovsky’s modified fixative 
(paraformaldehyde / glutaraldehyde 4% / 5%)) was used for preservation of 
tissue destined for resin embedding and electron microscopy evaluation.  
 
2.6.2 Fixation technique and processing 
 
2.6.2.1 Cardiac perfusion 
 
Mice over 10 days of age were euthanized in a CO2 chamber. Mice under 10 days 
of age were euthanized using Isoflurane. All mice older than 20 days were fixed 
via cardiac perfusion. This was performed as follows: once the mice were dead 
they were pinned down to a cork board.  The thorax was opened to expose the 
heart and the right atrium was incised to allow blood, saline and fixative to 
escape. Intracardiac injection of 20ml 0.85% saline was performed through a 25 
gauge 1.5 inch hypodermic needle into the left ventricle (Figure 9). Once all the 
blood was flushed out of the circulatory system, 2 x 10 - 20ml (depending on the 
mouse size) of fixative was injected into the left ventricle. 
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Figure 9. Correct needle placement is of major importance to achieve 
optimal perfusion of the specimen.  
Image of a midaxial section through a fixed mouse heart showing the correct positioning of the 
needle for optimal tissue perfusion. After correct placement of the needle into the left 
ventricle, injection of 0.8% NaCl was followed by the injection of the fixative solution, allowing 
even distribution into all organs supplied by the left ventricular system. The fixative returned to 
the heart via the right atrium, which was incised to allow drainage of excess fluid from the 
circulatory system (LV: left ventricle, LA: left atrium, RV: right ventricle, RA: right atrium, scale 
square 1 x 1mm) 
 
Figure 10. #72 homozygote mice were identified by progressive 
macroscopic changes in the optic nerve, which correlated with the degree of 
demyelination.  
Image of a wild type and a homozygote optic nerve at P120 extending from the sclera (*) 
caudally to the chiasm (6.4x magnification). The optic nerves have been dissected and removed 
from their calvaria.  The wild type optic nerve (WT), which appeared opaque and was clearly 
distinguishable from the #72 homozygote mouse optic nerve, which became, with progressive 
demyelination, increasingly translucent (HOMO). With experience the changes could be detected 
as early as P40. In general the changes were readily identifiable from P60 onwards.  
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2.6.2.2 Tissue dissection  
 
Tissues were harvested using a low power dissection microscope and 
microsurgical tools. Skin and muscles were removed from the head and from the 
dorsal part of the spinal cord. The calvarium was opened and the bone removed. 
Dorsal laminectomy of the entire spinal column was performed. After removing 
the meninges, the spinal cord was transected and separated from the brain at 
the atlanto-occipital level. The brain was gently removed from the calvarium. 
The optic nerves were cut at the caudal level of the optic tracts and were gently 
removed from the brain tissue leaving the optic chiasm intact. The brain was 
then removed and the visual system, including the caudal part of the optic tracts 
and the eye balls, was removed from the calvarium as a single unit. The spinal 
cord was completely removed from the spinal canal. An approximately 1cm long 
proximal section of the sciatic nerve was also removed after blunt exposure. 
 
The following tissues were collected and frozen: longitudinal sections of the 
brain, transverse sections of the brain where the rostral 5mm of the brain was 
removed using a brain matrix, longitudinal sections of optic nerve including the 
optic tract, transverse sections of the retinal, chiasmal and optic tract portion 
of the optic nerve, longitudinal and transverse sections of cervical spinal cord at 
C1 – C3 level and lumbar spinal cord at L4 – L6 level. Spleen, liver and distal 
colon for positive controls for various antibodies were also removed from the 
abdominal cavity. 
 
2.6.2.3 Morphological identification of homozygote Plp1 gene overexpressing 
#72 mice  
 
Homozygote animals become clinically apparent at around P90, with affected 
animals becoming increasingly more ataxic, demonstrating a mild body tremor 
and also developing generalised tonic-clonic seizures. However the homozygote 
status of an animal was definitively confirmed at the point of dissection by 
evaluating the optic nerves. From P40 on, the optic nerves from homozygote 
Plp1 transgene overexpressing #72 mice were macroscopically distinguishable 
from the wild type, as progressive demyelination resulted in the optic nerves 
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turning gradually more translucent (Figure 10). The optic nerves from 
hemizygote mice were indistinguishable from the wild type. Since the PCR 
technique utilised in this study could only confirm the presence of the Plp1 
transgene the presence of macroscopic changes in the optic nerve was used to 
distinguish between hemizygote and homozygote specimens.  
 
2.6.2.4 Processing of fixed tissue and storage 
 
PLP or 4% paraformaldehyde fixative perfused tissue was immediately dissected 
after perfusion and post fixed in in the same fixative for 2 hours. In the case of 
CFP expressing tissue the tissue was immediately dissected after perfusion and 
post fixed in 4% paraformaldehyde for 20 minutes only. The tissue was then 
placed in 0.1 M Glycine (Sigma, 7126-1kg) for 10 minutes to suppress auto 
fluorescence originating from paraformaldehyde. 
 
After fixation in PLP fixative or 4% paraformaldehyde the tissue was 
cryoprotected in 20% sucrose and then frozen in OCT (Sakura, 4583). The frozen 
OCT blocks were then wrapped in wax film and stored at either -20°C -80°C 
until further processing. Tissue fixed with modified Karnovsky’s fixative was 
dissected within 7 days and stored in fixative at 4°C until processing.  
 
2.6.3 Cryopreservation and sectioning 
 
2.6.3.1 Cryopreservation of fresh neural tissue 
 
Fresh, unfixed brain and optic nerve tissue for B-cell immunostaining (see Table 
2) was collected immediately after euthanasia. The tissue was suspended in an 
OCT compound filled, self-built aluminium container and frozen in 2-
methylbutane (Isopentane, Fisher, 78-78-4) cooled to at least -80°C in liquid 
nitrogen. The frozen OCT blocks were wrapped in Nescofilm (Carl Roth, 2569.1) 
and stored at –20°C or –80°C until further processing. 
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2.6.3.2 Cryopreservation of fixed material 
 
The following tissues were collected and frozen for immunohistochemistry: 
longitudinal and transverse sections of the brain, longitudinal sections of the 
optic nerve and the optic tract, transverse sections of the retinal, chiasmal and 
optic tract portion of the optic nerve, longitudinal and transverse sections of 
cervical spinal cord at C1 – C3 level and lumbar spinal cord at L4 – L6 level. After 
perfusion the tissue was cryoprotected by immersing the tissue into 20% sucrose 
in PBS for 24 hours and freezing in OCT as described above. The frozen OCT 
blocks were wrapped in Nescofilm and stored at –20°C or –80°C until further 
processing. 
 
2.6.3.3 Sectioning of cryopreserved tissue 
 
Cryopreserved tissue was sectioned on an OTF cryostat (Bright Instruments) at 10 
– 30µm thickness. The sections were mounted on poly-l-lysine coated slides, left 
for 2 hours at room temperature to dry and attach to the slide, then stored at –
20°C or –80°C. 
 
2.6.4 Resin processing and sectioning 
 
For resin embedding only neural tissue from mice processed with Karnovsky’s 
modified fixative were used. The Lynx microscopy tissue processor (Leica) 
automated the dehydration and resin infiltration process (7.2.1 Resin 
processing). 
  
After processing, the tissue was placed in resin filled rubber moulds and left 
overnight in an incubator at 60°C for polymerisation. Resin blocks were cut on 
an ultratome (Ultracut-E, Reichert Jung). For light microscopy 1µm thick 
sections were produced using a glass knife. The sections were then placed on 
plain slides, covered and sealed with glass coverslips using DPX (BDH, 36029417).  
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For electron microscopy 70nm thick sections were produced using a diamond 
knife. The sections were mounted on 200-mesh 3.06mm diameter copper grids.     
 
2.6.5 Processing of transplanted tissue 
 
2.6.5.1 Tissue sampling and processing for  - galactosidase staining and 
immunohistochemistry after cell transplantation 
 
Fourteen days after cell transplantation, the mice were euthanized using a CO2 
chamber. Intracardiac perfusion of 0.85% saline was followed by 4% 
paraformaldehyde perfusion to achieve optimal tissue fixation. The brain was 
then dissected and transferred into a mouse brain matrix and cut into 1 mm 
thick slices. In transplants where neurospheres containing the LacZ or GPF 
reporter gene were injected simultaneously, only the sections containing green 
cells were further processed. To identify the sections containing GFP +ve cells, 
fluorescence microscopy (Olympus IX-70) was used. To visualise LacZ reporter 
gene containing neurospheres, the whole brain section was processed using the 
X-gal method (7.3.3 X-gal staining). 
 
2.6.5.2 Tissue sampling and processing for electron microscopy after cell 
transplantation 
 
Samples used for electron microscopy (EM, Joel 100CX) evaluation were 
collected after perfusion. Samples containing green fluorescing cells or samples 
with blue sections in the corpus callosum after X-gal staining were selected for 
EM evaluation. The brain slices containing GFP positive or blue cells were then 
immersed overnight in 4% formaldehyde / 5% glutaraldehyde. Before EM 
processing, the brain samples were trimmed to approximately 20mm3 large 
pieces, containing corpus callosum and part of the injection tract. The prepared 
tissue samples were then embedded into resin blocks. 
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2.7 Staining techniques 
 
2.7.1 Immunofluorescence 
 
2.7.1.1 Immunohistochemical markers 
 
2.7.1.1.1 Primary antibodies used in the study 
 
The origin, titres and the host for specific antibodies are described in Table 2. 
 
2.7.1.1.2 A2B5 
 
A2B5, an early surface marker for oligodendrocyte precursor cells (Schnitzer and 
Schachner, 1982) was used to identify undifferentiated OPCs in vitro.  
 
2.7.1.1.3 Adenomatous polyposis coli (APC) 
 
Adenomatous polyposis coli (APC, CC1) is a protein involved in tumour 
suppression and cell division. The antibody against APC recognises the 
adenomatous polyposis coli protein and, in the CNS, is a specific marker for 
mature oligodendrocytes (Bhat et al., 1996). Antibodies against APC were used 
to label mature oligodendrocytes. 
 
2.7.1.1.4 Axin2 
 
Axin2 is a protein involved in the Wnt pathway. It serves as a negative feedback 
regulator like Axin1. However unlike Axin1, which is constitutively present at 
low levels, Axin2 is only expressed when the Wnt pathway is upregulated (Fancy 
et al., 2009). Antibody against Axin2 was used to identify cells where the Wnt 
pathway was activated.  
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2.7.1.1.5 5 – Bromo – 2 – deoxyuridine (BrdU) 
 
5 – Bromo – 2 – deoxyuridine (BrdU) is an analogue to thymidine and is 
incorporated, when present, into the DNA during the S-phase. Antibody against 
BrdU was used to label dividing cells incorporating BrdU.    
 
2.7.1.1.6 Caspase3 
 
Antibody against Caspase 3, which is an enzyme from the cysteine aspartic acid 
proteases involved in cell apoptosis pathway (Denault and Salvesen, 2002), was 
used to evaluate the effect of Plp1 gene overexpression on cell apoptosis in situ. 
 
2.7.1.1.7 Inflammatory cell population 
 
The following antibodies were used to characterise the inflammatory population: 
Antibodies against CD169, which is a marker for activated macrophages (Perry et 
al., 1992). CD3, which labels T-cells (Tsoukas et al., 1987). CD45, which is 
expressed on all nucleated haematopoietic cells and is used as a panleukocytic 
marker (Huntington and Tarlinton, 2004). CD45R, a marker for identifying B-cells 
(Coffman, 1982). 
 
2.7.1.1.8 Type 3 deiodinase (D3) 
 
Type 3 deiodinase (D3) is an intracellular enzyme expressed in various cell types 
such as neurons, neutrophils, macrophages, monocytes (reviewed in Visser et 
al., 2011). Antibody detecting Type 3 deiodinase (D3) (a gift from Dr. T. Visser) 
was used to identify D3. 
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2.7.1.1.9 Glial fibrillary acidic protein (GFAP) 
 
Glial fibrillary acidic protein (GFAP) is a structural intracellular protein in 
astrocytes (Bignami et al., 1972). Antibody against glial fibrillary acidic protein 
(GFAP) was used to label the astrocytic population. 
 
2.7.1.1.10 Green fluorescing protein (GFP) 
 
Depending on the associated promoter, the GFP is linked to specific cell lines, 
allowing the cell lines to be traced due their expression of GFP (Feng et al., 
2000). A GFP antibody, which recognises GFP and CFP was used to enhance the 
fluorescence of GFP and CFP in the tissue.  
 
2.7.1.1.11 Hyaluronan binding protein (HABP) 
 
Hyaluronic acid, a glycosaminoglycan in the extracellular matrix, is believed to 
have a negative influence on OPC differentiation after demyelination (Back et 
al., 2005) The biotinylated hyaluronic acid binding protein, was used to label 
hyaluronic acid in the CNS. 
 
2.7.1.1.12 Myelin basic protein (MBP) 
 
Myelin basic protein (MBP) is one of the major myelin proteins in mature myelin. 
MBP is synthesised in free ribosomes in the oligodendrocytic processes and 
becomes incorporated into the myelin sheath soon after synthesis (Colman et 
al., 1982). Antibody against MBP was applied to evaluate for the presence of 
myelin in the white matter. 
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2.7.1.1.13 Chondroitin sulphate proteoglycan NG2 
 
NG2 is a single spanning membranous chondroitin sulphate proteoglycan, which 
is expressed on residing OPCs (Nishiyama et al., 2009). Antibody against NG2 was 
used to label oligodendrocyte precursor cells  
 
2.7.1.1.14 O4 sulfatides 
 
O4 is an antigen of the O family, which are sulfatides located in the cell 
membrane. O4 is expressed at most stages of oligodendrocyte development and 
is detectable from early OPCs up to mature oligodendrocytes in culture (Sommer 
and Schachner, 1981). Antibody against O4 was applied during living cell culture 
experiments to label the cells belonging to the oligodendrocytic lineage.  
 
2.7.1.1.15 Basic Helix-Loop-Helix transcription factors Olig1 and Olig2 
 
Olig1 and Olig2 are basic Helix-Loop-Helix (bHLH) transcription factors expressed 
in OPCs and oligodendrocytes. (Lu et al., 2002). Antibodies detecting Olig1 and 
Olig2 were used to characterise the response of adult OPCs during the 
development of chronic demyelination. 
 
2.7.1.1.16 Platelet derived growth factor receptor alpha (PDGFRa) 
 
Platelet derived growth factor receptor alpha (PDGFRa) is expressed on 
developmental and adult OPCs from a relatively early time point (Pringle et al., 
1992). Antibody detecting PDGFRa (gift from Dr. C. Heldin) was used to identify 
OPCs.  
 
2.7.1.1.17 Proteolipid protein / DM20  
 
PLP/DM20 is the major myelin protein. It is a tetraspan protein located in the 
cell membrane. Antibody against the PLP-C terminal recognises the carboxy 
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terminus of the PLP protein isoforms and was used to label PLP and DM20 
(Fanarraga et al., 1992) in order to identify wild type and transgenic PLP. 
2.7.1.1.18 Polysialation of the neural cell adhesion molecule (PSA NCAM) 
 
Polysialation of the neural cell adhesion molecule (PSA NCAM) on axons has been 
suggested to play a role in inhibiting remyelination after demyelination (Charles 
et al., 2002). PSA - NCAM antibody was used to assess if axonal surface 
expression was altered. 
 
2.7.1.1.19 SMI31 and SMI32 
 
In the CNS axons, neurofilaments are structural proteins important for cell 
structural integrity, axonal and dendritic growth (reviewed in Lee and 
Cleveland, 1994;Grant and Pant, 2000). SMI-31 antibody recognises the 
phosphorylated neurofilaments, whereas SMI-32 antibody recognises non 
phosphorylated neurofilaments. These two markers were used to label axons.  
 
2.7.1.1.20 Secondary fluorescent antibodies 
 
All secondary fluorescent antibodies were raised in goat and their specific 
binding affinities to primary antibodies are listed in Table 3.  
For green fluorescence, secondary antibodies labelled with fluorescein 
isothiocyanate (FITC), with an excitation spectrum peak at 491nm and emission 
spectrum peak at 521nm, or labelled with Alexa Fluor (AF488, Invitrogen, A-
11008), with an excitation spectrum peak at 495nm and emission spectrum peak 
at 519nm, were used.   
 
For red fluorescence, secondary antibodies labelled with sulforhodamine 101 
acid chloride (Texas Red, TxR) with an excitation spectrum peak at 589nm and 
emission spectrum peak at 615nm were used.  
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2.7.1.1.21 Nuclear stain 
 
4’,6-diamidino-2-phenylindol (DAPI), a blue fluorescent nuclear stain, strongly 
binds to double stranded DNA, with a preference for binding at AT cluster sites, 
and has an excitation spectrum peak at 358nm and emission spectrum peak at 
461nm (Kubista et al., 1987). DAPI was used to counterstain the cell nucleus in 
cryosections.  
  
86 
Primary Antibody Host 
Manufacturer 
Cat. Nr. 
Dilution Method 
A2B5 Mouse IgM  1:3 live 
APC (CC1) IgG2b 
Abcam 
ab16794 
1:100 DV 
Axin2 Rabbit IgG 
Abcam 
ab32197 
1:100 
0.5% 
Triton X 
BrdU Mouse IgG1 Sigma B8434 1:500 HCl 
Caspase 3 Rabbit IgG 
Cell Signaling 
#9661 
1:4000 Methanol 
CD169 Rat IgG2a 
Serotec 
MCA884 
1:100 Methanol 
CD3 Rat IgG1 
Serotec 
MCA1477T 
1:100 Methanol 
CD45 Rat IgG 
AbD Serotec 
MCA1388 
1:600 Methanol 
CD45R Rat IgG2a 
BD 
Pharmingen 
550286 
1:100 
Fresh 
frozen 
D3 (676) Rabbit IgG 
Gift from Dr. T 
Visser 
1:1000 
0.5% 
Triton X 
GFAP Mouse IgG1 Sigma G3893 1:1000 Methanol 
GFP Rabbit IgG Abcam ab290 1:1000 Methanol 
HABP 
Biotinylated 
Protein 
Seikagaku 
400763 
2µg/ml Methanol 
MBP Rat IgG 
Serotec 
MCA4095 
1:500 Methanol 
NG2 Rabbit IgG 
Millipore 
AB5320 
1:150 
Methanol 
or 0.5% 
Triton X 
O4 Mouse IgM 
Gift from Dr. I  
Sommer 
1:5 Live 
Olig-1 Mouse IgG2b Millipore 1:1000 0.5% 
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Primary Antibody Host 
Manufacturer 
Cat. Nr. 
Dilution Method 
MAB5540 Triton X 
Olig-2 Rabbit IgG 
Millipore 
AB9610 
1:500 
0.5% 
Triton X 
PDGFRa2 Rabbit IgG 
Gift from Dr 
C. Heldin 
1:500 Methanol 
PLP-C term Rabbit IgG Groome 226/7 1:600 Methanol 
PSA (E-NCAM) Mouse IgM 
Millipore 
MAB5324 
1:500 Methanol 
SMI-31 Mouse IgG1 
Convance 
SMI31-R 
1:1500 Methanol 
SMI-32 Mouse IgG1 
Convance 
SMI32-R 
1:1500 Methanol 
 
Table 2. List of primary antibodies used in all studies.  
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Secondary Antibody Manufacturer / Cat Nr. Dilution 
Goat anti Rat IgG FITC Southern Biotech / 1050-02 1:50 
Goat anti Mouse IgG FITC Southern Biotech / 1034-02 1:30 
Goat anti Mouse IgG1 FITC Southern Biotech / 1070-02 1:80 
Goat anti Mouse IgG2a FITC Southern Biotech / 1080-02 1:25 
Goat anti Mouse IgG2b FITC Southern Biotech / 1090-02 1:100 
Goat anti Mouse IgM FITC Southern Biotech / 1021-02 1:50 
Goat anti Rabbit IgG FITC Southern Biotech / 4050-02 1:80 
   
Goat anti Rabbit IgG AF488 Invitrogen / A11008 1:1000 
   
Goat anti Rat IgG TxR Southern Biotech / 1050-07 1:50 
Goat anti Mouse IgG TxR Southern Biotech / 1034-07 1:50 
Goat anti Mouse IgG1 TxR Southern Biotech / 1070-07 1:75 
Goat anti Mouse IgG2b TxR Southern Biotech / 1090-07 1:70 
Goat anti Mouse IgM TxR Southern Biotech / 1021-07 1:50 
Goat anti Rabbit IgG TxR Southern Biotech / 4050-07 1:100 
   
Extravidin FITC Sigma / E2761 1:75 
   
DAPI Sigma / D1306 1:1500 (1 min) 
 
Table 3. List of secondary antibodies used in all studies.  
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2.7.1.2 Immunohistochemistry protocol using methanol to permeabilise cell 
membranes 
 
Immunohistochemistry was performed on PLP fixative and 4% paraformaldehyde 
fixed tissue. After thawing, the slides containing the sections were immersed in 
PBS for 10 minutes to remove the OCT embedding. Cell permeabilisation was 
performed by immersing the sections in –20°C methanol (Fisher, 67-56-1) for 10 
minutes. After permeabilisation the sections were washed twice in PBS for ten 
minutes. Blocking of non-specific binding of secondary antibodies was performed 
using PBS containing 10% normal goat serum (NGS, Sigma G9023)  was applied to 
the sections for 1 hour. After removing the excess fluid from the sections, the 
primary antibody was applied overnight at 4°C in PBS containing 10% NGS. After 
washing the sections three times in PBS for 10 minutes the secondary antibody 
was applied in PBS containing 10% NGS for one hour at room temperature and 
then again washed three times in PBS for ten minutes. For nuclear staining, 4'6-
Diamidino-2-Phenylindole (DAPI, Sigma, 32670) in PBS was applied for one 
minute. The samples were washed in PBS and running water for 5 minutes and 
mounted in glycine / PBS. The coverslips were sealed using nail varnish.    
  
2.7.1.3 Immunohistochemistry protocol using Triton-X 100 to permeabilise 
cell membranes 
 
Immunohistochemistry was performed on PLP and 4% paraformaldehyde fixed 
tissue. After thawing, the sections were immersed in PBS for 10 minutes to 
remove the OCT embedding. Cell permeabilisation was performed by applying 
Triton-X 100 (Sigma, 9002-93-1) for one hour at various concentrations (0.2 – 
0.5% in 10% NGS) to the sections. This procedure also served to block non-
specific binding of secondary antibodies. After removing the excess from the 
sections, the primary antibody was applied overnight at 4°C in PBS containing 
0.2 – 0.5% Triton-X and 10% NGS. The following day the sections were washed 
three times in PBS for 10 minutes followed by application of the secondary 
antibody in PBS containing 0.2 - 0.5% Triton-X and 10% NGS for one hour at room 
temperature.  
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The final steps, including nuclear staining and mounting, were performed as 
previously described. 
 
2.7.1.4 Immunohistochemistry protocol using the DV method 
 
Immunohistochemistry staining for APC (CC1) (see table for origin and dilution) 
was performed on PLP and 4% paraformaldehyde fixed tissue. After thawing, the 
sections were immersed in PBS for 10 minutes to remove the OCT embedding. 
Cell permeabilisation was performed by applying DV solution for one hour to the 
sections. This procedure also served to block non-specific binding of secondary 
antibodies. After removing the excess from the sections, the primary antibody 
was applied over night at 4°C in DV solution. The following day the sections 
were washed three times in PBS for 10 minutes followed by application of the 
secondary antibody in DV solution for one hour at room temperature. The final 
steps including nuclear staining and mounting were performed as previously 
described. 
 
2.7.1.5 Hydrochloric acid immunohistochemistry protocol for BrdU staining 
 
Double labelling of PDGFRα positive cells and BrdU positive cells on tissue fixed 
with PLP fixative was performed as follows: The staining protocol for the first 
antibody (OPC marker PDGFRα) has been previously described. After completion 
of the PDGFRα staining the slides were immersed in 50% ethanol / 50% glacial 
acetic acid (see Appendix) for ten minutes and then in 50% hydrochloric acid 
containing 1% Triton-X 100 (see Appendix) for ten minutes. The slides were 
washed three times in PBS for ten minutes. Antibody against BrdU in PBS 
containing 1% Triton-X 100 and 10% NGS was applied overnight at 4  C to the PBS 
washed slides. The unbound BrdU antibody was then removed by immersing the 
slides three times in PBS for 10 minutes. The secondary antibody recognising the 
BrdU antibody was applied for 2 hours at room temperature. The subsequent 
steps were as described for the PLP fixative fixed tissue staining protocol.        
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2.7.1.6 Immunohistochemistry protocol on unfixed, fresh frozen tissue 
 
Fresh frozen samples for staining with the B-cell marker CD45R were thawed and 
processed unfixed. The primary antibody was applied for one hour at room 
temperature. The samples were then fixed for 10 minutes in 4% 
paraformaldehyde before applying the secondary fluorescent antibody or before 
applying other primary antibodies. The subsequent steps were as described 
above. 
2.7.1.7 Immunohistochemistry protocol on live culture 
 
Live staining to identify OPCs and oligodendrocytes was performed on adult OPC 
cultures using the markers O4 or A2B5. The coverslips were washed three times 
in DMEM at 37°C for ten minutes. The antibody against A2B5 or O4 were 
suspended in DMEM, applied to the coverslips, and incubated for 1 hour at 37°C 
in a 5% CO2 atmosphere. The coverslips where then washed three times in DMEM 
at 37°C for ten minutes and once in PBS at 37°C before fixing the cells in 4% 
paraformaldehyde at room temperature for ten minutes. After fixation the 
methanol protocol was used for application of the subsequent second primary 
antibodies.    
 
2.7.1.8 Immunohistochemistry protocol of fixed cultured cells  
 
After fixation, the coverslips were washed three times in PBS then the secondary 
fluorescent antibody in DMEM was applied for one hour at room temperature. 
The coverslips were then washed three times in PBS and the cells were 
permeabilised in methanol for 10 minutes at -20°C. After 3 washes in PBS 10% 
normal goat serum in PBS for applied for one hour. In coverslips where O4 
antibody was applied to label the OPCs, the second primary antibody used was 
against GFP. In coverslips where antibody against O4 was not used, either an 
antibody against MBP (Table 2) or an antibody against PLP (Table 2) was 
combined with the GFP antibody. After incubation of the second primary 
antibody, the coverslips were washed in PBS and the second fluorescent 
antibody was applied (Table 3). Finally, after washing in PBS, the cell nuclei 
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were stained using DAPI (Table 3). Coverslips were then briefly washed in PBS 
and water before mounting and sealing the coverslips on a microscope slide.     
 
2.7.1.9 Immunofluorescence of transplanted tissue 
 
The following antibodies were used to label the transplanted cells. An antibody 
against GFP was used to identify the cell population originating from GFP 
expressing neurospheres. An antibody against MBP was used to identify myelin 
sheaths. To identify the astrocytic population, an antibody against GFAP was 
used. To identify the microglial population CD45 and CD169 antibodies were 
used. For nuclear staining, 4'6-Diamidino-2-Phenylindole (DAPI) was applied. 
Secondary antibodies used in this study were FITC labelled antibodies for GFP 
detection and TxR labelled antibodies to label the antibodies against MBP, GFAP, 
CD45 and CD169. Dilution and origin of the primary and secondary antibodies and 
DAPI are listed in Tables 2 and 3. 
 
2.7.2 Light microscopy 
 
2.7.2.1 X-gal staining of Plp1 LacZ expressing samples   
 
X-gal staining was performed on 4% paraformaldehyde fixed tissue either as a 
whole mount tissue or on 10µm thick frozen sections. After fixation, the 
transplanted brain was cut into 2mm thick axial sections using a 1mm step brain 
matrix (Harvard Apparatus, 62-0050). The sections were then briefly washed in 
PBS followed by 1M MgCl2 for 10 minutes on ice. The tissue was then immersed 
into detergent solution for another 10 minutes on ice, followed by the 
application of X-Gal staining solution (7.3.3 X-gal staining) over night at room 
temperature. The reaction product after X-Gal treatment of tissue containing β-
galactosidase is 5-bromo-4-chloro-3-indolyl β-D-galactoside, which is a blue 
product visible to the naked eye. The sections were then washed in and 
immersed in 20% sucrose for 24 hours, immersed in OCT and frozen and stored as 
described above.    
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Alternate 10 and 20µm thick mounted cryosections from NS transplanted brains 
were taken for β-galactosidase staining.  
 
2.7.2.1.1 Tissue sampling and processing for  - galactosidase staining 
and immunohistochemistry of P1 injected homozygote #72 mice 
 
Following the cell transplantation two mice were euthanized on each of the 
following days post cell transplantation: day 7, 14, 35, 80 and 120. The mice 
were euthanized using a CO2 chamber. The procedure for fixation and processing 
of the tissue was identical to that previously described.  
 
2.7.2.1.2 Methylene blue / azur II 
 
For light microscopy, resin sections were stained with methylene blue (VWR, 
340484B)/ azur II (VWR, 340064Y) (7.4.1 Methylene blue / azur II). Sections were 
placed on a hot plate (60  C) and flooded with stain. Once the rim of the stain 
solution appeared golden the sections were washed in running water. The 
sections were mounted in DPX (BDH, 360 294 17) after drying overnight on a hot 
plate (60 C). 
 
2.7.3 Electron microscopy 
 
2.7.3.1 Tissue sampling and processing for electron microscopy of P1 injected 
homozygote #72 mice 
 
Samples for electron microscopic (EM) evaluation were collected at P7, P14, 
P21, P40, P80 and  P120 after intracardiac perfusion with 4% PF. Post fixation 
was performed by immersion in 4% formaldehyde / 4% glutaraldehyde for one 
week.  
 
Before EM processing, the brain samples were cut to approximately 10mm3 large 
pieces, containing the corpus callosum and part of the injection tract. The 
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prepared tissue samples were then embedded into resin blocks (7.2.1 Resin 
processing).  
 
For EM evaluation resin blocks were trimmed and the brain samples were cut 
into 1µm thick sections for myelin sheath evaluation of the transplantation site 
using toluidine blue. After methylene blue/azur II evaluation, 60m thick 
sections of the areas containing myelin (presumed to be from the transplanted 
cells) were cut for EM evaluation. 
 
Uranyl acetate (AGAR Scientific, R1260) and lead nitrate (VWR, 290384R) was 
used to stain the copper grid mounted thin resin sections (7.3.4 Staining for 
electron microscopy). 
 
2.8 Morphological studies 
 
2.8.1 Cell quantification of immunolabelled samples 
 
Quantification of cells was performed on 10µm thick axial cryosections from the 
corpus callosum, retinal and chiasmal portion of optic nerve. Sections were 
placed on slides at 100µm intervals to avoid counting the same cell twice.   
 
Immediately after staining, images from the area of interest were taken using an 
Olympus IX70 microscope, QIcam Fast digital camera (Qimaging Surrey, Bcm 
Canada) and Image ProPlus 6.0 software (Media Cybernetic, Silver Spring, MD, 
USA). 
 
The cells positive for the immunohistochemical marker of interest were counted 
manually in a defined area of interest using Image ProPlus 6.0 software. For the 
immunohistochemical marker, the area of interest in the corpus callosum was 
20515.176µm2. In the optic nerve the area of interest was 28060.455µm2. DAPI 
was used to identify the nucleus for calculating the total cell density using the 
automatic cell count function in Image ProPlus 6.0. The area of interest in the 
corpus callosum and optic nerve for DAPI positive cells nuclei was 6986.3584µm2. 
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The cells were included in the cell count if they were lying within the area of 
interest. Cells crossing the top (north) and the right (east) side border were also 
included. Cells crossing the bottom (south) and left (west) side border were 
excluded from the cell count. 
 
2.8.2 Quantification of GFAP positive area in optic nerve after 
immunolabelling 
 
In the optic nerve the GFAP area was measured using a semi-automated 
programme in ImagePro 6.0. A minimum of six images per optic nerve were 
used. Briefly, the images were opened in ImagePro 6.0. A copy of the original 
was made and converted into a black and white image, where fluorescent areas 
appear white. The original image was used as a template for manual 
segmentation of the black and white image until the white area was judged to 
match the fluorescent area of the original image. An area of interest (AOI) of 
16397.771µm2 was applied to the image and the area occupied by white pixels 
within the AOI was then automatically calculated, giving the area occupied by 
GFAP in µm2 per µm2 of the total AOI. For each optic nerve the measurement 
was then used to calculate the area occupied by GFAP per mm2. 
 
2.8.3 Quantification of percentage myelinated axons 
 
Images obtained from electron microscopy were used to calculate the 
percentage of myelinated axons within the region of interest in the corpus 
callosum. Eight images were randomly taken from the mid corpus callosum at 
8000x magnification using a film camera system (JOEL 100CX). After developing 
the film negatives were scanned (EPSON Perfection 3200 PHOTO) and evaluated 
in ImagePro 6.0. Axonal numbers were manually counted using an area of 
interest of 45.166µm2. Myelinated axons and non myelinated axons were counted 
after placing a grid square over the digital image, from which to select fibres for 
counting.  All fibres lying under an intersection were only counted once. The 
percentage of myelinated axons was calculated in relation to myelinated and 
non myelinated axons, after placing a counting grid over the digital image. All 
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axons lying beneath the grid lines were counted and designated as myelinated or 
non myelinated 
 
2.8.4 Measurement of cell process length of cultured OPCs 
 
To evaluate and quantify the morphological changes of OPC differentiation in 
vitro, 6 semi randomly chosen fields per coverslip were photographed using 
phase microscopy and fluorescence microscopy (Olympus IX-70, x200 
magnification). The reason why the photographing process was not performed in 
a completely random fashion was the low yield of cells on the coverslips. Wild 
type differentiating OPCs were distinguished from homozygote OPCs by the 
presence of GFP. Semiautomatic tracing of OPC processes were performed in 
ImageJ® using the NeuronJ® plug-in on phase microscopy images. 
  
2.9 Statistical analysis and graphical presentation of the data 
 
In the histopathological study an unpaired t-test was used to analyse the cell 
count, axonal count and percentage myelinated area data. In the MRI study an 
unpaired and paired t-test was used to analyse the histological and diffusion 
data. In the cell culture study an unpaired t-test was used to compare the 
process length. Statistical significance was set at p< 0.05 throughout the study.  
 
Cell density and axonal density were always presented as the count per mm2. 
The percentage of myelinated axons was displayed as a proportion relative to 
the total axonal count. Area occupied by GFAP was presented as the area of 
GFAP in µm2 per 1000000µm2.  
 
Statistical analysis and the graphical presentation of data were performed using 
GraphPad Prism 4®.  
 
Specific Materials and Methods are described in 3.3 Material and Methods, 4.3 
Material and Methods and 5.3 Material and Methods. 
97 
3 The development of the phenotype and pathology of 
the homozygote #72 corpus callosum  
 
3.1 Introduction 
 
The Plp1 gene overexpressing mouse (homozygous; line #72) model of PMD due 
to gene duplication appears phenotypically normal during development and in 
early adulthood. At around 3 months of age however, mice develop a mild ataxia 
and exhibit seizure activity, particularly if disturbed. The generalised ataxia 
becomes progressively more pronounced, a very mild whole body intention 
tremor develops and the seizure activity increases. Mice rarely live beyond 4 
months of age and death probably occurs as a consequence of prolonged seizure 
activity, which most likely causes a cardio-respiratory arrest. 
 
Diffusion magnetic resonance imaging of the brain of 4 month old #72 mice 
demonstrated widespread changes in diffusion parameters in all major white 
matter tracts (Ruest et al., 2011). Quantification of myelination in three of 
these tracts, the anterior commissure, hippocampal fimbria and the mid corpus 
callosum, demonstrated that there was an almost complete lack of myelin 
sheaths. In the absence of an early clinical phenotype, the paucity of myelin 
sheaths at this age probably reflects a loss of previously formed myelin rather 
than a complete failure of developmental myelination. Indeed, both the optic 
nerve (Edgar et al., 2010) and the spinal cord (Anderson T.J. PhD thesis; 
Anderson et al., 1998) are well myelinated in the young #72 homozygote mouse.  
 
As described in Chapter 1, the myelin sheath, which surrounds axons in the CNS 
white matter can be successfully restored by endogenous OPCs, following injury 
(Zawadzka et al., 2010). The repair mechanisms that restore the myelin sheath 
are highly effective and full restoration often follows a demyelinating event. 
However, for reasons that are not fully understood, this repair process is not 
universal. Various models of dysmyelination and demyelination have been used 
to investigate (re)myelination biology and pathology and some of these models 
have been presented in Chapter 1. So far the most common model used in 
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demyelination research is the immune mediated inflammatory disease model of 
experimental autoimmune encephalitis (EAE). Although this model has 
facilitated the identification of immune mediated pathways in demyelination 
and has also helped to develop drugs to treat MS, it is not a particularly useful 
model with which to examine the (re)myelination biology, since the background 
on which repair must take place is hostile. The Plp1 gene overexpressing mouse 
model, where the phenotype develops spontaneously, and in which the immune 
response is mild may represent a better model to investigate (re)myelination 
biology. Therefore it is of interest to know if the paucity of myelin sheaths in 
the P120 #72 homozygote mouse represents a failure of developmental 
myelination and/or a failure of repair following demyelination. 
 
The corpus callosum is commonly used in the investigation of white matter 
development, myelination, remyelination biology and the pathology thereof. It is 
a large intracranial white matter structure, divided into five major regions; the 
rostrum, the genu, the midbody, the isthmus and the splenium (Highley et al., 
1999). As a pure white matter structure, it comprises axons, oligodendrocytes, 
OPCs, astrocytes, microglia and trafficking immunological cells and few, if any, 
neuronal cell bodies. The neurophysiological function of the corpus callosum is 
to conduct electrical signals between the cortical neurons of two hemispheres 
for interhemispheral communication (Zarei et al., 2006). In mice, approximately 
60 –70% of the axons are myelinated (Xie et al., 2010). A study by (Olivares et 
al., 2001) showed that the percentage of myelinated axons is similar across 
species such as rats, rabbits, cats, dogs, cows, horses and macaque. However 
other studies show a variation between species that, in reality, is probably due 
to the investigation of different corpus callosal regions and different time points 
at which myelination was evaluated (Sturrock, 1980;Looney and Elberger, 1986). 
Therefore, given the region and time dependent differences in myelin 
composition within the corpus callosum it is essential to characterise and specify 
the specific region to be examined.  
 
There are some major advantages that make the corpus callosum an ideal 
structure to investigate (re)myelination biology and pathology. Individual regions 
are easily identifiable in histological samples and with newer in vivo techniques 
such as magnetic resonance imaging. This has the advantage that myelination 
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changes and white matter responses to pathological impacts along the corpus 
callosum can be investigated over time in vivo (Harsan et al., 2006;Harsan et al., 
2010). Secondly, the development of the corpus callosum has been extensively 
described in mouse (Ozaki and Wahlsten, 1998) and the time point of 
myelination in various species is known (Olivares et al., 2001). Thirdly, the size 
of the corpus callosum facilitates the implantation of cells for transplantation 
studies and the structure can be reached with minimally invasive surgical 
techniques using stereotactic equipment for in vivo transplantation experiments. 
  
A disadvantage of the corpus callosum, however, is the high number of small 
diameter axons. Fibers with a diameter below 0.2µm do not become myelinated 
(reviewed in Hildebrand et al., 1993). However, external manipulation (specific 
training) or compensation of lost neuronal function by another area of the brain 
could induce small fibre growth. If the fibre diameter grows above 0.2µm, 
myelination will commence. If this is the case, the change in myelination would 
not be due to remyelination but to myelination. In this specific situation, it is 
nearly impossible to distinguish between these two entities, new myelin 
formation or remyelination. 
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3.2 Aims 
 
The overall aim of this Chapter was to characterise the white matter changes 
leading to the paucity of myelin and apparent lack of repair in the corpus 
callosum in the #72 homozygote mouse 
 
The specific aims were to: 
 
1.) Examine and quantify myelination in the corpus callosum at various ages 
up to P120 
2.) Describe and quantify accompanying changes in neighbouring white 
matter cells, including oligodendrocyte precursor cells 
3.) Examine and characterise OPC intrinsic and OPC extrinsic factors that 
could contribute to myelin pathology 
 
3.3 Material and Methods 
 
3.3.1 Animals 
 
Mice used in this study were the Plp1 overexpressing transgenic mouse (#72), 
generated by (Readhead et al., 1994) and the Thy1-cyan fluorescent protein 
(CFP) (B6.Cg-Tg(Thy1-CFP)23Jrs⁄J) expressing mouse model produced by (Feng 
et al., 2000). Animals were killed and tissue was collected at P40, P60, P90 and 
P120. Further details are provided in 2 Material and Methods. 
 
3.3.2 Intraperitoneal BrdU injection for OPC proliferation studies 
 
To label cells in the s-phase of the cell cycle, one single intraperitoneal 
injection of BrdU (50µg/g) was administered one hour prior to euthanasia, at 
12.00 midday ± 2 hours. BrdU in sterile saline, which was stored in aliquots at -
20oC, was warmed to room temperature before injecting. Sometimes BrdU 
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precipitated in the solution and was therefore vortexed to dissolve the BrdU 
before injecting. 
 
3.3.3 Tissue sampling and processing for histopathological examination 
 
After euthanasia, intracardiac injection of 0.85% saline followed by fixative was 
performed. The choice of the fixative was based on which histological technique 
followed. Detailed description of the fixatives and the techniques are listed in 
Chapter 2 and the Appendix. Samples used for B-cell evaluation were directly 
frozen after 0.85% saline injection without fixation. 
 
3.3.4 Tissue sectioning 
 
For immunohistochemical evaluation, 10µm thick tissue sections were prepared 
with a cryotome at -22oC, from frozen samples embedded in OCT. From each 
animal, a minimum of 80 sections were cut and mounted, consecutively, onto 10 
slides, such that each slide contained a series of sections, each separated by 
100µm from the next. For light and electron microscopic evaluation, the tissue 
was moulded into resin blocks and cut into 1µm and 60 nm thick sections, 
respectively. Immunohistochemistry was performed on fixed or unfixed frozen 
sections, depending on the primary antibody used. Details of staining protocols, 
primary and secondary antibodies and concentrations used are listed in (Chapter 
2 Table 2 & Table 3).  
 
3.3.5 Quantification of percentage myelinated axons 
 
Electron microscopy (EM) images were taken at 8000x magnification. The EM 
images were scanned and imported into Image ProPlus 6.0 software. Axonal 
density was calculated from six randomly taken images per animal, of the mid 
corpus callosal region using a rectangular area of interest (AOI: 47.269µm2). All 
axons in the AOI were counted except those touching its southern and western 
borders of the AOI. 
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To calculate the percentage of myelinated axons, a grid comprising 4 bisecting 
lines was applied to the rectangle AOI. The myelination status of all axons lying 
under any of the digital lines was assessed and the percentage of myelinated 
axons was calculated. Details of the quantification procedure are found in (2.8 
Morphological studies). 
 
3.3.6 Markers used for evaluation of the corpus callosum 
 
3.3.6.1 Characterisation of myelin integrity and identification of cells 
originating from the oligodendroglial lineage 
 
To identify the myelin integrity, antibodies against MBP and PLP/DM20 were 
used. For ultrastructural evaluation of the myelin sheath, resin sections were 
evaluated using light microscopy on methylenblue/azur II stained sections and 
using electron microscopy. Mature oligodendrocytes were identified using an 
antibody against APC (CC1). For identification of OPCs, antibodies against 
PDGFRα and NG2 were used. To characterise OPC proliferation, an antibody 
against BrdU was used in combination with an antibody against PDGFRα. For 
evaluation of OPC differentiation, an antibody against Olig1 was used in 
combination with an antibody to NG2 (Table 2 and Table 3).  
 
3.3.6.2 Identification extraglial changes 
 
The astrocytic population was identified using an antibody to GFAP. Immune 
cells, including B-cells, T–cells and microglia/macrophages were identified using 
antibodies against CD3, CD45R and CD45 and CD169, respectively. 
 
To identify axonal changes antibody SMI32, that recognises non-phosphorylated 
neurofilament, was used. In Thy1-CFP / Plp1 transgenic mouse, where CFP 
accumulates in axonal swellings, an antibody against GFP was used to enhance 
the CFP fluorescence. 
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To examine the Wnt pathway in cells from the oligodendrocytic lineage, an 
antibody against Axin2 in combination with an antibody against Olig1 was used. 
To characterise deiodinase 3 (D3) expression in microglia/macrophages an 
antibody against D3 was used in combination with an antibodies against CD45. 
 
To investigate PSA NCAM expression in demyelinating corpus callosum an 
antibody against PSA NCAM was used.  
 
The biotinylated hyaluronic acid binding protein (HABP) was used to identify the 
presence of hyaluronan in the extracellular matrix of the corpus callosum (Table 
2 and Table 3). 
 
3.3.6.3 Cell quantification 
 
Immediately after staining, two images of the corpus callosum, parasagittal to 
the midline and dorsal to the lateral ventricle, were taken from each brain 
section at x400 magnification, using an Olympus IX70 microscope with a QIcam 
Fast digital camera. A maximum of 20 images and minimum of 6 images from 
each mouse were available for cell quantification. The micrographs were opened 
in Image ProPlus 6.0 software and an area of interest (AOI: 20515.176µm2) was 
applied manually on each image covering the corpus callosum only. All cells, 
which were fully or partially located in the AOI, were counted except the cells 
touching the southern and the western borders of the AOI. The cell density per 
mm2 was then calculated based on the cell count from a minimum of 6 AOIs. 
 
3.3.7 Statistical analysis 
 
The unpaired student t-test was used to compare the cell count and percentage 
of myelinated axons between the wild type and the #72 homozygote. Statistical 
analysis was performed using GraphPad Prism 5®. 
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3.4 Results 
 
3.4.1 Extensive myelin degradation was observed in the #72 
homozygote corpus callosum 
 
To globally assess myelin integrity over time, cryostat sections containing the 
mid corpus callosum were labelled with antibodies against MBP (Figure 11) and 
PLP/DM20 (Figure 12) and examined by fluorescence microscopy. At P40, 
staining appeared similar in the #72 homozygote compared to the wild type. 
With time, a progressive reduction in MBP and PLP/DM20 staining was observed 
in the #72 mouse, reaching a minimum at P120, the oldest age examined. This 
staining pattern suggests that there is a progressive degeneration of myelin in 
the corpus callosum. The intense, patchy staining in some regions of the #72 
mouse corpus callosum (Figure 11 and Figure 12) probably represents increased 
penetration of antibodies into the degenerating myelin sheaths. PLP/DM20 was 
found in cell bodies as well as in myelin sheath-like structures and a substantial 
number of PLP/DM20 positive cells were present at the time point of complete 
demyelination (Insert Figure 12). 
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Figure 11. Progressive reduction in myelin staining in the #72 corpus 
callosum.  
Micrographs of MBP stained sections through the corpus callosum of wild type (A – D) and #72 
mice (E – H; x100, scale bar 400µm) between P40 and P120. At P40 MBP staining in the #72 
corpus callosum appeared similar to the wild type. MPB staining diminished with increasing age. 
The patchy appearance of the staining probably reflects the binding of the antibody to myelin 
breakdown products. Auto fluorescent lipofuscin (arrows) was present and contributed to the 
staining pattern.  
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Figure 12. Progressive loss of PLP/DM20 staining in the #72 corpus 
callosum.  
Micrographs of PLP/DM20 stained sections through the corpus callosum of wild type (A – D) and 
#72 mice (E – H; x100, scale bar 400µm) between P40 and P120. The progressive reduction in 
PLP/DM20 staining followed a comparable pattern when MBP was used as a marker. The myelin 
status at P40, in the #72 mouse was comparable to the wild type. Later, a progressive loss of 
PLP/DM20 staining was observed. The paucity of staining appeared less severe with the antibody 
recognising PLP/DM20 compared to staining with antibody to MBP. This was due to the presence 
of PLP/DM20 in cell bodies (I, x400, scale bar 25µm). 
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3.4.2 The corpus callosum is almost completely demyelinated at P120 
in the #72 mouse 
 
For qualitative and quantitative assessment of myelination, resin sections were 
examined using light and electron microscopy. Light microscopy revealed 
comparable amounts of myelin in the corpus callosum of P40 72 and the wild 
type mice. Subsequently, there was a progressive reduction in myelin volume, 
until demyelination was virtually complete at P120 (Figure 13). Electron 
microscopy demonstrated normal appearing myelin sheaths in the #72 mouse 
corpus callosum (Figure 14). The percentage of myelinated axons was calculated 
from electron micrographs. A significant reduction in the percentage of 
myelinated axons was observed in the #72 mouse compared to the wild type at 
P60, P90 and P120, with a virtually complete absence of myelinated axons at 
P120 (Figure 15). 
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Figure 13. Progressive demyelination follows initial myelination of the #72 
homozygote corpus callosum. 
Methylene blue / azur II stain of the mid corpus callosum between P40 and P120 in wild type (A - 
D) and 72 mice (E – H, x1000, scale bar 40 m). At P40, myelin volumes appeared similar in the 
#72 mouse compared to the wild type mouse. With increasing age, the amount of myelin 
appeared to increase in the wild type showing that myelination of the corpus callosum continued 
into adulthood. In contrast, in the #72 mouse, the corpus callosum became progressively 
demyelinated between P60 (B, F), P90 (C, G) and P120 (D, H). There was an almost complete 
absence of myelinated axons at P120. At this age cell nuclei (black arrows) appeared more 
numerous in the #72 mouse compared to the wild type and numerous large astrocytic processes 
(asterisk) were also observed.  
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Figure 14. Initial myelination of the #72 mouse corpus callosum was 
followed by progressive demyelination. 
Electron micrographs of the corpus callosum between P40 and P120 in wild type (A – D) and 72 
mice (E – H, x8000, scale bar 2 m). At P40, myelin volume in the #72 mouse corpus callosum 
appeared similar to that in the age-matched wild type mouse. The myelin that was present in 
the #72 mouse had a morphologically normal appearance. At subsequent time-points, the 
proportion of myelinated axons appeared to decrease progressively from P60 till P120, by which 
time the corpus callosum was almost completely demyelinated. 
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Figure 15. Demyelination progresses with increasing age in the corpus 
callosum.  
N=3 (for each given time point and genetic background), adding up to a total number of 24 
quantified specimens. Bars display s.e.m. There is a progressive loss of myelin sheaths with time 
in the #72 mouse corpus callosum, leading to a significant reduction in the percentage of 
myelinated axons in the #72 mouse corpus callosum compared to wild type, at P60, P90 and 
P120. At P40 the percentage of myelinated axons was similar in the #72 mouse compared to the 
wild type mouse, suggesting that developmental myelination is relatively normal in #72 mouse 
corpus callosum (**: p<0.01, ****: p<0.0001). 
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3.4.3 Mature oligodendrocytes were present in the demyelinating #72 
homozygote corpus callosum 
 
To determine if demyelination in the #72 homozygote corpus callosum was 
accompanied by a loss of mature oligodendrocytes, an antibody to APC, a marker 
for mature oligodendrocytes, was used. At all time points investigated, APC 
positive oligodendrocytes were present (Figure 16). The distribution of 
oligodendrocytes in the #72 mouse corpus callosum was comparable to the wild 
type. Even at P120, when the corpus callosum was completely demyelinated, 
APC positive cells were present. This suggests that myelin degeneration in the 
#72 mouse is not entirely due to oligodendroglial cell death. 
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Figure 16. Mature oligodendrocytes were present at all time points during 
demyelination. 
Micrographs of wild type (A – D, I) and #72 mouse (E – H, x100, scale bar 400µm; K, x400, scale 
bar 25µm) corpus callosum labeled with an antibody to APC (CC1), between P40 and P120. The 
distribution of mature oligodendrocytes appeared similar in the #72 mouse compared to the wild 
type. Despite progressive demyelination, mature oligodendrocytes were present in the corpus 
callosum, suggesting that the demyelination is not caused by primary oligodendrocyte cell death. 
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In summary, these studies demonstrate that there is a slowly progressing 
demyelination in the #72 mouse corpus callosum with no evidence of effective 
remyelination. Since, in rodents, remyelination is usually a default response to 
demyelination, I went on to examine various factors that could contribute to 
remyelination failure, such as the presence and response of OPCs and the 
astroglial and the microglial response in the #72 mouse. 
 
3.4.4 Oligodendrocyte precursor cells were abundantly present in the 
#72 corpus callosum 
 
OPCs are responsible for regenerating myelin sheaths in the CNS after a 
demyelinating event (Zawadzka et al., 2010). In the context of the progressive 
demyelination of the #72 homozygote corpus callosum and in the absence of 
effective remyelination, I examined the oligodendroglial lineage.  
 
To determine if OPCs were present in the demyelinating corpus callosum, OPC 
markers NG2 (Figure 17) and PDGFRα were used to label and to quantify the OPC 
population (Figure 18 & Figure 19). In the #72 mouse corpus callosum, NG2 and 
PDGFRα +ve cells were present at all time points examined, at a similar density 
to the wild type. The NG2 +ve cell density was significantly elevated at P120 in 
the #72 mouse, compared to the wild type. 
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Figure 17. NG2+ cells were present in the #72 mouse corpus callosum 
during all stages of demyelination. 
Micrographs of sections stained for NG2, between P40 and P120, in wild type (A – D) and #72 
mouse (E – H, x100, scale bar 400µm) corpus callosum. At all time points during the progressive 
demyelination, NG2 +ve cells were present in the #72 homozygote corpus callosum. The density 
appeared similar to the wild type. The NG2 cell processes appeared thicker and more branched 
in the #72 mouse (K) compared to the wild type (I, x400, scale bar 50µm). 
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Figure 18. NG2+ cells in the #72 mouse corpus callosum between P40 and 
P120. 
Graph illustrating the NG2 +ve cell density between P40 and P120 in wild type and #72 mice. N=3 
(for each given time point and genetic background), adding up to a total number of 24 quantified 
specimens. Bars display s.e.m. Mean NG2 cell density was similar in the #72 mice compared to 
the wild type up to P90. At P120, when demyelination is complete, there was a significant 
increase in NG2 +ve cell density in the #72 mice compared to wild type  (*: p<0.05). 
 
Figure 19. PDGFRα positive cells in the demyelinating #72 mouse corpus 
callosum.  
Graph illustrating PDGFRα +ve cell density in the wild type and #72 mouse corpus callosum 
between P40 and P120. N=3 (for each given time point and genetic background), adding up to a 
total number of 24 quantified specimens. Bars display s.e.m. Bars displaying s.e.m There was no 
significant difference in the density of PDGFRα +ve cells in the #72 mouse corpus callosum 
compared to the wild type. The PDGFRα +ve cell density was, in both wild type and #72 mouse 
corpus callosum, lower compared to the NG2 +ve cell population. 
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In short although progressive extensive demyelination occurs during adulthood in 
the #72, OPCs are abundantly present at all time points. Despite the abundant 
OPC population there was no evidence of an effective attempt at remyelination 
and the question therefore arises of how the OPCs respond to the demyelination. 
 
3.4.5 Characterisation of OPC response during progressive myelin loss 
 
3.4.5.1 Waves of OPC proliferation occurred during progressive 
demyelination  
 
To study the proliferation activity of OPCs in the #72 corpus callosum, one single 
intraperitoneal injection of the thymidine analogue Bromodeoxyuridine (BrdU) 
was performed one hour prior to euthanasia. BrdU is incorporated into 
replicating DNA during the s-phase of the cell cycle and can be used to identify 
proliferating cells. For quantification of OPC proliferation the sections were 
double labelled with antibodies against PDGFRα and BrdU (Figure 20).  
 
Initially the PDGFRα/BrdU +ve cell density was similar in #72 and wild type mice. 
There was a continuous decline in PDGFRα/BrdU +ve cell density in the wild type 
after P40 up to P120. In the #72 corpus callosum the PDGFRα/BrdU +ve cell 
density initially followed a similar decline between P40 and P60. However there 
was a significant increase in PDGFRα/BrdU +ve cell density at P90 in the #72 
compared to the wild type. This was followed by a decline in BrdU/PDGFRα +ve 
cell density at P120, when the cell density again appeared similar to wild type 
(Figure 21). 
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Figure 20. Cell proliferation occurred in response to demyelination. 
Micrographs of BrdU +ve cells in the corpus callosum between P40 and P120 in wild type (A - D) 
and #72 homozygote mice (E - H, x100, scale bar 400µm). Initially at P40 and P60 BrdU +ve cells 
were present in a comparable fashion between the wild type and #72 homozygote mice. However 
there was a marked increase in BrdU +ve cells in the #72 homozygote compared to the wild type 
at P90. At P120 the quantity of BrdU +ve cells appeared similar in the #72 and wild type mice. 
Some of these BrdU +ve cells were PDGFRα +ve, suggesting that OPC proliferation occurs during 
demyelination (I, K, x400, scale bar 25µm). 
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Figure 21. OPC proliferation occurred in association with progressive 
demyelination.  
Graph illustrating the OPC proliferation in wild type and #72 homozygote mouse during 
progressive demyelination. N=3 (for each given time point and genetic background), adding up to 
a total number of 24 quantified specimens. Bars display s.e.m. In order to focus on OPC 
proliferation only BrdU/PDGFRα +ve cells were counted. Initially the OPC proliferation was 
similar in both the wild type and the #72 mouse. Proliferation was higher at this age compared to 
older ages, probably reflecting ongoing myelination. There was a reduction in PDGFRα/BrdU +ve 
cell density at P60 in both the wild type and #72 mouse, followed by a significant increase in 
PDGFRα/BrdU +ve cells, suggesting an increased OPC proliferation at P90 in the #72 mouse. By 
P120, the proliferative pool was similar to the wild type.  
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3.4.5.2 OPC differentiation is virtually absent in the demyelinated #72 corpus 
callosum 
 
Since proliferation of the OPCs take place in response to progressive 
demyelination in the #72 corpus callosum, the next step was to identify the 
differentiation status of the OPCs during progressive demyelination. It has been 
shown that the basic Helix-Loop-Helix (bHLH) transcription factor Olig1 is 
required during remyelination and that the absence of Olig1 leads to 
remyelination failure (Arnett et al., 2004). For remyelination to be successful 
OPCs must differentiate into oligodendrocytes. The change in subcellular 
distribution of Olig1, which has been shown to be a translocation of Olig1 from 
cytoplasm into the nucleus during OPC differentiation, can be used to 
characterise the status of OPCs during demyelination and remyelination (Arnett 
et al., 2004;Kitada and Rowitch, 2006). To investigate if Olig1 translocates to 
the cell nucleus in OPCs in the #72 homozygote corpus callosum, the subcellular 
localisation of Olig1 in NG2 cells was analysed and quantified. NG2 +ve cells with 
(i) intranuclear, (ii) intranuclear and cytoplasmic, (iii) partial intranuclear and 
cytoplasmic or (iv) cytoplasmic Olig1 localisation were identified (Figure 22). 
NG2 +ve cells that were negative for Olig1 as well as Olig1 +ve cells that were 
negative for NG2 were also observed. P3 #72 mice had the expected intranuclear 
Olig1 expression during early neonatal development (Figure 23). In adult 
animals, only extremely rare NG2 +ve /intranuclear Olig1+ve cells were found in 
either wild type or the #72 mice (Table 4). In fact almost half of all NG2 +ve 
/Olig1 +ve cells in wild type and #72 mice had a pure cytoplasmic localisation of 
Olig1 (Figure 24).  
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Figure 22. All variants of subcellular Olig1 localisation in NG2+ cells were 
found in the #72 mouse during demyelination. 
Micrographs from #72 corpus callosum showing NG2 +ve cells with cytoplasmic localisation of 
Olig1 (A – D), with cytoplasmic and partially nuclear localisation of Olig1 (E – H), with 
cytoplasmic and nuclear localisation of Olig1 (I – L) and with nuclear localisation of Olig1 (M – P, 
x400, scale bar 25µm). This indicates that all stages of OPC proliferation and differentiation 
were present in the #72 homozygote mouse. Note that combined cytoplasmic and nuclear Olig1 
is also present in NG2 negative cells (arrow).  
  
121 
 
Figure 23. Different subcellular Olig1 localisation was observed in NG2 
negative cells. 
Micrographs from #72 corpus callosum. NG2 negative cells with nuclear localisation of Olig1 were 
also detected (A – D). There were also a few NG2 +ve cells, which were Olig1 negative. In the 
same image there is a cytoplasmic Olig1 only positive cell, which is most likely a mature 
oligodendrocyte (E – H x400, scale bar 25µm). This shows that not only in OPCs but also in other 
cells the subcellular localisation of Olig1 can vary. In order to verify the sensitivity of the Olig1 
antibody to penetrate intranuclear, tissue from P3 #72 homozygote mice was used where 
intranuclear localisation of Olig1 in Olig2 positive cells is expected to be present. Intranuclear 
localisation of Olig1 in Olig2 positive cells was detected in developing #72 homozygote corpus 
callosum (I – L, x400, scale bar 25µm). This is in agreement with observations described in the 
literature. 
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NG2 & Olig1 
intranuclear 
NG2 & Olig1 
cytoplasmic 
NG2 & Olig1 
intranuclear & 
partial 
cytoplasmic 
NG2 & Olig1 
intranuclear & 
cytoplasmic 
Mean 
(%) 
S.E.M 
Mean 
(%) 
S.E.M 
Mean 
(%) 
S.E.M 
Mean 
(%) 
S.E.M 
WT 
P40 
0.32 ±0.32 63.347 ±2.025 24.393 ±5.272 11.94 ±6.793 
#72 
P40 
0 0 38.69 ±2.38 50.29 ±3.965 11.02 ±3.154 
WT 
P60 
0.347 ±0.347 51.293 ±6.947 41.347 ±4.394 7.013 ±2.825 
#72 
P60 
1.367 ±0.803 34.137 ±6.332 44.803 ±6.345 19.693 ±2.788 
WT 
P90 
1.170 ±1.170 57.933 ±7.153 30.563 ±4.632 10.333 ±4.535 
#72 
P90 
0 0 47.277 ±3.078 48.79 ±3.987 3.933 ±1.695 
WT 
P120 
0 0 49.373 ±2.187 49.787 ±2.11 0.477 ±0.477 
#72 
P120 
0 0 45.673 ±4.014 50.905 ±4.328 3.423 ±0.965 
 
Table 4. Intranuclear Olig1 was rarely observed in wild type and #72 
homozygote NG2 +ve cells. 
N=3 (for each given time point and genetic background), adding up to a total number of 24 
quantified specimens. Olig1 was mainly found in the cytoplasm or in mixed cytoplasmic and 
nuclear locations. The population with mixed subcellular localisation of Olig1 were most likely 
proliferating OPCs. 
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Figure 24. The subcellular distribution of Olig1 in #72 mouse NG2 +ve cells. 
Graph representing the percentage of subcellular localisation of Olig1 in NG2 +ve cells. N=3 (for 
each given time point and genetic background), adding up to a total number of 24 quantified 
specimens. Bars display s.e.m. In NG2 +ve cells in the #72 mouse, Olig1 was mainly localised in 
both cytoplasm and nucleus. Only a very few NG2 +ve cells had a uniquely intranuclear 
localisation of Olig1.  
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3.4.6 Astrocytic response during demyelination of the #72 homozygote 
corpus callosum 
 
In general, astrocytes react to demyelination by proliferation and activation 
(reviewed in (Moore et al., 2011a;Ayers et al., 2004). The role of astrocytes in 
demyelinating pathology is controversial. Both beneficial (Franklin et al., 
1991;Liu et al., 1994;Moore et al., 2011b) and inhibitory (Back et al., 
2005;Blakemore et al., 2003;Su et al., 2011) roles in remyelination has been 
reported reviewed in (Nash et al., 2011). To characterise the astrocytic response 
during demyelination in the #72 mouse, an antibody to GFAP was used (Figure 
25). GFAP +ve cell density was increased in the #72 homozygote compared to the 
wild type at all ages examined. Significant increase was observed (p<0.05) from 
P60 onwards and increased with the severity of demyelination (Figure 26).   
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Figure 25. A progressive astrocytic response accompanied demyelination in 
the #72 mouse corpus callosum. 
Micrographs of sections stained for GFAP, between P40 and P120, in wild type (A – D) and #72 
mouse (E – H, x100, scale bar 400µm) corpus callosum. At P40 the density of astrocytes was 
similar in #72 and wild type mice. From P60 onwards, the astrocyte density was significantly 
increased in the #72 mouse corpus callosum compared to the wild type. Astrocyte morphology 
changed with progressive demyelination. In the #72 mouse, astrocyte processes appeared thicker 
and more branched (K, magnification x400, scale bar 25µm) than in wild type mice (I, x400, scale 
bar 25µm). 
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Figure 26. Astrocyte cell density is increased in the #72 mouse corpus 
callosum. 
Graph illustrating the astrocytic cell density during progressive demyelination in the #72 mouse 
corpus callosum. N=3 (for each given time point and genetic background), adding up to a total 
number of 24 quantified specimens. Bars display s.e.m. The astrocyte density in the #72 mouse is 
comparable to the wild type at P40. A progressive increase in astrocyte cell density was present 
after P40, with a particularly steep increase between P90 and P120. Cell density was 
significantly increased in the #72 mouse, compared to wild type, at P60, P90 and P120. (*: 
p<0.05, **: p<0.01, ***: p<0.001). 
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3.4.7 Immune cell response in the #72 homozygote corpus callosum 
 
3.4.7.1 Progressive demyelination is accompanied by an increase in CD45 and 
CD169 positive cell population 
 
The microglial/macrophage population has been shown to undergo marked 
upregulation (Tatar et al., 2010) and to contribute to the progression in 
demyelination (Ip et al., 2006;Ip et al., 2007) in Plp1 gene overexpressing mice 
(line #66). In context with remyelination, inflammation has been shown to have 
a promoting effect on remyelination efficacy (Foote and Blakemore, 2005a;Setzu 
et al., 2006). Also the phagocytic activity of microglia/macrophages is beneficial 
for remyelination (Kotter et al., 2006;Merson et al., 2010). On the other hand 
microglia mediated inflammation can also be cytotoxic, which can cause 
unspecific severe tissue damage also on remyelination capable OPCs (Merson et 
al., 2010). 
 
The pan leukocytic marker CD45 was used to characterise the 
microglia/macrophage population during demyelination in the #72 mouse corpus 
callosum. In the normal CNS there are only a few trafficking T and B cells so the 
majority of CD45+ cells are microglia. Most of the CD45 +ve cells were dendritic 
in appearance, resembling microglial cells (Figure 27). Only a few cells lacked 
processes, suggesting they were lymphocytes (arrows in Figure 27). Therefore 
the vast majority of CD45+ve cells most likely were microglial/macrophages. The 
density of CD45+ve cells was significantly increased from P60 onwards in the #72 
homozygote corpus callosum compared to the wild type, and increased in 
proportion to the severity of demyelination (Figure 28). 
 
Not only the increase in density of microglia but also their state of activation, 
which can be identified by the expression of the macrophage restricted adhesion 
molecule sialoadhesin (CD169), has been shown to be involved in the 
demyelination process and the development of axonal pathology. Knock out of 
sialoadhesin (CD169) expression on microglia/macrophages in a different Plp1 
overexpressing mouse model, (line #66) ameliorated demyelination and axonal 
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damage (Ip et al., 2007). Activated microglia also secret TNFα (reviewed in 
Merson et al., 2010), and may induce OPC apoptosis, which leads to a reduction 
in OPCs and therefore may have a negative influence on remyelination capacity 
(Mi et al., 2011). CD169 is normally not expressed on microglia and it is thought 
that CD169 expressing cells in the CNS are recruited from the periphery to the 
damaged CNS (Perry et al., 1992). However, activation of residential 
microglia/macrophages occurs in relation to pathological processes in the CNS 
and (Ip et al., 2007) suggested that at least some of the CD169+ cells in Plp1 
overexpressing mice CNS are resident microglia (Ip et al., 2007).  
 
In the #72 homozygote corpus callosum, CD169 expression was observed after 
P60 and markedly increased up to P120 (Figure 29 and Figure 30). CD169+ cells 
were also present in the choroid plexus and blood vessels as would be expected 
(Figure 29 arrows and arrowheads) and were only occasionally present in the 
wild type corpus callosum at any of the time points examined. 
 
Edgar et al (2010) showed that B cells are rare and that there are only a few T 
cells in the #72 mouse optic nerve (Edgar et al., 2010). In this study, B-cells 
were absent in the P120 #72 mouse corpus callosum (data not shown). 
Infiltrating T cells have been reported to contribute to the demyelination and 
axonal pathology in Plp1 gene overexpressing mice (Ip et al., 2006). To 
investigate if T-cells were present during demyelination in the #72 homozygote 
corpus callosum, CD3, a marker for T-cells, was examined. A small number of 
CD3+ve cells were present during the later stages of demyelination (Figure 31).  
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Figure 27. A marked increase in microglial/macrophages accompanies 
progressive demyelination. 
Micrographs of CD45 +ve cells in the corpus callosum at P40, P60, P90 and P120 in wild type (A – 
D) and 72 (E – F; x100, scale bar 400um) mice. An obvious increase in the density of CD45 
positive cells is evident in the #72 mouse compared to the wild type. Morphologically the CD45+ 
cells in the #72 mouse appeared altered, having thicker and shorter processes (K, x400, scale bar 
25µm) than wild type cells (I, magnification x400, scale bar 25µm). At P120 a few cells with a 
rounded morphology, resembling B or T lymphocytes, were present in the #72 mouse (arrow). 
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Figure 28. Microglial/macrophage cell density increases progressively in the 
#72 homozygote corpus callosum. 
Graph illustrating the microglial/macrophage cell density changes during progressive 
demyelination. N=3 (for each given time point and genetic background), adding up to a total 
number of 24 quantified specimens. Bars display s.e.m. The microglial/macrophage cell density 
was increased in the #72 homozygote corpus callosum compared to wild type, from P60 and 
progressively increased up to P120, when demyelination of the corpus callosum was virtually 
complete. (**: p<0.01, ***: p<0.001). 
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Figure 29. Sialoadhesin expressing cells were found in the demyelinating 
corpus callosum. 
Micrographs of CD169 +ve cells in the corpus callosum between P40 and P120, in wild type (A – D) 
and 72 mice (E – F; x100, scale bar 400um). At all time points in the wild type mice and up to 
P60 in the #72 mouse corpus callosum there were only occasional CD169 +ve cells detected. At 
P90 and P120, several CD169 +ve cells were observed in the #72 mouse corpus callosum. CD169 
+ve cells were present in wild type and #72 mouse choroid plexus (arrows) and blood vessels 
(arrowheads). CD169 expression was detected on both the cell body and on cell processes (I, 
x400, scale bar 25µm). 
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Figure 30. The density of activated microglial/macrophages is progressively 
increased in the #72 mouse corpus callosum. 
Graph illustrating CD169 +ve cell density changes during progressive demyelination. N=3 (for 
each given time point and genetic background), adding up to a total number of 24 quantified 
specimens. Bars display s.e.m. CD169+ve cells were observed in the corpus callosum after P60 
and the CD169 cell density increased between P90 and P120, corresponding with the severity of 
demyelination (***: p<0.001, ****: p<0.0001) 
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Figure 31. T cell infiltration accompanied progressive demyelination and 
activation of the microglial/macrophage cell population. 
Micrographs of CD3+ve cells in the corpus callosum, between P40 and P120, in #72 (A, B, C, E) 
and wild type mice (D, x100, scale bar 400µm). CD3+ve cells were only observed at P90 and P120 
(F, x400, scale bar 50µm), suggesting that the T cell infiltration succeeded the earliest stages of 
demyelination. 
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3.4.8 Progressive demyelination and inflammation is associated with 
axonal swelling in the #72 homozygote corpus callosum  
 
Axonal damage and neuronal degeneration is considered to be the main cause of 
permanent disability in multiple sclerosis (reviewed in Bjartmar and Trapp, 
2001). Dystrophic axons are also believed to become non permissive for 
remyelination (reviewed in Franklin and ffrench-Constant, 2008) and may 
contribute to remyelination failure. A previous study from (Edgar et al., 2010) 
showed the presence of axonal swellings in the inflamed, demyelinating 
chiasmal region of #72 homozygote mouse optic nerve. 
 
To test if axonal swellings occur in the #72 homozygote corpus callosum I used 
an antibody to SMI32 that labels non-phosphorylated neurofilaments. Prior to 
myelination, axonal neurofilaments are largely non-phosphorylated (Brady et al., 
1999;Petzold, 2005). Myelination is accompanied by increased phosphorylation of 
neurofilaments and increase in axonal diameter. Following demyelination, 
neurofilaments become dephosphorylated (Trapp et al., 1998). Antibodies that 
recognise non-phosphorylated neurofilaments are routinely used to identify 
axonal changes in relation to demyelination. At P40, SMI32 staining appeared 
similar in the #72 mouse compared to the wild type. However, at P120 SMI32 
staining appeared markedly increased in the #72 mouse, compared to the wild 
type (Figure 32).   
 
To visualise morphological changes in axons, a Thy-1 / CFP expressing mouse was 
crossed with the #72 homozygote mouse to create homozygous Plp1 
overexpressing mice that were hemizygous for the transgenic Thy-1 / CFP gene, 
as described in Chapter 2. Using CFP as a sensitive marker of axonal changes, 
axonal swellings appeared to be increasingly prevalent in the homozygote 72 
mice corpus callosum from P90 onwards (Figure 33).  
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Figure 32. Axonal changes increased with progressive demyelination and 
inflammation. 
Micrographs of sections stained using antibody to SMI32 in the corpus callosum of P40  and P120 
wild type (A, B) and #72 (C, D, magnification x100, scale bar 400µm) mice. SMI32 labels non-
phosphorylated neurofilaments and is a useful marker of pathology in the adult. Axons positive 
for SMI32 were more prevalent in the #72 mouse than in the wild type, at P120. An SMI32 +ve 
axonal swelling was observed occasionally (arrow).  
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Figure 33. Axonal swellings as a sign of axonal injury were increasingly 
present with progressive demyelination and inflammation. 
Micrographs of CFP +ve axons in the corpus callosum of P40 to P120 #72 (A, B, C, E) and P120 
wild type mice (D, x100, scale bar 400µm). CFP is expressed in a subset of sensory and motor 
neurons and is located in the cytoplasm (black asterisk). Visualisation of GFP analogues is a more 
sensitive marker of axonal swellings (arrows) than antibody staining (Bridge et al., 2009). A 
number of axonal swellings (K, confocal image, x670) were present after P90 in the #72 mouse.  
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3.4.9 Axonal density in the #72 homozygote was unaltered compared 
to the wild type corpus callosum  
 
Demyelination and associated processes, such as inflammation, can lead to 
axonal changes resulting in permanent axonal loss. To determine if axonal loss 
could contribute to the failure of remyelination in the #72 homozygote corpus 
callosum, electron micrographs were used to calculate axonal density. The 
axonal density decreased slightly with increasing age in wild type and in the #72 
homozygote corpus callosum. However, there was no significant difference in 
axonal density in the #72 homozygote corpus callosum compared to wild type, at 
any of the ages examined (Figure 34).  
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Figure 34. Axonal density was not reduced in the demyelinated corpus 
callosum of the #72 mouse. 
Graph of axonal density in the wild type and #72 mouse corpus callosum. N=3 (for each given 
time point and genetic background), adding up to a total number of 24 quantified specimens. 
Bars display s.e.m. There was no significant difference in axonal density in the #72 mouse corpus 
callosum compared to the wild type, at any of the time points examined.  
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Demyelination and remyelination failure was not caused by Caspase3 
mediated cell apoptosis 
 
In dysmyelinating mutants such as the jimpy mouse (Gow et al., 1998;Cerghet et 
al., 2001), the rumpshaker mouse (McLaughlin et al., 2007) or the msd mouse 
(Gow et al., 1998), the mutated PLP/DM20 accumulates in the cell body and 
causes an unfolded protein reaction (UPR) causing a Caspase12 mediated cleaved 
Caspase3 induction, leading to cell apoptosis. However it has also been shown 
that in another Plp1 gene overexpressing mouse model (line #66) the degree of 
cell apoptosis is less severe than for example in the jimpy mouse (Cerghet et al., 
2001). A recent study has shown that inflammation induces Caspase3 mediated 
OPC apoptosis by DR6 activation, which is highly expressed on immature OPCs 
leading to impaired remyelination capacity (Mi et al., 2011). Antibody against 
cleaved Caspase3 was used to characterise cell apoptosis mediated through 
Caspase3 signalling (Figure 35). Caspase3 +ve cells were scarce at all time points 
examined in the #72 homozygote corpus callosum, indicating that if cell 
apoptosis was present it is not Caspase3 mediated.  
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Figure 35. Caspase3 mediated cell apoptosis was not detected in the #72 
homozygote corpus callosum. 
Micrographs of Caspase3 +ve cells in the corpus callosum between P40 and P120 in #72 
homozygote mice (A - E), at P120 in wild type mice (F) and in spleen (G, x100, scale bar 400µm, 
H, x400, scale bar 50µm). Caspase3 positive cells were only rarely observed in the #72 mouse 
(E). Lipofuscin (arrows) contributes to the fluorescent signal in the #72 mouse.  
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3.4.10 OPC cell differentiation inhibition: an in situ screening of 
OPC intrinsic and extrinsic factors known to be involved in 
remyelination failure  
 
Multiple OPC intrinsic and extrinsic factors have been identified to interact 
during the complex remyelination process after demyelination. It has been 
stated that only a slight interruption in any of these finely tuned interactions 
during the remyelination processes can eventually lead to remyelination failure 
(reviewed in Franklin and ffrench-Constant, 2008). In my study I focused on a 
few potential factors, such as prolonged Wnt pathway activation, accumulation 
of hyaluronan, polysialation of neural cell adhesion molecule and local thyroid 
hormone regulation which have been described to alter remyelination capacity. 
 
3.4.10.1 There is no evidence that OPC cell differentiation is inhibited by 
abnormal Wnt pathway activation  
 
The activation of the Wnt pathway has been shown to play a pivotal role in 
coordinating remyelination after demyelination. During the OPC recruitment and 
proliferation phase, the Wnt pathway is activated. For OPC differentiation on 
the other hand, the Wnt pathway needs to be deactivated. It has been shown 
that in the case of prolonged Wnt pathway activation, remyelination after 
chemically induced demyelination is delayed (Fancy et al., 2009). It has been 
hypothesized that if the delay is prolonged, the narrow temporal window during 
which the demyelinated area is favourable for remyelination may be missed, 
potentially leading to remyelination failure (Fancy et al., 2009).  
 
To investigate the possibility that abnormal activation of the canonical Wnt 
pathway contributes to OPC differentiation block in the #72 mouse corpus 
callosum, antibody labelling of Axin 2 was undertaken. Axin2 provides negative 
feedback of the Wnt pathway and is only expressed when the pathway is 
activated. At P40 and P90, when BrdU +ve OPC density was elevated, Axin2 +ve 
cells were present. At P60 and P120, where BrdU +ve OPC density was low, Axin2 
was not detected (Figure 36). This is compatible with the Wnt pathway being 
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active during OPC proliferation phase. Double labelling with Olig1 confirmed 
that most of the Axin2 positive cells were of oligodendroglial lineage (Figure 37 
A - D). Incidentally, Axin2 staining also co-localised with axonal swellings (Figure 
37 E - H). 
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Figure 36. Activation of the canonical Wnt pathway was present at time 
points where OPC proliferation was upregulated. 
Micrographs of #72 (A - D) and wild type (I) corpus callosum and colon (K, x100, scale bar 
400µm), stained using antibody to Axin2. In the #72 corpus callosum, a higher proportion of Axin2 
positive cells were present at P40 and P90 compared to P60 and P120 as well as to the wild type. 
Axin2 localisation was intranuclear (E) or cytoplasmic (G). Axin2 positive structures that were 
not related to cell nucleus resembled axonal swellings. (F, H, x400, scale bar 25µm). 
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Figure 37. Axin2 is located in cells originating from the oligodendroglial 
lineage.  
Micrographs of #72 corpus callosum at P90. Double labeling with Olig1 (A – D) showed that Axin2 
positive cells expressed Olig1, indicating that the Wnt pathway is active in cells of the 
oligodendroglial lineage, during demyelination. Since the Axin2 structures, which could not be 
correlated with a nucleus, resembled axonal swellings, Axin2 expression in the Thy-1-CFP was 
investigated. (E –F, x400, scale bar 25µm) Axin2 staining overlapping with CFP in axonal swellings 
(arrows). Neuronal cell bodies (arrowhead), which were filled with CFP, were Axin2 negative, 
showing that Axin 2 labeling was not due to unspecific binding of Axin2 to CFP. There were also 
Axin2 positive cells that were negative for CFP (asterisk) that had a similar morphology to the 
Olig1/Axin2 positive cells in the #72 homozygote corpus callosum. 
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3.4.10.2 Accumulation of hyaluronan was present at the end stage of 
demyelination in the #72 homozygote corpus callosum 
 
Hyaluronan, which is secreted by astrocytes in chronic demyelination, is a 
potent inhibitor of OPC maturation and contributes to remyelination failure in 
chronic demyelinated lesions (Back et al., 2005). The inhibitory effect being 
mediated through TLR2 receptors on OPCs (Sloane et al., 2010). To test if 
hyaluronan was expressed in the extracellular matrix I used a biotinylated 
hyaluronan binding protein (bHABP). At P60, when demyelination is 
commencing, there was no evidence of hyaluronan expression in the #72 
homozygote corpus callosum, similar to wild type. At P120 an accumulation of 
hyaluronan was identified in the #72 homozygote corpus callosum. To rule out 
non-specific binding with myelin debris a double stain with MBP showed that 
HABP did not bind to myelin debris (Figure 38). 
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Figure 38. Hyaluronan accumulation was identified in the demyelinated 
corpus callosum at P120. 
Micrographs showing the hyaluronan labelling of wild type (A, B) and #72 mouse corpus callosum 
(C, D). At P60, when demyelination commenced, the distribution of hyaluronan in the #72 
homozygote appeared similar to the wild type. An increase in hyaluronan expression was 
observed at P120 in the #72 mouse and could potentially contribute to the OPC differentiation 
block. Tarsus was used as a positive control (E) The specificity of hyaluronan binding protein 
(HABP) was tested using tissue incubated with bovine hyaluronidase (F, x100, scale bar 400µm). 
To confirm that HABP was not binding to myelin debris, double labelling using HABP and an 
antibody to MBP was performed (G – I, x400, scale bar 25µm). The HABP positive structures did 
not co-label with myelin debris, stressing the specificity of the HABP to bind to hyaluronan. 
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3.4.10.3 Poly-sialated neural cell adhesion molecule (PSA-NCAM) 
expression was identified on astrocytes but not on axons in the 
chronically demyelinated #72 homozygote corpus callosum 
 
The polysialation of NCAM on axonal surfaces has been shown to inhibit the 
initiation of contact between OPC and unmyelinated axons. During development, 
PSA-NCAM plays a key role in regulating the precise timing of myelination and 
the expression of PSA-NCAM on axons is not detected after myelination 
commences (Coman et al., 2005). In pathology, such as in chronic MS, re-
expression of PSA-NCAM on demyelinated axons has been detected and it is 
thought to prevent remyelination by inhibiting the initial axonal glial contact 
which is needed to initiate remyelination after demyelination (Charles et al., 
2002). Antibodies against PSA-NCAM were used to examine the polysialation of 
NCAM on axons in the chronic demyelinated #72 homozygote corpus callosum. At 
P120, axons did not express PSA-NCAM, suggesting that is unlikely to be involved 
in the inhibition of myelination. However PSA-NCAM expression was detected on 
spindle shaped cells, which were also positive for GFAP (Figure 39).  
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Figure 39. PSA-NCAM expression was detected on astrocytes and not on 
axons in the #72 mouse corpus callosum.  
Micrographs form wild type (A) and #72 mouse corpus callosum (B, x100, scale bar 400µm) at 
P120. A few PSA-NCAM +ve cells were present in the P120 wild type corpus callosum (C). In 
contrast, the #72 mouse corpus callosum contained a marked number of PSA-NCAM positive cells 
(D, magnification x400, scale bar 25µm). Double labelling with PSA-NCAM and Olig2 to label 
oligodendroglia (E – H, x400, scale bar 50µm) or with PSA-NCAM and GFAP (I – L, x400, digitally 
magnified, scale bar 50µm) to label astrocytes, showed that most of the PSA-NCAM positive cells 
were GFAP +ve, suggesting that these cells are reactive astrocytes. 
149 
3.4.10.4 Deiodinase 3 expression was not detected on activated 
microglial cells in chronic demyelinated corpus callosum at P120  
 
The enzyme deiodinase 3, which converts T4 to reverse T3 (rT3) or T3 to T2 and 
therefore inactivates thyroid hormone activity, is believed to be responsible for 
tightly regulating the local concentration of active T3 in tissue (Bates et al., 
1999). It is believed that, especially in the case of inflammation, increased D3 
expression can cause local tissue specific hypothyroidism, which has negative 
effects on cell metabolism and repair. Since there is chronic inflammation with 
activation of microglia in the #72 homozygote mouse model, a potential 
expression of D3 on activated microglia/macrophages could contribute to the 
remyelination failure. To characterize D3 expression in the #72 corpus callosum, 
in this case mainly microglia/macrophages during chronic demyelination, an 
antibody to D3 in combination with antibody to CD45 were used. D3 was not 
detected by immunohistochemistry in the adult #72 mouse corpus callosum 
(Figure 40). 
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Figure 40. The microglia/macrophage population did not express D3 in the 
adult, chronically demyelinated #72 homozygote corpus callosum. 
Micrographs of wild type (A – C) and #72 homozygote (D – F, x100, scale bar 400µm) corpus 
callosum. Spleen was used as a positive control tissue (G – K, x400, scale bar 50µm). The CD45 
positive cell population in the #72 homozygote corpus callosum did not express D3. 
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3.5 Discussion 
 
3.5.1 Progressive demyelination was accompanied by remyelination 
failure in the #72 homozygote corpus callosum 
 
The data presented in this chapter demonstrates that myelination in the corpus 
callosum of the homozygous Plp1 overexpressing mouse (#72 mouse) proceeds 
relatively normally initially, but is followed by a progressive, non-remitting, 
demyelination, starting after P40 and terminating in virtually complete 
demyelination by P120. Demyelination is accompanied by activation of 
microglia/macrophages and astrocytes and by the infiltration of a small number 
of T cells. Axonal densities are unaltered, but in older mice, there is some 
evidence of axonal injury. These pathological changes, which are probably 
present throughout the brain as suggested by DTI findings (Ruest et al., 2011), 
account for the clinical signs observed in these mice. 
 
While it has previously been shown that demyelination is a characteristic of the 
optic nerve and spinal cord of various lines of Plp1 overexpressing mice 
(Anderson et al., 1998;Edgar et al., 2010;Ma et al., 2006), the evolution of 
demyelination has not been reported, except in the case of the #72 mouse optic 
nerve (Edgar et al., 2010). Therefore the nature and evolution of the 
degenerative and reparative processes are not known.  
 
Furthermore, despite the suggestion that in the hemizygous Plp1 transgenic 
mouse “remyelination intermingles with myelin destruction/degeneration” and 
that in older mice “most axons are demyelinated … with no signs of 
remyelination…” (line 4e of Ma et al., 2006) there is actually no evidence in the 
literature (including publications cited by Ma) to show that this is actually the 
case. Indeed the only evidence presented to support the assertion that 
remyelination fails in line 4e is a single high power image showing a marked 
reduction in PLP staining in the optic nerve of that model.  
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In the present study, a progressive demyelination in the absence of effective 
remyelination was demonstrated unequivocally, using a combination of 
immunofluorescence, light microscopy and EM. The initially formed myelin 
appeared morphologically normal, showing that during early post natal 
development, #72 OPCs are capable of appropriately myelinating axons. The 
inability to effectively (re)myelinate axons developed later on during the disease 
process. 
 
3.5.1.1 Demyelination in the #72 mouse corpus callosum 
 
Demyelination was not accompanied by an apparent decrease of mature 
oligodendrocytes, suggesting that the degenerative process in the #72 mouse 
represents a dying-back of the genetically defective oligodendrocyte, as 
suggested previously by (Anderson et al., 1998), which may be related to (i) an 
intrinsic instability of the biochemically abnormal sheath (Karim et al., 2007) as 
well as (ii) secondary immune reactions (Ip et al., 2006;Ip et al., 2007). In my 
study a marked increase and activation of microglia together with a subtle but 
definite elevation of intraparenchymal T cells accompanied the progressive 
demyelination, suggesting that secondary immune reactions also contribute to 
the demyelination in the #72 mouse, although leukodystrophies are classically 
considered to be non-inflammatory demyelinating diseases. 
 
Severe gliosis with astrocytic activation has also been reported to damage 
myelin and oligodendrocytes by secretion of TNFα (Selmaj and Raine, 1988; 
reviewed in Nash et al., 2011). Since there is a considerable astrocytic response 
accompanying demyelination in the #72 corpus callosum, the progression of the 
demyelination could also be mediated through the marked astrocytic response.   
 
3.5.1.2 The response of OPCs to demyelination 
 
It is notable that developmental myelination proceeds almost normally, 
demonstrating that juvenile #72 OPCs are myelination competent in contrast to 
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the situation in the adult, where there is no evidence of a remyelination 
attempt during progressive demyelination.  
 
OPCs, as identified using antibodies to NG2 and PDGFRa, were present in the 
corpus callosum during the entire period of demyelination. Using BrdU labelling 
of proliferating cells, I showed that OPCs responded to demyelination by 
proliferating. Surprisingly however, this did not lead to a marked increase in OPC 
densities, suggesting that either immature OPCs undergo apoptosis or that OPC 
proliferation is not extensive enough. OPC numbers were similar to those in the 
wild type mouse, except that at P120, where the density of NG2 +ve cells was 
increased in the #72 mouse. However, no such change was observed in the 
PDGFRα population and the NG2 data must be regarded with caution since NG2 
antibodies show unspecific binding to pericytes and a subset of macrophage like 
cells (MacFadyen et al., 2007;Matsumoto et al., 2008). NG2 +ve cells have also 
been shown not only to develop into oligodendroglia but also into astroglia, and 
neurons, which suggests that not all NG2 +ve cells are per se OPCs (Zhu et al., 
2008b;Zhu et al., 2008a;Nishiyama et al., 2009). Nonetheless, this data suggests 
that repair in the #72 mouse is not due to the complete absence of OPCs, and 
the increase in OPC proliferation at P90 suggests that the cells respond to the 
demyelinating stimulus. 
 
In MS lesions, remyelination sometimes fails despite OPCs being present 
(Wolswijk, 1998;Chang et al., 2002;Back et al., 2005;Kuhlmann et al., 2008). To 
determine if a differentiation block contributes to remyelination failure in the 
#72 mouse, I analysed OPC characteristics during demyelination by 
characterising the subcellular localisation of Olig1 in NG2+ cells. It has 
previously been demonstrated that the localisation of Olig1 during myelination 
and remyelination is a useful indicator of the developmental stage of the OPCs 
(Arnett et al., 2004;Kitada and Rowitch, 2006). Notably, the translocation of 
Olig1 from the cytoplasm to the cell nucleus is a prerequisite for (re)myelination 
(Arnett et al., 2004). In the demyelinating #72 mouse, there was an almost 
complete absence of pure intranuclear Olig1 in NG2+ cells, suggesting that the 
differentiation of OPCs into myelinating oligodendrocytes is either not initiated 
by the OPC or is inhibited.  
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In both the #72 and wild type mouse, a relatively large proportion of NG2 +ve 
cells had a cytoplasmic Olig1 localisation. This type of cell was only rarely 
observed in a recent detailed study focusing on the subcellular localisation of 
Olig1 (Kitada and Rowitch, 2006). However the study by Kitada and Rowitch 
focused on OPCs in the spinal cord but not on intracranial white matter 
structures raising the possibility that corpus callosal OPCs may behave 
differently from spinal cord cells. Notably, both dys- and demyelination have 
been observed preferentially in the corpus callosum in some mice (Kassmann et 
al., 2007;Taveggia et al., 2008). 
 
In short it appeared that the final step in myelin repair, the OPC differentiation, 
was blocked in the #72 mouse, contributing to remyelination failure.  
 
3.5.2 Potential inhibitors of OPC differentiation 
 
The final step, where OPC differentiate into oligodendrocytes, has been 
suggested to be the most vulnerable step during the entire remyelination 
process and often minimal disturbances at this time point leads to remyelination 
failure (reviewed in Franklin and ffrench-Constant, 2008). Based on the previous 
findings in this study, OPC differentiation block also seems to lead to 
remyelination failure in the #72 mouse and the question now arises why OPC 
differentiation is impaired in the adult #72 mice. Recently, different intrinsic 
and extrinsic factors, such as canonical Wnt pathway signalling (Fancy et al., 
2009), inhibited axonal glial contacts (Charles et al., 2002;Coman et al., 2005) 
or changes in the extracellular matrix (Back et al., 2005), have been identified 
to specifically block OPC differentiation during remyelination after 
demyelination and were further subject to this study.  
 
3.5.2.1 OPC intrinsic factor 
 
The study by (Fancy et al., 2009) showed that the canonical Wnt pathway is 
active during OPC proliferation but needed to be downregulated for successful 
OPC differentiation. The study also showed that prolonged activation of the 
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canonical Wnt pathway lead to delayed myelination and impaired remyelination 
capacity after chemically induced demyelination (Fancy et al., 2009). 
 
In the #72 mouse, the Wnt pathway activation pattern corresponded to the 
proliferation study using BrdU. Initially at P40, the Wnt pathway activity was 
similar in the #72 homozygote compared to the wild type, most likely reflecting 
developmental myelination activity. The peak, which was observed in P90 old 
#72 mice and not in the wild type, was believed to be an OPC proliferation 
response to the ongoing demyelination. Double labelling with Olig1 confirmed 
that most of the Axin2 positive cells were from the oligodendroglial lineage. At 
P120, when demyelination was virtually complete and remyelination would be 
expected, Axin2 expression was rare, suggesting that the Wnt pathway was not 
active at the point of virtually complete demyelination. The results suggested 
that an abnormal Wnt pathway activity was not involved in the development of 
an absent remyelination response. However the weakness in this study was that 
the conclusion was based only on Axin2 staining and the described canonical Wnt 
pathway expression pattern needs to be confirmed by identifying other Wnt 
pathway induced proteins such as Tcf4 and by proving the increase in Axin2 using 
western blot techniques. Also the effect of pharmacological manipulation of the 
canonical Wnt pathway as described in (Fancy et al., 2011) had not been 
performed and may provide further information about the influence of the Wnt 
pathway in the #72 mouse on remyelination failure. 
 
Interestingly in this study I identified the presence of Axin2 in axonal swellings. 
The reason for Axin2 expression in the swellings is not understood and has not 
been previously reported to my knowledge. The presence of Axin2 in axonal 
swellings may be due to either accumulation of Axin2 in the swellings as a result 
of disturbed axonal transport or it may be explained by an upregulation of the 
Wnt pathway in axons as a response to axonal damage or demyelination.  
 
With regard to abnormal Wnt pathway activation, age has been shown to 
influence the canonical Wnt pathway by reduced HDAC1 and HDAC2 function, 
leading to impaired OPC recruitment and differentiation, which had a reductive 
effect on remyelination efficacy (Sim et al., 2002). However the #72 homozygote 
model does not live much longer than 4 months. Despite this, when looking at 
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the successful initial myelination during post natal development, which is then 
followed by remyelination failure during adulthood, a discrepancy between 
neonate and adult OPCs seems to be present. Although repeated focal chemical 
injury to normal CNS is known not to negatively influence the remyelination 
capacity (Penderis et al., 2003), this does not reflect a pathology affecting the 
entire CNS. OPCs can migrate from unaffected areas to affected areas. The 
majority of the OPCs will therefore not be subject to repeated injury. A 
continuous injury, at least in vitro, to the total OPC population has shown to 
have a marked negative impact on the remyelination capacity (Fressinaud, 2005) 
and reflects probably better the situation in the #72 mouse. Chronic 
environmental changes accompanying the progressive demyelination in the #72 
corpus callosum could cause sustained injury to the total intracranial OPC pool, 
suggesting that repeated chronic injury may impair the remyelination capacity of 
#72 OPCs with time.  
 
3.5.2.2 OPC extrinsic factors  
 
When looking at the histopathological changes in the cell population of the #72 
corpus callosum during demyelination, some of the observed changes may be 
responsible for interfere with OPC differentiation. 
 
Mature oligodendrocytes, which are still abundantly present despite complete 
demyelination of the #72 corpus callosum, are known to be unable to 
remyelinate the demyelinated axons. The presence of mature oligodendrocytes 
in demyelinated areas potentially may inhibit OPC migration into the 
demyelinated lesions (Keirstead and Blakemore, 1997). The mature 
oligodendrocytes present in the #72 may therefore contribute to low OPC 
migration into demyelinated regions, which may lead to insufficient numbers of 
OPCs to maintain effective remyelination.   
 
Marked increase in, and activation of, the microglia/macrophage population has 
been shown to accompany the progressive demyelination in the #72 corpus 
callosum. Microglial activation has been proven to aggravate the demyelination 
and to be involved in the development of axonal pathology (Popovic et al., 
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2002;Ip et al., 2006;Howell et al., 2010). However, in correlation to 
remyelination the microglia/macrophage cell population has been shown to 
positively influence the remyelination process (Arnett et al., 2003;Neumann et 
al., 2009). In general, acute inflammation and activation of the 
microglia/macrophage population, even when superimposed on chronic 
demyelinated tissue (Foote and Blakemore, 2005a), has been shown to have a 
beneficial effect on remyelination (Setzu et al., 2006;Kondo et al., 2011). Even 
in MS, the presence of activated microglia/macrophages enhanced the 
remyelination capacity (Patani et al., 2007). This remyelination enhancing effect 
is believed to be mediated through phagocytic activity (Kotter et al., 2001) and 
secretion of promoting substances such as TNFα (Arnett et al., 2001), which is 
secreted by activated microglia (reviewed in Merson et al., 2010). However, 
TNFα seems to play a controversial role in the remyelination process. An 
inhibitory effect mediated through LPS activated microglia secreting TNFα has 
also been observed to have a negative impact on remyelination capacity in vitro 
(Miller et al., 2007). The negative effect of microglial activation, which leads to 
increased OPC apoptosis, appears mainly to depend on the differentiation status 
of OPCs. More mature OPCs, which are differentiating towards oligodendrocytes 
show less apoptosis compared to the immature OPCs, where apoptosis was 
increased after microglial activation (Miller et al., 2007). These findings were in 
agreement with a recent study of (Mi et al., 2011), which has shown that 
immature OPC express death receptor 6 (DR6), a receptor from the TNF family, 
and activation of this receptor mediates Caspase3 induced cell apoptosis (Mi et 
al., 2011). Since TNFα induced apoptosis of OPCs is mediated through Caspase3, 
it is questionable if a negative effect mediated through TNFα is present in the 
#72 corpus callosum, where Caspase3 mediated apoptosis could not be detected 
at any time point in this study. However, in the Plp1 gene overexpressing mouse 
models, sialoadhesin expressing microglia/macrophages definitively aggravates 
demyelination (Ip et al., 2007) and may still negatively impact remyelination 
through another unknown mechanism.  
Another role of the present inflammation in the #72 corpus callosum may the 
influence of inflammatory cells on local tissue thyroid homeostasis mediated 
through D3. Treatment with relatively high doses of the active thyroid hormone 
T3 have been shown to have an enhancing effect on remyelination after 
demyelination (Harsan et al., 2008;D'Intino et al., 2011). As previously 
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mentioned, deiodinases control tissue specific thyroid hormone levels, where D3 
is responsible for inactivation of the thyroid hormone (Huang, 2005). Increased 
expression of D3 has been reported in experimentally induced focal chronic 
inflammation (Boelen et al., 2005) and in an EAE model on macrophages and 
granulocytes (Boelen et al., 2009). The upregulation of D3 can lead to a local, or 
in severe cases, to a general non-thyroid induced hypothyroidism leading to a 
reduced cell metabolism and consequently to an impaired tissue repair. So far 
D3 expression on activated microglia has never been described and in this study 
D3 expression on the activated microglia was examined.  
 
In the #72 homozygote mouse the expression of D3, which could potentially lead 
to a restricted availability of T3 for the OPCs to differentiate during 
demyelination, was not present in the corpus callosum. Local T3 depletion 
causing a local hypothyroid state in white matter therefore seemed unlikely to 
play a role in the development of remyelination failure in the #72 homozygote 
mouse. However, if D3 expression was below the detectable level for the 
antibody, final proof that D3 is not involved in the development of remyelination 
failure in the #72 brain would be gained by the measurement of #72 CNS D3 
activity.  
 
The progressive astrocytic response which is observed in context with the 
progressive demyelination in the #72 corpus callosum may also influence OPC 
differentiation. The astrocytic population is also considered to play an 
ambivalent role by influencing remyelination both negatively (Blakemore et al., 
2003;Su et al., 2011) and positively (Liu et al., 1994;Moore et al., 2011a;Franklin 
et al., 1991). The interaction of the astrocytes with OPCs is regulated by the 
direct effect of promoting molecules such as IGF-1 (Liu et al., 1994) or inhibitory 
molecules such as hyaluronan (Back et al., 2005;Sloane et al., 2010) or the 
ambivalent TNFα (Su et al., 2011). Astrocytes can also indirectly interact with 
other cells such as microglia or neurons, which then secrete substances, such as 
FGF-2 (reviewed in Moore et al., 2011a), influencing OPC development. 
Hyaluronan is certainly present during the late stage of demyelination at P120 in 
the #72 corpus callosum.  
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Hyaluronan is known to inhibit remyelination in vitro and in vivo (Back et al., 
2005) and is mediated through activation of toll like receptor 2 expressed on 
OPCs. For hyaluronan mediated activation of the TLR2 receptor, the presence of 
the adaptor molecule MyD88 is required (Sloane et al., 2010). Unlike previously 
described, it is not the high molecular weight hyaluronan which causes the 
inhibitory effect, but through low molecular weight hyaluronan oligomers, which 
are generated by hyaluronidase expressed on OPCs (Back et al., 2005;Sloane et 
al., 2010). There is an obvious accumulation of hyaluronan present in the #72 
homozygote corpus callosum compared to the wild type and which could 
potentially contribute to the remyelination failure. When looking at the cellular 
changes in the #72 tissue, the astrocytes are probably the source of hyaluronan. 
However, the HABP used in this study did not distinguish between high or low 
molecular weight hyaluronan. Also the amount of hyaluronan was not quantified 
by western blotting and the expression of TLR2 receptors as well as the presence 
of MyD88 was not investigated.  
 
Another alteration in the #72 corpus callosum extracellular matrix was the 
persistence of myelin breakdown products up to P120.  Accumulation of myelin 
debris in demyelinated regions has been shown to inhibit OPC differentiation 
(Kotter et al., 2006). The OPC inhibition can be overcome by pharmacological 
induction of Fyn Rho and PKC signalling (Baer et al., 2009). In the #72 mouse, a 
substantial amount of myelin debris was present at the time of complete 
demyelination and could therefore potentially contribute to OPC differentiation 
block.  
 
Finally the observed axonal changes and their influence on the remyelination 
process also need to be addressed in the #72 mouse, which potentially can have 
a negative effect on remyelination. In the adult Plp1 overexpressing #66 and #72 
mice, inflammation and activation of microglia have also been suggested to 
cause axonal damage (Ip et al., 2006;Ip et al., 2007;Edgar et al., 2010) and 
dystrophic or destroyed axons are believed not to become remyelinated. In 
general after pure demyelination without axonal loss an increase in axonal 
density would be expected. However the glial response could fill the gap caused 
by demyelination. Since extensive axonal loss would cause a decrease in axonal 
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density the comparable axonal density between wild type and #72 homozygote 
suggests that extensive axonal loss is not present.  
 
Because of the difficulties to establish axonal numbers in the corpus callosum 
due to its size and its spatial variability of axonal number, I decided to calculate 
axonal density of the selected corpus callosum region. The use of axonal density 
in screening and evaluating axonal loss, however, is problematic because axonal 
loss may not be reflected properly by changes in axonal density. The insensitivity 
of axonal density to evaluate axonal loss is caused by the influence of extra 
axonal structures on axonal density. Demyelination will cause an increase in 
axonal density by the loss of the space expanding property of the myelin sheath. 
On the other hand the astrocytic response may fill the space for the lost myelin 
sheath. Stereological estimation, which is used to estimate entities of large 
dimensional samples based on the information from lower dimensional samples, 
could solve the problem of evaluating axonal numbers within the corpus 
callosum. 
 
However, axonal injury, mainly axonal swellings, were observed during the late 
stages of demyelination in the #72 homozygote corpus callosum Axonal changes 
are believed to render damaged axons non-permissive for remyelination 
(reviewed in Franklin and ffrench-Constant, 2008) and therefore extensive 
axonal damage may contribute to remyelination failure. Axonal swellings may 
also inhibit the initial axon-glial contact required to initiate remyelination. In 
order for OPCs to myelinate axons they must engage with the naked axon. 
Integrin signalling between the oligodendrocyte and the axon (Camara et al., 
2009;Laursen et al., 2009) and axonal electrical activity (Zalc and Fields, 2000) 
are important modulators of the early events of myelination in the CNS. Extreme 
distention of the axonal membrane at the site of axonal swelling could 
potentially have a bearing on both of these factors. 
The importance of the initial engagement of demyelinated axons with OPCs can 
also be seen in context with re-expression of PSA NCAM on axons. In chronic MS 
tissue, PSA NCAM expression on demyelinated axons was suggested to contribute 
to the remyelination failure by blocking this crucial initial contact between OPCs 
and axons and therefore causing a block of OPC differentiation and contributing 
to the failure of remyelination (Charles et al., 2002). 
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In the #72 homozygote corpus callosum, PSA NCAM was not detected on 
demyelinated axons. However at P120, astrocytes expressed PSA NCAM, which 
has been reported to occur on activated astrocytes (Massaro, 2002;Massaro et 
al., 2002). In this study the PSA NCAM positive astrocytes were considered to be 
reactive astrocytes and were only found at P120. 
 
3.6 Conclusion 
 
The pathological development of the demyelination and remyelination failure 
has now been described in detail in the #72 mouse. The characterisation of the 
corpus callosum is a prerequisite for the transplantation studies that follow in 
Chapter 4. Future experiments will involve the investigation of the role of the 
cell intrinsic and cell extrinsic compartment in the development of the 
remyelination failure. The cell intrinsic and cell extrinsic compartment 
preferably should be tested individually. The possibility to isolate and culture 
OPCs in vitro gives an opportunity to investigate the cell intrinsic compartment 
without influence of the cell extrinsic compartment. In vivo experiments using 
cell transplantation or pharmacological intervention will give the opportunity to 
evaluate the influence of cell extrinsic and to a certain extent the cell intrinsic 
compartment in the development of remyelination failure.    
162 
4 An evaluation of cell intrinsic and cell extrinsic factors 
that contribute to remyelination failure 
 
4.1 Introduction 
 
In Chapter 3 I showed that after initial myelination of the corpus callosum, a 
spontaneous progressive demyelination followed. Despite the fact that OPCs 
were present in the demyelinating environment, there was no evidence of 
successful remyelination. This was somewhat unexpected, since, with relatively 
normal myelin formation during development, a certain remyelination capacity 
during the advanced disease process might have been expected. The histological 
studies described in Chapter 3 indicated that both OPC intrinsic and OPC 
extrinsic factors could potentially be implicated in remyelination failure. In this 
chapter I use cell culture and cell transplantation to address these issues more 
directly.  
 
For remyelination to occur successfully, cell intrinsic and extrinsic factors must 
interact together in a precise spatial and temporal manner (reviewed in 
(Franklin, 2002;Franklin and ffrench-Constant, 2008;Peru et al., 2008). Briefly, 
microglia/macrophages first clear the affected region of myelin debris (Kotter et 
al., 2001). OPCs then migrate into the demyelinated area, where they 
proliferate leading to repopulation of the demyelinated area (Foote and 
Blakemore, 2005b).  Following repopulation, the OPCs differentiate into early 
oligodendrocytes (Shen et al., 2008). The newly formed oligodendrocyte 
processes contact the demyelinated axons after which the upregulation of 
myelin related genes in the contacting OPC are induced (Coman et al., 2005). 
Finally, the restoration of the myelin sheath leads to functional recovery 
(Duncan et al., 2009; reviewed in Franklin and ffrench-Constant, 2008). Given 
the complexity of the repair process, dysregulation of intracellular or 
extracellular signalling can perturb the finely balanced remyelination process, 
which in the worst case could end in the failure of remyelination. 
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Remyelination failure as a consequent of Plp1 gene overexpression has been 
investigated in another model, the 4e mouse line (Ma et al., 2006). In that study 
it was suggested that a combination of OPC intrinsic and OPC extrinsic 
abnormalities led to remyelination failure. However, demyelination and 
remyelination were only assumed in this mouse model and only a very limited 
histological assessment of the OPC extrinsic compartment were performed in 
situ. Adult OPC differentiation was only evaluated in vitro and was considered to 
be normal. 
 
The complex interaction between the cell intrinsic and cell extrinsic pathways 
during remyelination makes it difficult to evaluate the two compartments 
individually in vivo. To investigate the role of cell intrinsic factors in OPC 
differentiation, in vitro systems possess the advantage that the extrinsic 
influence (i.e. potentially inhibitory factors in the in vivo environment) on OPC 
differentiation and maturation can be eliminated. To date the differentiation 
potential of young and adult #72 mouse brain derived OPCs has not been 
evaluated in vitro. 
 
The OPC extrinsic compartment consists of multiple different cellular 
components, which have been shown to interact with the remyelination process 
such as axons (Charles et al., 2002;Coman et al., 2005;Piaton et al., 2010;Zalc 
and Fields, 2000), astroglia (Blakemore et al., 2003;Liu et al., 1994), microglia 
and trafficking immune cells (Foote and Blakemore, 2005a;Kotter et al., 
2001;Kotter et al., 2005;Arnett et al., 2003) as well as the extracellular matrix 
(Arnett et al., 2001;Back et al., 2005). To assess the role of the extrinsic 
compartment in remyelination failure in the #72 mouse, these components 
should be left as unaltered as possible. One way to study the extrinsic 
compartment is to perform in vivo transplantation experiments in the 
demyelinated region. Transplantation of myelination competent cells such as 
neurospheres into demyelinated areas can be used to evaluate the 
permissiveness of the environment for remyelination (Foote and Blakemore, 
2005a;Blakemore et al., 2003;Setzu et al., 2006;Zhang et al., 2003). The 
(re)myelination capacity of transplanted neuronal stem cells or glial progenitor 
cells have been shown in various dys- and demyelinating animal models (Edgar et 
al., 2004a;Fukuhara et al., 2006;Mothe and Tator, 2008;Pluchino et al., 
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2003;Windrem et al., 2008;Zhang et al., 2003) with successful, long lasting, 
stable chimerisation of the CNS leading, in some cases, to phenotypic 
normalisation of affected animals (Windrem et al., 2008).  
 
So far, cell transplant experiments aiming to evaluate the influence of the cell 
extrinsic compartment in chronically demyelinated white matter on 
remyelination failure has not been conducted in the #72 homozygote mouse 
model.  
 
  
165 
4.2 Aims of the study 
 
The overall aim of the work presented in this Chapter was to determine if OPC 
intrinsic and/or environmental factors contribute to remyelination failure in the 
#72 homozygote mouse. We used the corpus callosum, a major white matter 
tract where the pathology has been described in detail in Chapter 3, to address 
the role of the cell intrinsic compartment and the cell extrinsic compartment in 
remyelination failure in this model. 
 
Specifically the aims were:   
 
1. To determine if adult #72 homozygote OPCs are capable of differentiating 
normally if removed from demyelinated environment  
 
2. To determine if the #72 homozygote corpus callosum is permissive for 
(re)myelination 
 
To elaborate these two problems, the following experimental methods were 
used:  
 
1.) A co-culture system of isolated, adult #72 homozygote and wild type 
OPCs, where the differentiation of the cells can occur in the absence of 
confounding environmental factors. 
2.) Transplantation of wild type neurospheres into a predefined region of the 
adult #72 homozygote corpus callosum to evaluate if the cell extrinsic 
compartment is permissive for remyelination by myelination competent 
cells.  
3.) Injection of wild type neurospheres into P1 #72 homozygote mice to test 
the proof-of-principle that normal neurospheres can survive, integrate 
into the #72 homozygote CNS, replace the genetically altered 
oligodendroglial cells and generate stable myelin, essentially rescuing the 
#72 homozygote mouse phenotype. 
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4.3 Material and Methods 
 
4.3.1 Mouse colony 
 
Homozygote male #72 mice expressing GFP under the β-actin promoter and mice 
harbouring a Plp1-LacZ fusion gene were used in the cell culture and cell 
transplant experiments. Technical details, generation and maintenance of the 
different mouse lines are described in Chapter 2.2 Mouse breeding. 
 
4.3.2 Identification of GFP expression in the β-actin-GFP expressing 
line 
 
In the β-actin-GFP expressing mouse model GFP is, amongst other cells, also 
present in epithelial cells. GFP positive pups can therefore be identified by 
simply exposing them to a handheld UV light in darkness. In these circumstances, 
green fluorescence is visible to the human eye. Further details are found in 
Chapter 2.2 Mouse breeding. 
 
4.3.3 Isolation and culture of adult and neonate OPCs from the corpus 
callosum for culture 
 
Preliminary studies of isolating OPCs using a Percoll® gradient showed that, 
especially when using adult #72 homozygote corpus callosum, contamination by 
microglia was unavoidable. To expose the wild type and #72 homozygote OPCs to 
the same in vitro environment I cultured wild type and #72 OPCs and 
contaminating microglia together.   
 
For each OPC co-culture experiment, OPCs were isolated from two adult GFP 
expressing and two adult #72 homozygote corpus callosa. The same number of 
isolated wild type cells (mainly OPCs) and isolated #72 homozygote cells (mainly 
OPCs and microglia/macrophages) were mixed together immediately before 
plating down on poly-L-lysine coated glass coverslips. The same procedure was 
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also followed when performing this experiment using neonate OPCs. The 
isolation procedure and maintenance of the culture is described in Chapter 2.2 
Mouse breeding. 
 
4.3.4 Generation of Plp1 Lac-Z and β-actin GFP expressing 
neurospheres 
 
As described in Chapter 2, neurospheres carrying the LacZ or GFP reporter genes 
under the control of Plp1 (Wight et al., 1993) and β-actin promoter (Okabe et 
al., 1997), respectively, were generated from transgenic mice. These mice were 
wild type at the Plp1 locus. Detailed information about neurosphere generation 
can be found in Chapter 2.5.3 Generation of Plp1 Lac-Z expressing neurospheres 
and generation of β-actin GFP expressing neurospheres. 
 
4.3.5 Preparation of neurosphere for transplantation  
 
On the day of transplantation the neurospheres were prepared for 
transplantation as described in Chapter 2.5.3.1 Preparation of neurosphere for 
transplantation into homozygote #72 mice.  
 
4.3.6 Adult mice used in the transplant study 
 
Male #72 homozygote mice at P100 were used in the transplantation experiment. 
As previously described in Chapter 3 The development of the phenotype and 
pathology of the homozygote #72 corpus callosum, the corpus callosum is almost 
completely demyelinated at this stage. After transplantation, mice were kept 
for 14 days then the brains were processed for immunofluorescence, histological 
and ultrastructural analysis as described in Chapter 2.6 Tissue sampling and 
processing; 2.7 Staining techniques. As a control, an adult male shiverer mouse 
was transplanted at the same time. The CNS of adult shiverer mice is permissive 
to myelination by transplanted neurospheres (J.M. Edgar personal 
communication). None of the mice were immunosuppressed. Details of the 
surgical procedure, including the Bregma coordinates, are described in Chapter 
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2.5.5 Surgical procedure and injection of neurospheres into adult homozygote 
#72 corpus callosum. 
4.3.7 Neonate mice used in the transplant study  
 
One day old (P1) neonatal #72 homozygote male pups were used for injection of 
wild type neurospheres into the forebrain parenchyma at four locations. Details 
of the surgical procedure are described in Chapter 2.5.5.1Injection of 
neurospheres into neonate homozygote #72 mice. 
 
4.3.8 Processing of cell cultures and transplanted tissue 
 
Processing of cell cultures and the transplanted tissue for light microscopy, 
epifluorescence microscopy and electron microscopy are described in Chapter 2 
(2.7 Staining techniques). Antibodies against O4, GFP, MBP, PLP, NG2, PDGFRa, 
GFAP, CD45, CD169 were used in this study. Protocols and antibody dilutions are 
described in Chapter 2 (Table 2 & Table 3) and in Chapter 7 Appendix.    
 
4.3.9 Measurement of oligodendrocytic processes from co-cultured 
OPCs 
 
In this study the measurement of oligodendrocyte process length was used as a 
parameter for OPC differentiation in vitro using NeuronJ (Meijering et al., 2004), 
a plugin program in ImageJ. The culture experiment was repeated 3 times using 
adult cells and twice using neonatal cells. A total of 234 wild type and 49 #72 
homozygote cells were measured in the experiment using adult OPCs. A total of 
145 wild type and 166 #72 homozygote cells were measured in the experiment 
using neonatal OPCs. The mean of the mean total process length per cell from 
all wild type OPCs was compared with the mean of the mean total process 
length per cell from all the #72 homozygote OPCs. Details of the procedure can 
be found in Chapter 2 (2.5.2 Cell culture).    
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4.3.10 Statistical analysis 
 
An unpaired Student’s t-test was used to analyse the data obtained from the cell 
culture experiment. Statistical analysis was made in GraphPad Prism 5®.   
 
4.4 Results 
 
4.4.1 Evaluation of the differentiation potential of OPCs using an in 
vitro co-culture system  
 
To determine if remyelination failure in the #72 mouse is due to an intrinsic 
defect in the adult OPCs, I removed these cells from a potentially inhibitory 
environment and analysed their potential to differentiate in vitro, in comparison 
to wild type OPCs. 
 
4.4.1.1 Contamination of activated microglial cells was unavoidable when 
using a Percoll® gradient to isolate OPCs from #72 homozygote brain 
tissue 
 
Preliminary experiments evaluating the OPC purification technique using a 
Percoll® gradient showed that cells expressing PDGFRa and O4 were present 
after one day in vitro. This demonstrated that OPCs were successfully isolated 
using this technique (Figure 41). However, a second population was present in 
even greater numbers. Immunostaining with an antibody to sialoadhesin (CD169), 
a macrophage restricted sialic acid binding protein that is expressed in the CNS 
following damage to the blood–brain barrier (Perry et al., 1992), demonstrated 
that these cells were activated microglia/macrophage (Figure 42). The 
microglia/macrophages survived well in the culture system and were present, 
together with differentiated OPCs, after seven days in vitro. 
 
Since I was unable to separate the adult #72 OPCs from the microglia it became 
imperative that the wild type OPCs, against which the #72 OPCs were to be 
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compared, were cultured in the same environment. To achieve this, I isolated 
normal adult OPCs from β-actin-GFP expressing mice and combined them with 
the OPC/microglial mix derived from the adult #72 mice. Thus, I was able to 
distinguish the normal from the mutant cells on the basis of GFP expression. 
 
4.4.1.2 Adult #72 OPCs showed an impaired development compared to the 
wild type OPCs in vitro 
 
Adult OPCs from the ~P120 corpus callosum survived and differentiated in vitro. 
After seven days in culture #72 cell processes appeared shorter and showed 
reduced branching compared to the wild type cells. I measured the length of all 
processes branching from the cell body on phase contrast images taken from 
cells that stained for 04. The mean total process length per cell after seven days 
in vitro was significantly (p<0.05) reduced in the #72 homozygote cells compared 
to the wild type cells (Figure 43).  
 
To test if this impairment in differentiation of adult #72 OPCs was related solely 
to their genotype, I next determined whether neonatal #72 OPCs behaved 
similarly.   
 
4.4.1.3 Neonatal #72 and wild type OPCs were morphologically 
indistinguishable after 7 days in vitro  
 
Co-cultures containing neonatal GFP positive wild type and non-GFP positive #72 
homozygote OPCs were established. The isolated neonatal normal and #72 OPCs 
developed similarly during seven days in vitro (Figure 44). The average of the 
total process length per cell obtained from two separate experiments showed no 
significant difference (p = 0.44) between the two genotypes.  
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Figure 41. OPCs were successfully isolated from adult corpus callosum using 
a Percoll® gradient technique.  
Micrographs of cultured cells isolated from adult corpus callosum at 1 day in vitro using antibody 
against PDGFRα and O4 to identify OPCs. During the early stages of differentiation, OPCs co-
express PDGFRα (A) and the surface marker O4 (B). DAPI was used to identify the cell nucleus 
(C). After one day in vitro, multiple, PDGFRα and O4 positive cells were present (D). This 
suggests that the purified cells are OPCs (x400, scale bar 50µm).       
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Figure 42. Microglial/macrophage contamination could not be prevented 
when using the Percoll® gradient protocol to purify adult #72 homozygote 
OPCs. 
Micrograph of a cell culture using only cells isolated from adult #72 homozygote corpus callosum. 
Antibody against CD169 was used to identify activated microglia/macrophages and antibody 
against O4 was used to identify cells from the oligodendroglial lineage. It was not possible to 
exclude activated microglial/macrophage cells (A) when using the Percoll® gradient protocol. 
Both microglia/macrophages and OPCs were present after seven days in vitro (B). DAPI was used 
to identify the cell nuclei (C). The two cell types were growing in close proximity to each other 
(D, x200, scale bar 100µm).  
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Figure 43. The cell process length of adult #72 homozygote OPCs was 
significantly reduced when compared to the co-cultured wild type OPCs. 
Micrographs of co-cultured adult #72 and wild type to the Plp1 gene, GFP expressing cells after 
seven days in vitro. O4 was used to identify cells of oligodendroglial origin (A). The presence of 
GFP (B) was used to differentiate between the wild type and #72 homozygote cells (D, asterisk), 
of which the latter lack GFP (A – D, x200, scale bar 100µm). Phase contrast images were used to 
quantify the process length per cell as previously described (E, F, x200, digitally magnified, scale 
bar 50µm). The adult #72 homozygote cells appeared morphologically different (F) compared to 
the wild type (E) and had a significantly reduced mean total cellular process length per cell after 
seven days in vitro when compared to the wild type cells (G, *: p<0.05). The graph shows the 
mean total length of all processes per OPC (+ s.e.m.); each experiment was repeated 3 times.  
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Figure 44. The mean total process length of neonatal #72 and wild type 
OPCs was not significantly different after 7 days in vitro. 
Micrographs of co-cultured neonatal wild type to the Plp1 gene (green) and #72 OPCs at 7 DIV. 
The surface marker O4 (A) was used to confirm that the cells were from the oligodendroglial 
lineage. The presence of cytoplasmic green fluorescent protein (B) indicated that the cells were 
of wild type origin. DAPI was used to label the nuclei (C). The merged image was used to 
distinguish between wild type and #72 homozygote (asterisk) OPCs, in which GFP was absent (D, 
x200, scale bar 100µm). Very rarely, astrocytes (arrowhead) were present in the cultures. After 
identifying the genotype of the differentiating OPCs, phase contrast images were used to 
measure, in a semi-automated manner, the total process length per cell (E, F, x200, digitally 
magnified, scale bar 50µm). There was no significant (p=0.44) difference in total process length 
between the neonate #72 homozygote OPCs and wild type cells (G) after 7 days in vitro. The 
graph shows the mean total length of all processes per OPC (+ s.e.m.); each experiment was 
repeated 3 times.   
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4.4.2 Evaluating the cell extrinsic compartment: Cell transplantation 
into demyelinated corpus callosum 
 
The results from the in vitro experiment suggest that adult #72 OPCs are 
impaired in their differentiation compared to wild type cells. To determine if 
their environment is permissive for myelination, I transplanted myelination 
competent cells into the adult #72 mouse corpus callosum. 
 
4.4.2.1 Advanced demyelination and a marked microglial/astroglial response 
was present in the #72 homozygote corpus callosum at P100 before 
transplantation 
 
In Chapter 3, I quantified cellular changes in the #72 corpus callosum at P40, 60, 
90 and 120. Before transplanting cells into the P100 corpus callosum, I confirmed 
by immunostaining, that the environment was similar to that at P120. The PLP 
and MBP staining showed a loss of myelin integrity. There was an increase in 
microglia, which was accompanied by microglial activation and an astroglial 
response. NG2 positive cells were abundantly present (Figure 45). 
 
4.4.2.2 The transplanted neurospheres were viable and showed multipotency 
in vitro   
 
To evaluate the viability and the differentiation potential of transplanted 
neurospheres, surplus cells remaining at the end of the transplantation 
procedure were plated onto poly-L-lysine coated coverslips. Neurosphere-
derived cells used in the transplant study developed within three days in vitro 
into O4, MBP and PLP/DM20 positive cells proving the viability and the 
differentiation potential of the neurospheres. Cultured neurospheres also 
developed into GFAP+ astrocytes and occasionally also into neurons, identified 
by the neuronal nuclear marker NeuN (Figure 46), confirming the multipotency 
of the neurospheres in vitro, as described by others (Zhang et al., 1998;Mokry et 
al., 2005). 
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Figure 45. Pronounced changes in myelin integrity and astroglial, microglial 
and OPC populations were present in the #72 mouse corpus callosum at 
P100. 
Micrographs of #72 corpus callosum at P100 using antibody against MBP, PLP/DM20, CD45, CD169, 
GFAP and NG2 to characterise the environmental changes. Myelin integrity was severely 
compromised, as shown using immunohistochemistry against myelin proteins PLP/DM20 (A) and 
MBP (B). There was also an apparent microglial (C) and astroglial (D) cell response. A proportion 
of microglia/macrophage cells expressed CD169 (E) a macrophage restricted sialic acid binding 
protein. At the same time there were abundant NG2 positive (F) cells in the corpus callosum 
(x100, scale bar 400µm). 
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Figure 46. LacZ transgene expressing neurospheres are multipotent and 
develop into oligodendrocytes, astrocytes and neurons in vitro. 
Micrographs of coverslips with cultured surplus neurospheres after transplantation for three days 
in vitro. Antibody to O4, MBP, GFAP and NeuN were used to identify the multipotency of 
transplanted cells in vitro. X-Gal staining was used to visualise PLP/DM20 expression (β-
galactosidase generates enzymatically the blue appearing 5-bromo-4-chloro-3-indolyl β-D-
galactoside product after X-gal treatment). After 3 days in vitro a relatively high density of O4 
positive cells was present (A, x200, scale bar 200µm, insert, x400), some of which expressed MBP 
(B, x400) and PLP/DM20 (C, x200, scale bar 100µm). This showed the capacity of the 
transplanted neurospheres to differentiate into oligodendroglia. However, the neurospheres also 
differentiated into GFAP expressing astrocytes (D, x400) and even into a few neurons 
(arrowheads) expressing NeuN (E, x400, scale bar 50µm) when plated in differentiating media.  
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4.4.2.3 Transplanted neurospheres survived for 14 days in the adult #72 
homozygote corpus callosum 
 
To assess the influence of the OPC extrinsic compartment on remyelination 
failure in the #72 homozygote mouse, wild type neurospheres expressing GFP or 
carrying a Plp1 LacZ fusion gene were introduced, together, into the 
demyelinated corpus callosum of #72 homozygote mice at P100. 
 
Fourteen days after transplantation, GFP and β-galactosidase positive 
transplanted cells were present within the #72 homozygote mouse corpus 
callosum. Transplanted cells were observed in close proximity to the needle 
track and also up to approximately 1.2mm distal from the injection site (Figure 
47).  
 
4.4.2.4 Axons in the demyelinated #72 homozygote mouse corpus callosum 
are myelination competent 
 
On high power images of the transplant region, β-galactosidase positive cells 
showed a morphology which resembled myelin sheath producing 
oligodendrocytes. Most of the GFP positive cells appeared similar to the β-
galactosidase positive oligodendroglia. Co-labelling with GFP and MBP (the latter 
a relatively late marker of oligodendroglial differentiation and myelin 
compaction) indicated that transplanted GFP positive neurospheres had 
differentiated into ensheathing/myelinating oligodendrocytes (Figure 47). 
 
To test if the transplanted cells formed a compact myelin sheath around axons, I 
examined resin section of areas containing transplanted cells in the corpus 
callosum. On the resin sections thin, ring like structures were seen around axons 
in the area where cells had been transplanted (Figure 48). The relative 
abundance of ring like structures (arrows in A) became obvious when compared 
to a non-transplanted region of the corpus callosum from the same animal, 
where only a few similar structures were present (arrows in B).  
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Electron microscopy was used to evaluate the ultrastructure of the myelin 
sheath in the transplanted corpus callosum. The corpus callosum treated with 
transplanted cells was compared to an untreated corpus callosum and showed an 
increased presence of myelinated axons. Ultrastructural evaluation of the myelin 
sheath showed a normal myelin sheath with an inner tongue, and normal 
appearing major dense and intraperiod lines (Figure 49).  
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Figure 47. Transplanted neurospheres survived and (re)myelinated axons in 
the adult chronically demyelinated #72 homozygote corpus callosum. 
Micrographs of the corpus callosum of an adult #72 homozygote mouse 14 days after 
transplantation, using antibodies to MBP and GFP. X-gal treatment was used to visualise 
PLP/DM20 expression. Transplanted neurospheres differentiated into (re)myelinating 
oligodendrocytes in the adult #72 homozygote mouse. The transplanted neurospheres 
differentiated into Plp1 expressing oligodendrocytes indicated by cells turning blue after X-gal 
treatment (A, x40, scale bar 400µm, insert in A, x400, scale bar 20µm). The X-gal positive cells 
formed myelin sheath-like structures (insert in A, x400, scale bar 20µm). Co-expression of MBP 
on the GFP positive myelin-like structures confirmed that the transplanted cells formed 
myelinating oligodendrocytes (B, C, D, x100, scale bar 200µm, insert in D, x400, scale bar 20µm). 
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Figure 48. Neurospheres formed myelin sheaths after transplantation into 
the adult #72 corpus callosum. 
Micrograph of methylene blue/azur II sections from a #72 homozygote mouse 14 days after 
injection of neurospheres. On the methylene blue/azur II stained, 1µm thick resin sections, ring 
like structures resembling myelin sheaths were identified. When comparing a transplanted #72 
homozygote mouse corpus callosum (A) with an untreated corpus callosum (B), more myelin 
sheaths (arrows in A) were present in the transplanted corpus callosum than in the untreated 
corpus callosum (arrows in B) (x1000, scale bar 20µm). 
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Figure 49. Formation of normal compact myelin sheaths 14 days after 
neurosphere transplantation into #72 homozygote corpus callosum. 
EM micrographs from areas of neurosphere transplantation in the #72 homozygote corpus 
callosum 14 days after transplantation. To illustrate the changes after neurosphere 
transplantation an untreated #72 corpus callosum, which was almost completely demyelinated at 
P120 (A, x8000) was compared to the transplanted region of the corpus callosum (B, x8000, scale 
bar 2µm). After transplanting neurospheres into the demyelinated region, axons became 
(re)myelinated by an ultrastructural normal myelin sheath (B, x8000, C, D, x50000, scale bar 
250nm) with normal appearing inner tongue (arrow in C) and periaxonal space (arrowheads C) 
and its characteristic major dense (asterisks in D) and intraperiod (dots in D) lines. 
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4.4.2.5 Transplanted neurospheres differentiated into astroglial cells 
 
These results suggest that the axons in the adult #72 corpus callosum are 
permissive for myelination. However neonatal neurospheres differentiate into 
cell types other than oligodendrocytes and it was important to determine if 
other neurosphere derived cells populations were produced, that could 
potentially alter the environment.  
 
In the transplanted region, some of the neurospheres differentiated into stellar 
shaped cells, resembling astrocytes. The identity of the cells was confirmed by 
double immunohistochemical staining with antibodies to GFP and the astrocytic 
marker, GFAP (Figure 50). 
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Figure 50. Transplanted neurospheres also differentiated into astroglia. 
Micrographs of a #72 homozygote corpus callosum after X-Gal treatment to visualise the β-
galactosidase positive transplanted cells. The transplanted neurospheres also developed into 
astrocytes reflecting their multipotent capacity in vivo. After transplantation of neurospheres 
into the demyelinated #72 homozygote corpus callosum there were not only Plp1 expressing cells 
(A, x100) but also a subset of the GFP+ (B) transplanted cells, which had differentiated into 
astrocytes (C, D, x100, scale bar 200µm; insert, x400, scale bar 20µm). 
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4.4.3 Long term survival and integration of transplanted wild type 
neurospheres after neonatal cell transplantation into CNS 
parenchyma 
 
Besides addressing the basic questions posed at the start of this Chapter, the 
results of these experiments suggest that transplanted cells could potentially be 
used therapeutically to restore myelin in the adult CNS. However, the literature 
has shown that widespread myelination of the adult CNS is virtually impossible to 
achieve through focal transplantation of cells, principally because the 
transplanted cells are relatively slow in populating the adult CNS, failing to 
reach the pro (re)myelinating environment of acute lesions in time and therefore 
fail to initiate remyelination in the demyelinated region (Blakemore et al., 
2002). Additionally, migration through normal tissue has been shown to be less 
effective than through lesioned tissue (Franklin et al., 1996) and finally the 
presence of dysfunctional OPCs within the demyelinated region may inhibit the 
population by transplanted cells (Chari et al., 2003). The advantage of 
transplanting multipotent cells in the new-born has been shown to be more 
effective for wide spread distribution and integration of the transplanted cells in 
the CNS (Learish et al., 1999;Windrem et al., 2008). With this in mind, I asked if 
transplantation of neurospheres into the brain of new-born #72 mice would 
provide proof-of-principle of the potential for cell transplantation to treat PMD. 
Previous transplant studies, mainly from the Duncan laboratory, have focussed 
on models of PMD due to point or missense mutations ((Duncan et al., 
1988;Zhang and Duncan, 2000;Zhang et al., 2003) and a recent study by 
(Windrem et al., 2008) achieved a complete replacement of CNS oligodendroglia 
after neonatal injection of human glial progenitor cells in shiverer mice. 
However the potential of cell transplantation to treat PMD due to gene 
duplication has not previously been tested. The main difference in PMD models 
caused by mild overexpression of Plp1 gene is that early post natal OPCs are 
relatively healthy and the initial myelination of the CNS is virtually normal, 
unlike in the missense mutations where virtually no myelin is formed in the first 
place. Therefore the competition between transplanted cells and relatively 
healthy endogenous OPCs may lead to a less effective establishment of 
transplanted cells. 
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At 7, 14, 35, 80 and 120 days post transplantation, two male mice were 
sacrificed and the brain was evaluated for donor cell survival, integration and 
ensheathment/myelin formation. Macroscopically, extensive regions of β-
galactosidase positive cells in white and grey matter were found from P35 to 
P120. At P35 cells of transplant origin were mainly present in major white 
matter tracts. At P120 patches of X-gal staining were found in the corpus 
callosum, anterior commissure, thalamus, hypothalamus, optic chiasm and 
hippocampus. At P14, the first β-galactosidase positive cells with myelin-like 
structures could be seen using light microscopy. With time the areas of 
transplanted cells forming myelin-like structures in white matter tracts 
increased, showing that the transplanted cells had survived, migrated after focal 
injection to various white matter tracts in the cerebrum, and successfully 
integrated and ensheathed/myelinated axons in the host brain parenchyma 
(Figure 51). 
 
To see if the transplanted cells formed a normal myelin sheath EM was used to 
evaluate the myelin morphology. A substantial amount of myelinated axons were 
found in the transplant integrated white matter at P120 when comparing areas 
of successful integration of transplanted cells to areas without integration of 
transplanted cells in the same mouse. The myelin sheath appeared 
morphologically normal although some myelin sheaths appeared thicker than 
others and occasionally redundant myelin was observed (Figure 52). 
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Figure 51. Successful integration, ensheathment/myelination and long term 
survival of neurospheres after intracerebral transplantation into neonatal 
#72 homozygote mice. 
Photographs of 2mm thick brain tissue slices taken from mice at 14, 35 and 120 days after 
transplantation of neurospheres harbouring the Plp1/LacZ transgene into neonatal brain 
parenchyma. At 35 (A) and 120 (B, scale bar 5mm) days post injection (DPI) the areas containing 
myelin of donor cell origin was made visible after X-Gal treatment, which stained cells and the 
myelin sheath expressing Plp1 gene promoted β-galactosidase blue. In general, LacZ expressing 
transplant derived cells occurred in clusters. Myelin-like sheaths of transplant origin were 
detected from 14 DPI (C, x100, scale bar 200µm). The transplanted neurospheres had not only 
integrated into various regions such as the corpus callosum (black arrow), anterior commissure 
(white arrow), thalamus (black arrowhead) and hippocampal regions (white arrowhead) but had 
also differentiated into Plp1 expressing oligodendrocytes, which formed myelin sheath-like 
structures, presumably around axons. Transplanted donor cells were present at 14 (C), 35 (D, x40 
scale bar 400µm), 80 (data not shown) and 120 (E, x40, scale bar 400µm) DPI, suggesting that the 
transplanted cells survived and differentiated into myelin synthesising oligodendrocytes, which 
were stably integrated up until 120 DPI, without immunosuppression.    
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Figure 52. A large amount of transplant-derived myelin is present in regions 
of the adult #72 mouse corpus callosum after transplantation of 
neurospheres into the neonatal brain. 
EM micrographs of a transplanted #72 corpus callosum 120 days post injection, in which 
transplant-derived myelin is absent (A, x5000) compared to an area in which transplant-derived 
myelin is present (B, x5000, scale bar 2µm). At this age, the areas of corpus callosum where cell 
transplants did not integrate are virtually devoid of myelin sheaths, confirming that the myelin 
that is present is likely to be derived from the transplanted cells. The myelin appears relatively 
normal (C, D x40000, scale bar 250nm), although some redundant myelin is present (arrows 
head) and some sheaths appear thicker (filled arrow) or thinner (empty arrow) than normal.   
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4.4.3.1 Early post natally injected donor cells locally ameliorate the white 
matter microglial response 
To investigate if the changes in the local environment are mainly a response to 
demyelination I also investigated the effect of the neonatal cell transplantation 
on the local environment at 120 DPI. In regions where the transplanted cells had 
formed extensive myelin the cell density was visibly reduced (Figure 53). This 
was primarily due to the fact that the leukocyte population, labelled with an 
antibody recognising CD45, appeared reduced in areas containing large amounts 
of transplant-derived myelin (Figure 54).   
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Figure 53. The cell density appeared normal in white matter regions where 
donor cells populated and myelinated the white matter. 
Micrographs from two prominent white matter tract regions, the corpus callosum (A – D) and the 
rostral part of the anterior commissure (E – H, x400, scale bar 50µm), from #72 homozygote mice 
120 days after neonatal implantation of transgenic neurospheres containing a LacZ Plp1 fusion 
gene. The myelin, which was produced by transplanted cells, stained blue (5-bromo-4-chloro-3-
indolyl β-D-galactoside) after X-Gal treatment, due to the incorporation of the PLP/β-
galactosidase fusion protein into the myelin sheath. Using DAPI as a nuclear stain, there were 
obvious differences between regions where there was extensive myelin formation of transplant 
origin compared to a similar region with only a few or no myelin sheaths from transplanted cells.  
When comparing  the areas without (B) or with only few (F) transplanted cells there was a visible 
reduction of cell nuclear density in the anterior commissure (D) and in the corpus callosum (H) 
when myelinating oligodendrocytes of transplant origin were present.  
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Figure 54. The inflammatory response was reduced in white matter regions 
if the #72 CNS was populated by transplanted, Plp1 expressing 
oligodendroglia.  
Micrographs from two prominent white matter tract regions, the corpus callosum (A – D) and the 
rostral part of the anterior commissure (E – H, x400, scale bar 50µm), from #72 homozygote mice 
120 days after neonatal implantation of transgenic neurospheres containing a LacZ Plp1 fusion 
gene. A marked microglial response was present in regions containing none or only a few donor 
cells (A, B, E, F). This was in contrast to regions where many myelinating donor cells were 
present (C, D, G, H, x400, scale bar 50µm). In the myelinated regions, the microglia appeared 
normal. This suggested that the previously observed reduction of cell nuclei in regions where 
extensive amounts of myelin of donor cell origin were synthesised was mainly due to a reduction 
of CD45 positive leukocytes. Note that the 5-bromo-4-chloro-3-indolyl β-D-galactoside appeared 
dark when using the red spectra in immunofluorescence microscopy.  
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4.5 Discussion 
 
In this study I assessed the role of the OPC intrinsic and the OPC extrinsic 
compartments in remyelination failure in the #72 mouse corpus callosum, using 
cell culture and cell transplantation techniques. The in vitro and in vivo results 
suggest that there is mainly an intrinsically mediated impairment in OPC 
function contributing to the remyelination failure. The reduced cell 
development of OPCs appears to be age related, as neonatally derived #72 OPCs 
developed comparable to wild type cells in vitro. The in vivo evaluation of the 
OPC extrinsic compartment by using neurosphere cell transplants showed that 
the axons are permissive for remyelination in the adult #72 corpus callosum.  
 
This suggests that the OPC differentiation block and the remyelination failure, 
which has been observed in adult #72 mouse in situ is most likely cell 
intrinsically mediated. 
 
The development of an age dependent OPC differentiation block mediated by 
cell intrinsic abnormalities results in a limited or even absent endogenous 
remyelination response. Whether endogenous remyelination can be stimulated in 
this model is questionable and the benefit is doubtful since differentiating OPCs 
would still harbour the gene defect, which is known to lead to unstable myelin 
sheaths. This raises the question of whether it would not be more beneficial to 
patients suffering from PMD caused by gene duplication to consider early 
replacement of endogenous OPCs with genetically normal glial progenitor cells, 
rather than to initiate treatment during the stage of progressive demyelination. 
By transplanting neurospheres, which are wild type to the Plp1 gene, I provided 
proof-of-principle for the potential of cell transplantation into the neonate as a 
therapy for PMD caused by gene duplication.  
 
4.5.1 Impaired OPC differentiation is age dependent in #72 mouse  
 
Here I attempted to assess the differentiation potential of adult #72 OPCs, 
compared to normal age-matched OPCs, in the absence of confounding 
environmental factors, using cell culture. However, using an established protocol 
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to isolate OPCs, I was unable to obtain pure OPCs without contaminating 
microglia/macrophages. To eliminate the contaminating cells, I attempted to 
enrich for OPCs using a magnetic bead separation method. However, the cell 
yield was prohibitively low and the cells became severely damaged during the 
purification procedure and did not survive in vitro. Furthermore the total cell 
yield obtained per experiment using the Percoll gradient separation was 
maximally 600000 cells and was considered too low for FACS sorting of OPCs and 
microglia/macrophages.   
 
Since the contaminating microglia/macrophages from the demyelinated #72 
corpus callosum could potentially influence the differentiation potential of the 
OPCs, it was imperative that the normal OPCs and the #72 OPCs were cultured 
under the same conditions. In order to be able to distinguish the two genotypes, 
the normal OPCs were generated from mice expressing GFP under the β-actin 
promoter, rendering the cells green.     
 
Under these conditions, adult #72 homozygote OPCs had a reduced process 
outgrowth compared to adult wild type OPCs. In contrast, #72 OPCs derived from 
neonates differentiated similarly to wild type OPCs, suggesting that the 
genotype of the cells alone is not responsible for the impaired differentiation. 
Rather, factors specific to the adult #72 OPCs, seem to play a role in impairing 
the process growth. Assuming this is also true in vivo, the impaired 
morphological development would be predicted to lead to a delayed or reduced 
development of a myelin sheath. Axonal glial interactions, for example as 
mediated through NRG1-III (Brinkmann et al., 2008), are important for the 
induction of remyelination in the CNS but appear not to be the sole required 
component. Instead the remyelination process is also influenced by a complex 
interaction of different secreted myelin inducing signals such as insulin growth 
factor 1 (Carson et al., 1993), apotransferrin (Marta et al., 2003) and astrocyte 
leukaemia inhibitory factor (Ishibashi et al., 2006;Nave, 2010a). The time 
window, where the remyelination process is positively influenced after the 
demyelination, is thought to be limited and something as simple as a delay in 
OPC differentiation has been shown to be sufficient to impair the remyelination 
process (Fancy et al., 2009). With slow OPC differentiation and growth, as might 
be the case in the #72 adult OPCs, which leads to a prolonged delay of the 
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remyelination process by delayed axonal-glial interactions, the extracellular 
remyelination permissive environment might change to a more restrictive one, 
which would additionally contribute to an OPC differentiation block (reviewed in 
Fancy et al., 2010).      
 
To find an explanation for the abnormal in vitro growth of differentiating OPCs, 
it may be relevant that the DM20 transcript and protein is expressed in pre-
myelinating oligodendrocytes in vitro (Yamada et al., 1999) and in a subset of 
murine spinal cord OPCs (Dickinson et al., 1996) before active myelination takes 
place. In the Plp1 gene overexpressing mice, both PLP and DM20 will be 
overexpressed. Although the published results are from normal embryonic cells 
and observed in vivo during embryonic development up till P20, the results may 
be extrapolated to explain the differentiation block in adult #72 homozygote 
OPCs. If chronic abnormal overexpression of Dm20 into adulthood is present in 
#72 OPCs, a low grade accumulation of DM20 may occur with time. This low 
grade accumulation could potentially stress cells, leading to an inhibitory effect 
on adult OPC differentiation during the demyelinating process. Further evidence 
that overexpression of DM20 alone can cause late onset myelin impairment is 
derived from a mouse model where overexpression of Dm20 only has been shown 
to induce a slowly progressing demyelinating phenotype, which developed over 8 
months (Mastronardi et al., 1993) suggesting that accumulation of DM20 as a 
minimum impairs myelin integrity and, over time, potentially the capacity for 
remyelination. However, DM20 expression in non myelinating cells has only been 
demonstrated in the spinal cord and around the ventricular zone between E12 
and E14 (Yu et al., 1994) and it is questionable if DM20 is expressed in OPCs at 
all and if DM20 plays a role in the #72 mouse model.  
 
An age dependent derangement of intracellular pathways may be responsible for 
the differentiation block of OPCs. Histone deacetylase (HDACs) induced 
deacetylation of remyelination promoter regions is an important step in the 
regulation of remyelination. With age the regeneration in white matter generally 
becomes altered, amongst other mechanisms by a reduction in the HDAC 
activity, leading to impaired remyelination (Shen et al., 2008). Alteration of 
HDAC1 and/or HDAC2 has been shown to lead to β-catenin stabilisation, a pivotal 
part of the canonical Wnt pathway, which resulted in blocked OPC 
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differentiation (Ye et al., 2009). The canonical Wnt pathway has been 
investigated in Chapter 3 and abnormal prolonged activation had not been 
observed. However, the apparent normal development of neonate OPCs in my in 
vitro experiment still underlines an age dependent component leading to an OPC 
differentiation block.  
 
This is in contrast to the similar study by (Ma et al., 2006) where they stated 
that “The ability of oligodendrocytes from older Plp1 gene overexpressing 
transgenic animals to produce a myelin membrane-like structure was not 
impaired when cultured in vitro, which indicates that the lack of remyelination 
is not simply caused by changes in the intrinsic properties of the 
oligodendrocytes.” Nevertheless, this study is inconclusive and while Ma et al. 
reported the characteristics of adult OPCs in the brain or in isolated form of the 
4e-PLP model, there is no evidence in the literature (including publications cited 
by Ma) to show that the brain is demyelinated and that a remyelination failure 
occurs in the 4e-PLP model.  
 
Another study by (Karim et al., 2010) however, showed that the development of 
oligodendrocytes derived from P5 #72 mouse spinal cord developed significantly 
less membranous sheaths compared to the wild type cells in cultures. The 
observed differences where reversible by applying siRNA to suppress PLP 
overexpression in vitro (Karim et al., 2010). In my study I did not see any 
difference in development of #72 and wild type neonatal brain derived OPCs. 
However it is difficult to compare the study from (Karim et al., 2010) with my 
experiment because firstly they used a different cell isolation protocol, where a 
mixed population of OPCs and young oligodendrocytes were cultured. This is in 
comparison to my study were only OPCs, which will develop differently from 
young oligodendrocytes, were cultured. Secondly they cultured only spinal cord 
derived cells, which is in contrast to my study, where I only cultured cerebral 
derived OPCs, which are known to have a different developmental background 
(Kessaris et al., 2006). Thirdly in my study the significant effect occurred only in 
adult OPCs and (Karim et al., 2010) did not investigate adult cells. 
 
PLP expression is present in isolated OPCs after 7DIV (data not shown) and, due 
to the primary genetic defect leading to the overexpression of PLP, may 
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interfere with the differentiation phase eventually being responsible for the 
impaired development in #72 OPCs. On the other hand PLP expression starts 
after the OPC has differentiated into an oligodendrocyte and it shows that the 
OPCs can differentiate in vitro under ideal conditions which may lead to the 
reduced cell growth. However PLP expression is also present in the neonatally 
derived OPCs after 7DIV and these cells developed similarly compared to the 
wild type. Again an age dependent component is probably involved in the 
development of impaired differentiation. 
 
Finally the ability of adult #72 to differentiate into PLP expressing 
oligodendrocytes in vivo also suggest that with age changes in the cell extrinsic 
component may also contribute to the OPC differentiation block. 
 
4.5.2 The adult #72 homozygote corpus callosum is permissive for 
(re)myelination when neurospheres are transplanted. 
 
Transplanted multipotent cells from the neuroglial lineage have been shown to 
be capable of restoring demyelinated areas in young and adult genetically 
altered mouse models of dysmyelination, including the myelin deficient (md) rat 
(Learish et al., 1999;Brustle et al., 1999) and the shiverer mouse (Warrington et 
al., 1993;Nistor et al., 2005;Windrem et al., 2008). The myelination capacity 
and the effect after intravenous and intracranial injection of adult neurospheres 
in chronic EAE mouse models have also been evaluated (Pluchino et al., 
2003;Einstein et al., 2006). However, the permissiveness for remyelination in the 
#72 homozygote mouse model has never been investigated and I used the known 
(re)myelinating potential of neurospheres in this study to evaluate the role of 
the cell extrinsic compartment on remyelination failure in the #72 homozygote 
mouse. I also decided to use neurospheres for this study, because like rat OPCs, 
but in contrast to mouse OPCs, they can be generated in large numbers (Kondo 
and Duncan, 2009) 
 
In my study I showed that neurospheres derived from neonatal wild type mice 
transplanted into demyelinated corpus callosum survive, integrate and locally 
(re)myelinate the #72 homozygote CNS. Electron microscopy was used to confirm 
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that the newly generated oligodendrocytes formed compact myelin sheaths. I 
was unable to confirm that the sheaths that were imaged by EM were derived 
from the LacZ expressing cells, because the X-gal staining could not be discerned 
by EM. However, since demyelination was virtually complete at this age, the 
relative abundance of sheaths in the transplanted regions suggested that they 
were derived from the transplanted cells. 
 
Considering the short time given for the transplanted neurospheres to 
differentiate and remyelinate, the local remyelination process appears to be 
relatively effective in the #72 homozygote corpus callosum after 
transplantation. This finding suggests that the OPC extrinsic compartment is, to 
a certain degree, permissive for remyelination. The results show that the axons 
are capable of being (re)myelinated. The transplants survived and remyelinated 
in an area with a marked activated microglial/macrophage population, many of 
which expressed sialoadhesin. Sialoadhesin positive microglia/macrophages have 
been shown to contribute to demyelination in another Plp1 gene overexpressing 
transgenic mouse model (#66) (Ip et al., 2007), possibly through the recruitment 
of pathogenically relevant CD8+ve T cells. In my study the 
microglia/macrophages population seemed not to interfere with the 
transplanted cells, at least within an intermediate timeframe (14 days). 
 
With regard to remyelination failure, the influence of activated microglia on 
OPCs is controversial. A study using cell culture and tissue slice culture 
suggested that the activation of microglia supports OPC proliferation (Filipovic 
and Zecevic, 2005). However this was an in vitro study and the proliferation of 
OPCs is not indicative that differentiation and remyelination will eventually take 
place. On the other hand it has been observed that after suppressing the 
microglial response in a dysmyelinating rat model using minocycline in vivo, 
more effective remyelination after neuronal stem cell transplantation took 
place, suggesting that activation of microglia inhibits the remyelination process 
after transplantation (Zhang et al., 2003). But then again a more recent study by 
the same group showed that genetic depletion of microglia/macrophages 
worsens disease severity in a mouse model of globoid cell leukodystrophy (Kondo 
et al., 2011). In general, microglial/macrophage responses (Kotter et al., 
2001;Kotter et al., 2005) and acute inflammation (Foote and Blakemore, 
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2005a;Setzu et al., 2006).have been shown to promote OPC differentiation and 
remyelination  
 
It is important to keep in mind that after cell transplantation, an acute 
inflammation will result, additional to the existing chronic inflammation. This 
will cause considerable change in the OPC extrinsic environment and could 
potentially shift the inhibitory environment into a permissive, supportive 
environment. It has been shown that an acute lesion induced on top of a chronic 
inflammatory demyelinated lesion has a promoting effect for implanted neuronal 
stem cells to develop into myelinating oligodendrocytes (Foote and Blakemore, 
2005a). It may well be that in my study the cells were only capable of 
remyelinating the demyelinated area because of the change in environment 
caused by external manipulation. A certain capacity of immunomodulation has 
also been attributed to neonatal neurospheres themselves after implantation 
into acute and chronic EAE mice (Einstein et al., 2006;Einstein et al., 2003). 
 
By using GFP expressing neurospheres, I was able to show that the transplanted 
cells differentiated into astrocytes, as well as into oligodendrocytes. Astrocytes 
are known to influence myelination either positively by secreting for example 
IGF-1 (Liu et al., 1994) or CNTF (Albrecht et al., 2003) or negatively by secreting 
semaphorin 3 (Syed et al., 2011;Williams et al., 2007a) or hyaluronan (Back et 
al., 2005; reviewed by Williams et al., 2007b). The bivalent role of the astrocyte 
is also influenced by their functional status, where activated astrocytes are 
considered to promote remyelination and reactive astrocytes to inhibit the 
remyelination process (reviewed in Nash et al., 2011). Therefore the 
neurosphere derived astrocytes could also influence the remyelination potential 
of the environment and since the astrocytes of neurosphere origin are in close 
physical relationship to the transplanted OPCs, a locally confined supportive 
environment could be the reason for the observed focal remyelination. 
 
It is possible that some of the newly formed myelin sheath originated from 
endogenous OPCs that acquired remyelination competence in the altered 
environment. Nevertheless, if there was a response by the endogenous OPC 
population then it did not seem to be extensive, since most of the MBP positive 
sheath-like structures were also GFP positive, confirming that they were derived 
199 
from cells of transplant origin. Taking the findings from the cell intrinsic 
evaluation of the in vitro experiment into consideration, the adult #72 
homozygote OPCs seemed in general to be impaired in their differentiation into 
oligodendrocytes.     
 
A more parsimonious view, but one that cannot be completely discounted, is 
that failed remyelination could also be due to the short life span of the #72 
homozygote mice. It may be that remyelination is just about to begin 
effectively. However since none of the mice during this study period had 
survived longer than 135 days it is difficult to say if this is the case. An answer to 
this unsolved question may be found when looking at the #72 homozygote optic 
nerve, where two pathologically distinct regions can be identified at P120 (Edgar 
et al., 2010). The retinal region, which seems to be demyelinated earlier than 
the rest of the optic nerve turns into a non-inflammatory, chronic demyelinated 
region where OPCs are still present (shown in Chapter 5 Evaluation of advanced 
diffusion weighted magnetic resonance imaging as a molecular probe to 
distinguish between acute and chronic demyelination in the optic nerve of the 
#72 mouse). The chiasmal region shows a high degree of demyelination but is 
also filled with activated microglia (as seen in the Chapter 5 and in Edgar et al., 
2010) which is believed to be a less advanced stage of the disease process. Given 
the presence of an acute inflamed demyelinating region and a chronic “silent” 
demyelinated region, the pathology in the #72 homozygote seems to evolve 
towards a chronic demyelinating disease.    
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4.5.3 Early post natal transplanted gene wild type neurospheres 
integrate and form a stable myelinating cell population in the #72 
CNS – a potential treatment for PMD 
 
Duplication of the X-linked PLP1 gene is the most common cause of PMD. In the 
absence of a treatment for PMD, the replacement of genetically defective 
oligodendrocytes with intact ones through cell transplantation represents a 
potential therapeutic approach. PMD spans a broad clinical spectrum, ranging 
from connatal forms associated with an almost complete lack of CNS myelin to 
milder forms with nearly normal numbers of, but structurally defective, myelin 
sheaths. For cell transplantation to bring about functional recovery in PMD, 
transplanted cells would have to produce and maintain widespread myelination 
of the CNS. While previous studies have shown that transplanted cells can form 
large amounts of myelin in murine (Hammang et al., 1997;Learish et al., 1999) 
and canine (Archer et al., 1997;Milward et al., 1997) models of the most severe 
forms of the disease, studies to test the feasibility of this approach in animal 
models of milder (but still profoundly disabling forms) are lacking. Here I showed 
that the transplantation of neural stem cells at multiple sites, into the brain of 
new-born Plp1 gene overexpressing mice led to the production and maintenance 
of CNS myelin in competition with the myelination competent, but defective, 
endogenous cells. 
 
I showed, using X-gal staining and electron microscopy that the transplanted 
neurospheres differentiated into myelin forming oligodendrocytes that populated 
diverse white matter tracts in the forebrain. Transplant cell derived sheaths 
were not evident in P7 brains by X-gal staining, but could be detected by P14. 
Given that increasing volumes of myelin were present with time after 
transplantation, it seems most likely that at least some of the myelin that was 
present at P120 had been generated much earlier. Thus, I tentatively concluded 
that, unlike the endogenous myelin, the transplant derived myelin does not 
undergo degradation.   
 
The X-Gal staining, however, turns the cell in vicinity of intracellular β-
galactosidase blue. This process causes unexpected difficulties, when using the 
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tissue for immunofluorescence microscopy. The blue product (if present in high 
concentration) obliterates the epifluorescent signal, as seen in my study. This 
effect on epifluorescent microscopy renders the image difficult to interpret. A 
simple and effective way to solve this problem is to avoid using the X-Gal 
technique and to visualise intracellular β-galactosidase by using normal antibody 
labelling technique.  
 
Since myelin degradation in the Plp1 overexpressers has been shown to be 
related to the presence of sialoadhesin positive microglia/macrophages (Ip et 
al., 2007), I examined the relationship between microglial/macrophage cell 
density and transplant myelin. Given the previously described pathological 
changes involving the activation of microglia in the #72 homozygote mouse 
corpus callosum, it is of interest that the neonatally transplanted cells appear to 
interact locally with the environment. In areas, where myelin originated mainly 
from transplanted cells, the cell density was visible lower than in areas 
containing no or only a few myelin forming transplanted cells Regions where a 
substantial amount of transplanted cells turned into a stable, myelin forming 
population at P120 seemed to have a less severe microglial response, suggesting 
that the intact transplants don’t elicit the microglial response, or when looking 
at this finding the other way round, the progressive breakdown of the abnormal 
#72 homozygote mouse myelin most likely fuels the microglial response, starting 
a negative spiral of increased demyelination and probably impaired 
remyelination. 
 
The distribution cells derived from the neonatal transplanted neurospheres 
demonstrates that the transplanted cells migrate into white and grey matter. 
Why the transplants grow in a patchy pattern cannot be explained at this stage. 
However when looking at other studies, similar patterns have been observed 
(Archer et al., 1997;Learish et al., 1999;Windrem et al., 2004;Yandava et al., 
1999) and a competition between the endogenous and transplanted cells 
probably occurs during development, where the successful population finally 
establishes locally, possibly as a result of clonal expansion (Edgar et al., 2002). 
 
Most experiments involving neuronal stem cell transplantation into murine 
neonates were either of shorter duration (Learish et al., 1999;Webber et al., 
202 
2009;Yandava et al., 1999), in normal animals (Learish et al., 1999), in 
immunocompromised animals (Windrem et al., 2008) or in shiverer mice, where 
severe dysmyelination is already present during development (Nistor et al., 
2005;Windrem et al., 2004;Windrem et al., 2008;Yandava et al., 1999). 
 
The long term survival of cells without immunosuppression is of interest. As 
others have shown in different models of dysmyelination (Windrem et al., 
2004;Archer et al., 1997) the absence of graft rejection is probably due to 
perinatal toleration of the injected cells (Windrem et al., 2004;Ridge et al., 
1996). This shows that at least in mice and dogs, neuronal stem cells can be 
introduced into the neonate CNS parenchyma without the necessity of 
immunosuppression.  This finding could be of importance for humans suffering 
from severe PMD, where neonatal injection of neuronal stem cells is FDA 
approved (http://www.stemcellsinc.com/Therapeutic-Programs/PMD.htm). 
 
4.6 Conclusion  
 
I have shown that an OPC intrinsic impairment is most likely the cause of the 
remyelination failure in the #72 homozygote mouse. Based on in vitro an in vivo 
data the adult OPCs seem to be impaired in differentiation, which causes the 
OPCs to be blocked in a premyelinating state, failing to initiate the 
remyelination process. The in vivo experiments have shown that the cell 
extrinsic compartment seems to be permissive for a certain degree of 
remyelination, or at least that the axons are not inhibiting myelination after 
implantation with normal neurospheres derived from young mice. However, I 
cannot exclude the possibility that the environment becomes permissive to 
myelination due to the effect of the transplantation itself.  
 
I have also shown that the neurospheres derived from young animals integrate, 
myelinate and persist without immunosuppression in the #72 homozygote mouse 
brain, either after neonatal or adult injection. In particular, the data obtained 
from neonatal transplantation of stem cells is of practical interest. 
Overexpression of the PLP1 gene is the most frequent genetic aberration leading 
to PMD in humans (Sistermans et al., 1998) and the #72 mouse is a valid model of 
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this disease. Post natal injection of stem cells has been approved in patients 
with PMD and is a potential treatment option. The results show the potential of 
early stem cell injection to compete and integrate into #72 homozygote CNS 
tissue, with stable long term myelin formation. With this observed finding in 
mind, transplantation of neuronal stem cells may ameliorate or even result in 
the rescue of the PMD phenotype in some human patients.   
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5 Evaluation of advanced diffusion weighted magnetic 
resonance imaging as a molecular probe to distinguish 
between acute and chronic demyelination in the optic 
nerve of the #72 mouse 
 
5.1 Introduction 
 
In Chapter 3 and 4 I showed that the #72 mouse develops a progressive 
demyelination with failed remyelination. A previous study (Edgar et al., 2010) of 
the optic nerve of this model demonstrated a progressive demyelination that 
resulted in the development of two spatially separate regions, a chronic 
demyelinated region without inflammation and an acute inflamed demyelinated 
region. MRI has facilitated the detection and distribution of CNS pathologies in 
vivo (Ciumas et al., 2008;Fox, 2008;Guttmann et al., 1995;Inglese et al., 
2005b;Inglese et al., 2005a). However, the specificity is still low and 
identification of lesion type often remains speculative. New MRI techniques, 
such as diffusion weighted MRI, which aims to serve as a molecular probe, have 
been developed but remain poorly understood. The #72 mouse brain has 
previously been analysed using diffusion weighted MRI (DW MRI) (Ruest et al., 
2011), showing that DW MRI is a valuable tool for detecting widespread white 
matter changes in relation to myelin integrity. I speculated that the #72 mouse 
optic nerve, with its clear anatomical features and its spatially defined 
histopathology (Edgar et al., 2010), would make an ideal model to evaluate the 
capability of modified DW MRI sequences to distinguish white matter lesion 
types.  
 
5.1.1 The impact of conventional magnetic resonance imaging in 
diagnosing central nervous system white matter changes 
 
Historically, the diagnosis and monitoring of progression of demyelinating lesions 
in vivo has been difficult.  In order to investigate lesion development, surgical 
procedures to obtain serial biopsy samples from CNS tissue were necessary. 
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However, the invasive nature of this procedure meant that disease progression 
was altered (complicating evaluation of disease development). Additionally, the 
surgical procedures were associated with detrimental effects on the 
animal/patient. The full distribution and extent of the pathology could 
previously only be assessed at the point of necropsy.  
  
With progress in the development of advanced imaging modalities, including 
magnetic resonance imaging (MRI), in vivo evaluation and monitoring of white 
matter lesions dispersed over the whole CNS, has become possible.  In the case 
of multiple sclerosis, MRI has improved the accuracy of diagnosing, localising and 
monitoring the course and extent of white matter pathology (reviewed in Ciumas 
et al., 2008;Inglese et al., 2005b). Repeated MRI allows mapping of lesion 
distribution and reveals temporal changes in lesion size and location (Guttmann 
et al., 1995; reviewed in Ciumas et al., 2008). One major weakness of 
conventional MRI sequences in the characterisation of white matter pathology is 
the low sensitivity to distinguish lesion types, in particular between areas of 
acute active inflammation with ongoing demyelination and inactive, chronic 
demyelination (Bitsch et al., 2001; reviewed in Inglese et al., 2005b). 
 
5.1.2 The use of diffusion weighted imaging of central nervous system 
white and grey matter in the research and clinical settings 
 
The provision of a modality capable of distinguishing active inflammation with 
ongoing demyelination from inactive, chronic demyelination would have a major 
impact on monitoring disease development, response to treatment and accurate 
determination of the long-term prognosis for the affected patient. It may also 
provide greater insight into myelination dynamics that lead to the failure of 
remyelination observed in experimental demyelinating models and in MS.  
 
One modality that might permit differentiation of lesion types is diffusion 
weighted imaging (DWI).  DWI sequences measure the movement of water 
molecules within tissues (Basser et al., 1994; reviewed in Basser and Oezarslan 
E, 2009).  The diffusion of water molecules refers to the natural phenomenon of 
random thermal motion that all molecules at temperatures above zero degrees 
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Kelvin undergo; also referred to as Brownian motion (reviewed in Mori and 
Zhang, 2006).  In liquids, individual molecules can move freely, with the 
diffusion coefficient depending on molecular size, viscosity and temperature of 
the media (reviewed in Beaulieu, 2002;Mori and Zhang, 2006).  In tissue such as 
the white matter, the degree and direction of diffusion of water molecules is 
restricted by the tissue microstructure (Moseley et al., 1990a;Turner et al., 
1990).  Intracellular structures, cell membranes and tissue properties (including 
cell type, density, size and integrity, as well as extracellular matrix) all 
influence water diffusivity (reviewed in Beaulieu, 2009).   
 
The sensitivity of DWI in detecting changes in water diffusion due to pathological 
processes in the CNS means that DWI is being increasingly used in clinical 
applications (Warach et al., 1995;Larsson et al., 1992; reviewed in Goldberg-
Zimring et al., 2005). One example is in the early detection of cerebral 
ischemia: while standard sequences still appear normal during the pre-acute 
stage, pathological changes are usually already apparent in DWI (Mintorovitch et 
al., 1991;Moseley et al., 1990b;Warach et al., 1995).  Following white matter 
ischemia, DWI differentiates cytotoxic oedema, which is present soon after the 
ischaemic event, and vasogenic oedema, which is present at a later stage (Ebisu 
et al., 1993). DWI is also more sensitive in detecting white matter lesions than 
standard T2 weighted magnetic resonance sequences, as demonstrated in a 
monkey model of experimental autoimmune encephalitis (Heide et al., 1993). 
 
5.1.3 Diffusion tensor imaging and its application in investigating 
central nervous system white matter physiology and pathology 
 
In order to measure diffusion, diffusion sensitising gradients are applied to a 
pulsed gradient spin echo (PGSE) sequence (reviewed in Beaulieu, 2002).  In 
“standard” diffusion weighted imaging (DWI) the diffusion sensitising gradients 
are applied along a single direction, sensitising the signal to diffusion only along 
that direction.  Two gradient pulses separated by a defined time and a gradient 
strength of a defined duration are applied to the scan area.  These adjustable 
parameters are part of the b-value, which is a diffusion sensitising factor 
(reviewed in Basser and Oezarslan E, 2009). The attenuation of the signal 
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measured after applying the sequence is caused by diffusion of the ‘labelled’ 
water molecules (Norris, 2001). 
 
The b-value is defined as follows:  
 
Equation 1:     (   )  (   
 
 
) 
 
 is the magnetogyric ratio (depends on the nucleus used e.g. 1H), G is the 
gradient strength,  is the duration of the applied gradient and  is the time 
between the two gradient pulses (called the observation time).   
 
Diffusion can be measured in any direction using a linear combination of the X, Y 
and Z gradients (Basser et al., 1994; reviewed in Jones, 2009). This directional 
application of the gradient is also used in diffusion tensor imaging (DTI), a 
modification of DWI (Basser et al., 1994; reviewed in Jones, 2009).  Using the 
assumption that there is a Gaussian diffusion process and that the signal decay 
occurs mono-exponentially as a direct result of water molecule diffusion, DTI 
requires diffusions to be measured along a minimum of 6 directions. In DTI, 
diffusion in each direction is measured using a PGSE pulse sequence with two 
different b-values, usually 0 and ~ 1000 s/mm2.  This allows the calculation of 
diffusion and diffusivity in any direction of interest (reviewed in Jones, 2009). 
Quantification of diffusion directionality, which is the basis of DTI, is possible 
because diffusion can be anisotropic or isotropic, depending on the 
microstructure of tissue (Doran et al., 1990;Moseley et al., 1990a).  Anisotropy 
arises when the water molecule movement is more restricted in certain 
directions than others (Doran et al., 1990;LeBihan D. et al., 1993;Moseley et al., 
1990a; reviewed in Beaulieu, 2002;Mori and Zhang, 2006). Faster diffusion in 
certain directions compared to others results in a specific directionality of bulk 
water molecule movement in tissue, which can be expressed in terms of an 
ellipsoid.  In contrast, isotropic diffusion is present when water diffusion is equal 
in all directions, and can be expressed in terms of a sphere (reviewed in 
Beaulieu, 2002;Mori and Zhang, 2006).  As mentioned before, water diffusivity 
can be measured in different directions, allowing determination of the direction 
of the largest versus the mid-range versus the lowest principal diffusivity.  The 
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higher the anisotropy of tissue, the simpler it is to determine the main 
directionality of diffusion by means of DTI (reviewed in Mori and Zhang, 2006).  
High anisotropy is particularly evident in tissue such as the CNS white matter 
(reviewed in Beaulieu, 2002), which comprises parallel arrays of nerve fibres 
(Figure 55). 
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Figure 55. Examples of anisotropic and isotropic diffusion.  
Dorsal view of a 3D fast spoiled gradient echo image of a cat brain (A). White matter tracts such 
as the internal capsule (rectangle with dotted lines) are composed of dense axonal bundles. The 
strict anatomical organisation of nerve fibers guides the bulk diffusion along a main direction, 
which is the basis of anisotropic diffusion in white matter (B, C). Anisotropic diffusion is 
expressed in form of a diffusion ellipsoid (D). The diffusion ellipsoid reflects the difference 
between the parallel (ADCII or λ1) and perpendicular (ADC┴ or λ2 and λ3) diffusion in relation to 
the neural fibers, showing that diffusion is faster in the parallel than perpendicular direction to 
the nerve fibers (ADCII > ADC┴). An example of isotropic diffusion in the CNS is found in the 
ventricular system (rectangles with solid lines in A; E; three dimensional reconstruction of the 
ventricular system in a dog), which contains cerebrospinal fluid (CSF), a virtually acellular fluid 
with low protein content. In the CSF filled ventricular system, diffusion similar in all directions, 
and can be expressed in terms of a sphere. (F, ADCII = ADC┴). Adapted from (Beaulieu, 2009). 
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Studies aimed at understanding the tissue correlates of the DTI parameters have 
shown that axons, with the axonal membrane as the main barrier, are the main 
contributors to anisotropy (reviewed in Beaulieu, 2002;Beaulieu, 2009). The 
influence of intra-axonal structures on diffusion is considered to be insignificant 
(Beaulieu and Allen, 1994;Ono et al., 1995;Gulani et al., 2001;Mori and Zhang, 
2006). Furthermore, correlative studies in dysmyelinating and demyelinating 
mouse models such as shiverer (Nair et al., 2005;Song et al., 2002), jimpy (Ono 
et al., 1995;Harsan et al., 2007), the transgenic olig-TTK mouse (Harsan et al., 
2006) or lysolecithin induced demyelination models (Xie et al., 2010) have shown 
that myelin sheaths have a modulatory effect on diffusion anisotropy. 
Consequently DTI sequences can be used to identify pathological changes in 
myelin, which interfere with the normal diffusion of water along white matter 
tracts (reviewed in Barkovich, 2000;Laule et al., 2007). For example, it has been 
shown that demyelination is associated with increased radial (perpendicular to 
the axons) diffusivity (Song et al., 2002;Song et al., 2005) and axonopathy with 
reduced axial (parallel to the axons) diffusivity (Budde et al., 2008).  
Interestingly remyelination reverses the changes in radial diffusivity (Harsan et 
al., 2006).  
 
The potential influence on diffusion measures of other white matter components 
such as of astrocytes, microglia, trafficking immune cells and OPCs has often 
been neglected. However, recent studies investigating the role of extra-axonal 
factors on diffusion parameters have shown that these cells also influence 
diffusion (Harsan et al., 2007;Xie et al., 2010;Ruest et al., 2011), albeit to a 
considerably lesser extent than the nerve fibres themselves.  
 
5.1.4 Multiexponential signal decay – an opportunity to differentiate 
between inflammation with acute demyelination and chronic 
silent demyelination? 
 
In DWI, the diffusion of water molecules (i.e. H nuclei) results in signal 
attenuation, which can be directly related to diffusion rate. The higher the 
diffusion rate the more pronounced is the signal decay (Westbrook et al., 
2005;Jones, 2009). Generally, diffusion is considered to produce 
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monoexponential signal decay. However, a number of studies have shown that 
there is non-monoexponential signal decay if the DWI sequence is extended by 
applying multiple increasing b-values, extending up to 40000 s/mm2 (Stanisz et 
al., 1997;Clark and LeBihan D., 2000;Ronen et al., 2006). The origin of 
biexponential, or even triexponential (Assaf and Cohen, 1998) signal decay is not 
fully understood and various models have been investigated and proposed.   
 
Some groups have suggested that biexponential decay is the result of 
microstructures restricting or hindering diffusion in characteristic ways (Stanisz 
et al., 1997;Pfeuffer et al., 1999). If this is assumed to be the case then 
multiexponential diffusion decay can be analysed by dividing the data into two 
or more independent monoexponential diffusion components, each representing 
a distinct micro anatomical entity within the tissue. In white matter these micro 
anatomical entities have been classified as the intracellular space versus the 
extracellular space, or more specifically, the intraaxonal space versus the extra 
axonal space including the myelin sheath (reviewed in C. Beaulieu, 2002). 
 
Others state that the compartmentalisation into slow and fast diffusion does not 
sufficiently explain the presence of biexponential signal decay (Niendorf et al., 
1996;Schwarcz et al., 2004). It has been suggested that different binding states 
of water molecules to protein fragments or conformational changes in proteins 
after injury may also contribute to the presence of the biexponential signal 
decay phenomenon (Schwarcz et al., 2004).  
 
Demyelinating lesions in MS patients possess the capacity to remyelinate, even 
after long term disease (Patani et al., 2007;Patrikios et al., 2006). However, 
some chronically demyelinated regions fail to remyelinate (Chang et al., 2002). 
Axonal loss, which is considered to be the major contributor to permanent 
disability (Kornek et al., 2000;Bjartmar and Trapp, 2003;Bjartmar et al., 2003), 
is associated with chronic demyelination, highlighting the importance of 
preventing the development of chronic lesions. If a method such as DWI with 
multiple increasing b-values is capable of identifying lesion type non-invasively, 
this would substantially improve the diagnostic accuracy, inform the most 
suitable treatment and allow accurate determination of the long term prognosis.  
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I hypothesised that using multiple increasing b-values might increase the 
sensitivity of DWI to differentiate between different pathological states such as 
inflammation and demyelination versus chronic demyelination without 
inflammation. If true, then this technique may become particularly useful as a 
molecular probe for diagnosing different stages of inflammatory demyelinating 
white matter disease.  In particular, in MS where it could help to distinguish 
chronic, silent demyelination and active inflamed demyelination. 
 
5.1.5 The #72 mouse optic nerve as a model system in which to assess 
the potential of DWI to distinguish complete demyelination from 
inflammatory demyelination 
 
Anatomically the optic nerve comprises a region of parallel axons with a defined 
supporting cell population. In terms of the application of DWI, the 
unidirectionality of optic nerve axons allows the reduction of the full diffusion 
tensor (as used in DTI) to two directions; parallel and perpendicular to the fibres 
(Tu et al., 2010). The adult #72 mouse optic nerve displays a highly reproducible 
persistent demyelination in the rostral segment and active demyelination with 
inflammation in the caudal segment (Edgar et al., 2010).  The predictable lesion 
progression in the optic nerve of the #72 mouse creates an ideal model with 
which to test the hypothesis that applying multiple increasing b-values to the 
DWI sequence can increase the sensitivity of DWI to distinguish lesion types 
within nerve fibre tracts.  
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5.2 The aims of the chapter 
 
1.) To establish a protocol for the preparation of isolated optic nerves for 
high resolution DWI of CNS white matter  
2.) To apply DWI with multiple increasing b-values to normal, completely 
demyelinated and actively demyelinating optic nerve regions 
3.) To undertake a detailed histological examination of the regions of interest 
of the scanned nerves for comparison with the DWI data 
4.) To assess whether DWI with increasing b-values is more sensitive than 
conventional DWI using two b-values, to distinguish active demyelination 
from complete demyelination  
 
5.3 Material and Methods 
 
5.3.1 Breeding and identification of homozygote 72 mice  
 
Plp1 overexpressing 72 transgenic mice were generated and genotyped as 
described in Chapter 2.2 Mouse breeding. Optic nerves from homozygote #72 and 
wild type mice were used. 
 
5.3.2 Coil and sample holder design for mouse optic nerve DWI 
 
5.3.2.1 Coil design 
 
Commercially available coils did not meet the requirements for scanning the 
small diameter of the mouse optic nerves (diameter of approximately 300µm 
each). A purpose built coil, designed and built by William Holmes and Jim 
McMullen was used.  The coil was of a transmit/receive solenoid design, directly 
connected to the standard scanner electronics. In order to avoid metal related 
artefacts the metal part was the coil itself, for which magnetic susceptibility 
matched wire was used. Acrylic glass was used for the front part of the coil 
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(Figure 56). To prevent the sample from moving during the scan, an adjustable 
acrylic screw was placed beneath the coil. The acrylic screw was also used to 
adjust the position of the samples vertically within the coil (one revolution = 1 
mm movement). 
 
5.3.2.2 Sample holder design 
 
The sample holder was designed to allow three pairs of optic nerves to be 
imaged simultaneously. The orientation of the nerves within the sample tube 
was critical because diffusion was to be measured in two directions only. The 
sample itself had to be confined in order to avoid motion during the scan. 
Additionally, the samples had to be surrounded by fluid, in order to prevent 
them from drying out, as this would lead to irreversible tissue damage and 
interfere with diffusion of H2O molecules. Therefore the sample holder had to 
fulfil certain criteria: it had to be small in diameter to avoid movement of the 
optic nerve, linear, waterproof and ideally made of plastic to avoid interference 
with the magnetic field. A commercially available plastic tube commonly used 
for microinfusion in rats fulfilled all the requirements. The tube was readily 
available, made of plastic and had an intraluminal diameter of 500µm. Two 
centimetre long sections of tubing were cut to act as sample holders. These 
were mounted on a steel needle (0.5 x 20mm) and were left overnight on a hot 
plate (60°C) to straighten. A bundle of seven tubes were glued together using 
nail varnish to form a cylinder, which fitted tightly into a larger plastic tube. 
The larger tube was used as a template to define the coil diameter when the coil 
was built and therefore fitted securely inside the coil (Figure 57). 
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Figure 56. Image of the purpose built transmit/receive coil. 
The scanning part of the coil, with a diameter of 4mm is marked with an asterisk. Acrylic glass 
was used in close proximity to the coil to avoid artefact generation. An acrylic screw (arrow) just 
below the coil region was used to adjust the location of the samples, and to immobilise the 
samples, which were placed vertically inside the coil.   
 
 
Figure 57. Image of the optic nerve sample holder used for the diffusion 
weighted imaging experiment. 
Seven plastic microtubes with an inner diameter of 500µm, each assigned to hold one optic nerve 
and one to contain PBS/Multihance, were glued together using clear nail varnish. The cylinder of 
seven tubes was then fitted tightly into a larger sample tube with a 4mm outer diameter. The 
large tube was used as a template for determining the diameter of the transmit/receive coil and 
therefore fitted securely inside the coil (horizontal line 4mm, vertical line 0.5mm). 
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5.3.3 Preparation of optic nerves for DW MRI scan 
 
Twelve 72 mice and six wild type mice were euthanized in a CO2 chamber.  
Intracardiac perfusion of 0.85% saline (20ml) followed by 4% paraformaldehyde 
(PF, 20ml) was performed, as described in Chapter 2.6 Tissue sampling and 
processing, for optimal tissue fixation. Immediately after perfusion, both optic 
nerves were dissected, leaving the eyes, the optic nerves, the chiasm and a part 
of the optic tract as one intact unit. The optic nerves were freed of surrounding 
tissue as thoroughly as possible. The optic nerves were separated from each 
other longitudinally at the chiasm leaving two intact single optic nerves with 
chiasm and optic tract. After removing the lens and retina the optic nerve was 
pinned down at the sclera and at the optic tract on a wax board, without 
applying tension, to straighten the nerve. The pinned nerves were then 
transferred into 4% paraformaldehyde for another six hours. Since 
paraformaldehyde may interfere with diffusion (Kim et al., 2009;Shepherd et 
al., 2009;Sun et al., 2003), extensive washing of the tissue was performed to 
remove all free paraformaldehyde from the tissue. After the fixation period the 
nerves were transferred into PBS for 24 hours at 4°C. To enhance the MR signal 
the PBS solution was subsequently incubated in a 2.5mM solution of gadobenate 
dimeglumine (MultiHance, Bracco, 0.5M containing 334mg/ml gadobenic acid) 
in PBS (250l MultiHance/50ml PBS) for 6 days at 4°C. 
 
On the day of the scan the nerves were removed from the wax board, submerged 
in a Multihance®/PBS bath and microsurgical threads (SurgiPro® II 7-0, 
polypropylene, monofilament, Surgalloy) were sutured to the sclera.  Each nerve 
was then pulled through a designated plastic microtube filled with 
Multihance®/PBS solution. The optic nerves were aligned with each other 
longitudinally, under magnification, using the scleral-optic nerve junction as a 
landmark. Six microtubes were filled with three optic nerve pairs. The seventh 
tube containing Multihance®/PBS only, served as a control. While still 
submerged in solution, the barrel containing the samples was transferred into 
the large sample holder (Figure 58). Once the barrel was in place the sample 
holder was sealed using Blu-Tack® (Figure 59). The alignment of the nerves was 
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verified under high magnification and a mark was placed on the holder at 1 mm 
and 4mm caudal to the scleral-nerve junction, using graph paper as a ruler. 
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Figure 58. Image of the sample holder filled with seven microtubes, each 
containing one optic nerve or just PBS/Multihance. 
Seven plastic microtubes were merged together to form a cylinder containing a total of 3 pairs of 
optic nerves and one empty tube filled with Multihance®/PBS. Microsurgical sutures (blue) were 
attached to the sclera (arrow) to facilitate placement of each optic nerve in its designated 
microtube. 
 
 
 
Figure 59. Image of a sealed sample holder containing optic nerves ready to 
be placed into the coil for scanning.  
The large sample tube was filled with Multihance®/PBS to prevent the tissue from drying out 
during the scan procedure.  The tube was sealed with Blu-Tack® at both ends.  The scan region, 
which was positioned in the middle of the coil was 1mm (asterisk) and 4mm (o) distal to the 
scleral-optic nerve attachment. The regions were identified under magnification using graph 
paper and the external tube was marked with a permanent marker.  
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5.3.4 Instrumentation 
 
The MR images were acquired on a 7 Tesla Bruker Biospin Biospec 70/30 MRI 
system with a micro imaging gradient insert (model BG-6) and 100-A gradient 
amplifiers. The gradient system provides linear magnetic field gradient pulses up 
1000mT/m. 
 
5.3.5 Scan protocol 
 
A three dimensional pilot image was acquired. As the region of interest was 
physically positioned in the middle of the RF coil, the centre of the scan field 
was in the middle region of the pilot image. The imaging slice was manually 
positioned to be perpendicular to the axis of the optic nerve using the pilot 
image. In the pulse program the diffusion sensitising gradients were defined to 
be parallel and perpendicular to the imaging slice, thus avoiding the need for 
manual adjustments to the coil placement. 
 
The DW MRI of the optic nerves was acquired by performing a spin echo DTI with 
a spin echo imaging sequence (TR/TE of 500ms/24.35ms, 4 NEX).  Since the 
directionality of the nerve fibres is known a full tensor was not required (Tu et 
al., 2010). Diffusion gradient pulses were instead applied along three diffusion 
directions, one parallel and two perpendicular directions in relation to the 
axonal fibre orientation.  Sixteen increasing b-values were applied along each 
gradient directions (94.6, 270.7, 492.3, 708.9, 922.9, 1135.3, 1661.5, 2183.6, 
2703.1, 3220.8, 3737, 4252.1, 4766.3, 5279.7, 5792.4, 6304.6 s/mm2). Gradient 
pulse timing was fixed at  = 4ms and  = 16ms. The slice thickness was 1mm. 
The matrix of the scan region was 62 x 62, with a 65µm x 65µm resolution per 
voxel.  In each sample, a water phantom was scanned simultaneously with the 
optic nerve samples. All scans were performed at room temperature (20ºC). The 
diffusivity of water at room temperature is known and the water sample served 
as a control. 
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5.3.6 Processing and analysis of DWI data 
 
The DWI raw data was extracted using ImageJ®. The data was further processed 
in MatLab®, where curve fitting, diffusion coefficient and fractional anisotropy 
were calculated.  
 
5.3.7 Conventional analysis of the data using two b-values only 
 
The diffusion coefficient D of water molecule can be calculated based on the 
signal in spin echo sequences which is derived from proton density (PD), T1 and 
T2 relaxation time using this simplified formula (Stejskal and Tanner, 1965;Mori 
and Zhang, 2006) 
 
Equation 2       (          )            
Equation 3        
    
 
In diffusion experiment using two b-values: 
 
Equation 4         
     
Equation 5         
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   (Mori and Zhang, 2006) 
 
Based on Equation 7 the apparent diffusion coefficient for ADCII and ADC┴ is 
calculated. When working with only two b-values in an assumingly 
monoexponential diffusion decay experiment, the optimal b-values are in 
general considered to be for b1 close to 0 and for b2 between 900 and 1200 
s/mm2 (Jones, 2009). In this case we used for b1 94.6 s/mm
2 and for b2 1135.3 
s/mm2 to calculate ADCII and b1 68.4 s/mm2 and b2 1018.4 s/mm
2 to calculate 
ADC┴. 
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The fractional anisotropy (FA) is a numeric value that provides an indication of 
the “directionality” of diffusion in tissue. Values lie between 0 (isotropic 
diffusion) and 1 (completely anisotropic diffusion, in one direction).  
FA is calculated from the parallel and perpendicular apparent diffusion 
coefficient ADC or, when applying the full tensor, from the three eigenvalues λ1, 
λ2, λ3. In our case, where the fibre orientation is known, ADCII is λ1 and ADC ┴ is 
λ2 and λ3. 
 
Equation 8       
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where 
 
Equation 9        
          
 
 
 
this is also the mean diffusivity <D>, a measurement of diffusion without 
considering directionality (Beaulieu, 2009). 
 
Equation 10      
               
 
 
 
5.3.8 Analysis of the data using multiple increasing b-values 
 
The data was further analysed by fitting the signal attenuation with 
biexponential fitting routine using the following formula: 
 
Equation 11 
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Equation 12    ( )                   
 
S(g)/S0 or E(b) is the signal intensity change,  is the contribution of the fast 
portion from the total signal decay,  is the contribution of the slow portion 
from the total signal decay,  is the magnetogyric ratio of 1H, g is the gradient 
strength,  is the length of duration of the applied gradient and  is the time 
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between the two gradient pulses. D1 is the diffusion coefficient of the fast 
diffusion and D2 is the coefficient of the slow diffusion component. The b-value 
is defined as described in Equation 1. The fast diffusion (D1) and the slow 
diffusion (D2) as well as the contribution of fast diffusion (α) and slow diffusion 
(β) on total diffusion can be calculated using Equation 12 (Figure 60).  
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Figure 60. Illustration of the two components identified after applying the 
curve fitting routine on the signal decay curve obtained from multiple 
increasing b-values.  
Using Equations 11 and 12 for curve fitting allowed the differentiation between two different 
components, a fast diffusion component (D1) and a slow diffusion component (D2), where the 
slope of the components, expressed as red and blue lines, displays the different diffusivities. 
Additional data were generated by calculating the contribution of each diffusion component, in 
percentage, relative to the total diffusion process.  
224 
5.3.9 Tissue sampling for histological examination 
 
Immediately following the scan, the optic nerves were sectioned into three 
parts. The first part included the sclera and the retinal portion of the optic 
nerve, extending 1.5mm caudally from the optic disc.  The second and third 
parts consisted of 1.5mm long segments, starting 1.5 and 3mm, respectively, 
from the optic disc. The first and the third parts (equivalent to the two scan 
regions) were frozen as described in Chapter 2. Ten µm thick transverse sections 
were cut on a cryostat and mounted on APES coated slides. Serial sections, 
spanning 1mm through the nerve, were collected on 10 slides (consecutive 
sections were mounted on consecutively numbered slides). Each slide contained 
up to 10 sections, each one sectioned at a distance of 100µm from the previous 
one. These sections were used for immunofluorescence. The middle part each 
nerve was cut in half and processed for electron microscopic evaluation as 
described in Chapter 2 Material and Methods. Sample processing, 
immunohistochemistry and EM procedures are described in Chapter 2.7.3 
Electron microscopy. 
 
5.3.10 Primary antibodies for characterisation of cell types in the 
optic nerve 
 
The following antibodies were used to identify specific cell populations: 
adenomatous polyposis coli (APC) to identify mature oligodendrocytes, 
chondroitin sulphate proteoglycan (NG2) to identify oligodendrocyte precursor 
cells, glial fibrillary acidic protein (GFAP) to identify astrocytes and CD45 to 
identify the microglial/macrophage/leukocytic population. For dilutions and 
suppliers, see Table 2. 
 
5.3.11 Secondary antibodies  
 
Secondary FITC labelled antibodies were used to visualise primary antibody 
binding.  Anti-mouse IgG1 for APC, anti-rabbit IgG for NG2, anti-mouse IgG1 for 
GFAP and anti-rat IgG for CD45. For dilutions and suppliers, see Table 3. 
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5.3.12 Quantification of cell densities 
 
A minimum of 6 sections, each 90µm apart from the previous, were analysed for 
cell quantification. Micrographs were opened in Image ProPlus 6.0 software and 
an area of interest (AOI: 28060.45µm2) was applied manually onto each image. 
To calculate total cell density, semi-automated quantification of DAPI stained 
nuclei, applying a signal threshold value between 5 and 200, was obtained from 
an AOI of 9983.98µm2. All cells, which were fully or partially located in the AOI, 
except cells touching the southern and the western borders of the AOI, were 
counted. Cell density per mm2 was calculated based on counts from a minimum 
of 6 AOIs. A similar procedure was used to quantify densities of specific cell 
types, but in this case, the immuno-labelled cells with a DAPI nucleus were 
identified and quantified manually. 
 
5.3.13 Statistics 
 
For both DW MRI and histological analyses, a two tailed, paired t-test was used 
to compare retinal and chiasmal regions of wild type or #72 optic nerves. 
Comparisons between genotypes were made using an unpaired two tailed t-test. 
No corrections for multiple comparisons were made. All statistical analyses were 
done using GraphPad Prism® 5. 
 
5.4 Results 
 
An initial scan of 6 wild type nerves was undertaken in order to test the 
reproducibility of the protocol and the stability of the device. Once optimised, 
18 optic nerves of sex and age matched control (wild type) and #72 nerves were 
scanned. DW MRI data was obtained from 16 increasing b-values ranging from 
94.6 to 6304.4 s/mm2.  
 
Initially the DW MRI data generated from the analysis of 2 b-values was 
extracted from the complete dataset b-values (b1 = 94.6 s/mm
2; b2 = 1135.3 
s/mm2), was analysed. These results are summarised in Table 5 and Table 6. The 
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complete dataset (i.e. using all b-values) was then used to unveil fast and slow 
diffusion components. The results are summarised in Table Table 7, Table 8, 
Table 9, Table 10, Table 11, Table 12.  
 
5.4.1 Good signal quality was obtained from the scanned optic nerves 
 
The signal obtained from the optic nerves during the scan in the sample holder 
was stable and a good signal to noise ratio of 25 : 1 was achieved (Figure 61).  
The data were used to measure diffusion parallel and perpendicular to the 
orientation of the optic nerve fibres. 
 
5.4.2 Analysis of the data using two b-values 
 
5.4.2.1 Fractional anisotropy was reduced in the #72 optic nerves  
 
The fractional anisotropy (FA), a measure of diffusion directionality, was 
calculated using Equation 8 from the data generated using two b-values. There 
was a significant reduction in FA in both the retinal and chiasmal regions of the 
#72 optic nerves compared to the same regions in the wild type nerves (Figure 
62, Table 5).  There was also a significant reduction in FA in the chiasmal region 
compared to the retinal region in #72 nerves (Figure 62, Table 6). 
 
5.4.2.2 Mean diffusivity increased with demyelination 
 
Mean diffusion, calculated using Equation 10, was significantly increased in both 
retinal and chiasmal regions of the #72 nerves, compared to the same regions in 
the wild type nerves (Figure 63). Furthermore, although diffusion was similar in 
both regions of wild type nerves, it was significantly greater in the retinal region 
than in the chiasmal region of the #72 nerves (Figure 63).   
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Figure 61. Good signal to noise ratio was achieved with the purpose built 
coil.  
Representative examples of two diffusion weighted (DW) images obtained at a b-value of 94.6 
(A) and 1135.3 (B) s/mm2 along the parallel direction in relation to the orientation of the optic 
nerve fibers. Depending on the quantity of the b–value the optic nerves can be identified as grey 
(arrowheads in A) or white (arrowheads in B), circular objects. H2O served as a control (asterisk 
in A & B). The slower the diffusion, the more 1H protons remain in the scan region, generating 
the bright signal in the object at high b-values. A quadrate region of interest was chosen in the 
middle of the optic nerve with an area composed of 2 x 2 voxels resulting in a measured area of 
130µm x 130µm x 1000µm.  
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Figure 62. Fractional anisotropy was reduced in both #72 optic nerve 
regions, compared to wild type.  
Graph representing the mean fractional anisotropy (FA) values (+ s.e.m.) in the two scanned 
regions of wild type and #72 optic nerves using two b-values b1=94.6 s/mm2; b2=1135.3 s/mm2. 
There was a significant decrease in FA in both regions of the #72 optic nerve compared to the 
same regions in the wild type. There was also a significant decrease in FA in the chiasmal region 
compared to the retinal region of the #72 optic nerves. Wild type: N=12, #72: N=24; WT RR: wild 
type retinal region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: 
#72 chiasmal region. Stars indicate p values: **p < 0.01. ***p < 0.001; ****p < 0.0001. 
 
Figure 63.  Mean diffusion was increased in the #72 mouse optic nerve. 
Graph representing the mean apparent diffusion coefficient (+ s.e.m.) in wild type and #72 optic 
nerves obtained using two b-values b1=94.6 s/mm
2; b2=1135.3 s/mm
2. The mean diffusion was 
significantly higher in the retinal and chiasmal regions of the #72 nerves compared to the same 
regions in the wild type nerve. Within the #72 nerve, the mean diffusion was significantly higher 
in the retinal region than in the chiasmal region. WT RR: wild type retinal region. Wild type: 
N=12, #72: N=24; WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: #72 
chiasmal region. Stars indicate p values: **p < 0.01; ***p < 0.001; ****p < 0.0001. 
229 
5.4.2.3 Changes in the parallel apparent diffusion coefficient (ADCII) and 
perpendicular apparent diffusion coefficient (ADC┴) in the #72 nerve  
 
To calculate ADCII and ADC┴, Equation 7 was used (Jones, 2009). ADC┴ was 
significantly increased in both the retinal and chiasmal regions of the #72 nerves 
compared to the corresponding regions in the wild type nerves (Figure 64, Table 
5, Table 6).  In contrast, ADC// was significantly increased in only the retinal 
region of the #72 nerve compared to (i) the same region in the wild type nerve 
and (ii) to the chiasmal region of the #72 nerve. Conversely, in the wild type 
nerve, ADC// was slightly, but significantly, higher in the chiasmal region than in 
the retinal region. (Figure 65, Table 5, Table 6). 
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Figure 64. Perpendicular apparent diffusion coefficient was increased in 
the #72 optic nerve.  
Graph presenting the mean values (+ s.e.m.) of the perpendicular apparent diffusion coefficient 
(ADC┴) taken from the two scanned regions in the wild type and the #72 optic nerves using two 
b-values b1=68.4 s/mm2; b2=1018.4 s/mm2. There was a highly significant increase in ADC┴ in 
both regions of the demyelinated #72 optic nerve compared to the same regions in the wild type. 
Wild type: N=12, #72: N=24; WT RR: wild type retinal region. WT CR: wild type chiasmal region. 
Homo RR: #72 retinal region. Homo CR: #72 chiasmal region. Stars indicate p value: ****p < 
0.0001. 
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Figure 65. Parallel apparent diffusion coefficient was increased in the 
retinal, but not the chiasmal region of the #72 nerve, compared to wild type.  
Graph presenting the mean values (+ s.e.m.) of the parallel apparent diffusion coefficients 
(ADCII) in the retinal and chiasmal regions of the wild type and #72 optic nerves using two b-
values b1=94.6 s/mm
2; b2=1135.3 s/mm
2. There was a significant increase in parallel diffusion in 
the #72 retinal region compared to the same region in the wild type nerve. There was also a 
significant increase in ADC// in the #72 retinal region compared to the #72 chiasmal region. In 
contrast, in the wild type nerve, ADC// was very slightly, but significantly, higher in the chiasmal 
region compared to the retinal region. Wild type: N=12, #72: N=24; WT RR: wild type retinal 
region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: #72 chiasmal 
region. Stars indicate p values: *p < 0.05; ****p < 0.0001.  
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In summary, ADC┴ was significantly increased in the #72 optic nerves compared 
to the wild type. This contributed to the decreased FA values and to the 
increased mean diffusion. A significant increase in ADCII in the #72 retinal region 
was also present when compared to the wild type and the #72 chiasmal region. 
Results are summarised in Table 5 and Table 6. 
 
5.4.3 Analysis of the data using multiple increasing b-values 
 
5.4.3.1 A biexponential signal decay became apparent in the optic nerve 
when applying multiple increasing b-values  
 
I hypothesised that the application of multiple increasing b-values would 
increase the sensitivity of DWI to detect differences between white matter 
lesions. Therefore, in the following sections, the entire data set generated using 
16 b-values was analysed. Signal decay curves were created, by plotting signal 
intensity as a function of b-value, for both parallel and perpendicular diffusion 
gradient directions. Signal decay deviated from mono-exponential behaviour 
(Figure 66) in both wild type and #72 nerves. 
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Figure 66. Biexponential signal decay became apparent with increasing 
b-values.  
Signal decay curves obtained from a scanned optic nerve and from H2O, in the parallel (II, red 
line) and perpendicular (┴, green and blue lines) directions (in relation to optic nerve fibers). 
The signal changes were plotted on a natural logarithmic scale in relation to the b-value. 
Biexponential signal decay was present in optic nerves suggesting the presence of two different 
diffusion components; a fast and a slow. In the parallel diffusion direction (red line), the slow 
diffusion component only became visible at higher b-values, suggesting that this information was 
lost when using b-values only up to 1500 s/mm2. Water, in which diffusion was unrestricted, 
showed a monoexponential characteristic and served as a negative control. The noise level 
(arrow) did not interfere with the parallel and perpendicular DWI measurement in the optic 
nerve.  
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5.4.3.2 Fast and slow diffusion were altered in #72 nerves compared to wild 
type  
 
Curve fitting using Equation 11 was applied in order to obtain information 
regarding fast and slow diffusion components of CNS water.  
 
The perpendicular and parallel diffusion within the fast and slow components 
were calculated using Equation 12 and the results are summarised in Table 7, 
Table 8, Table 9, Table 10, Table 11 and Table 12. Although perpendicular fast 
diffusion (D1┴) was similar in wild type and #72 nerves, there was a significant 
increase in the slow diffusion (D2┴) in both retinal and chiasmal regions of the 
#72 optic nerves compared to the corresponding regions in the wild type (Figure 
67).  
 
Small, but significant differences between samples were found in fast parallel 
diffusion (D1//). D1// was slightly, but significantly increased in retinal and 
reduced in chiasmal regions of the #72 nerves compared to the wild type nerves. 
D1// was significantly higher in the retinal region of the #72 nerve than in the 
chiasmal region. More marked differences were found in slow parallel diffusion 
(D2//). D2II was significantly increased in both retinal and chiasmal regions of the 
#72 nerves compared to that in the corresponding regions of the wild type 
nerves and was also markedly higher in the retinal region of the #72 nerve than 
in the chiasmal region (Figure 68). 
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Figure 67. Perpendicular slow diffusion was increased in #72 nerves 
compared to wild type.  
Graph displaying the means (+s.e.m) of the fast (D1┴) and slow (D2┴) perpendicular diffusion in 
wild type and #72 optic nerves. D2┴ was significantly increased in both regions of the #72 nerves 
compared to the corresponding regions in wild type nerves. WT RR: wild type retinal region. 
Wild type: N=12, #72: N=24; WT CR: wild type chiasmal region. Homo RR: #72 retinal region. 
Homo CR: #72 chiasmal region. Stars indicate p values: **p < 0.01; ****p < 0.0001. 
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Figure 68. Parallel slow diffusion was increased in the #72 nerve compared 
to wild type.  
Graph displaying the means (+s.e.m) of the fast (D1II) and slow (D2II) perpendicular diffusion in 
wild type and #72 optic nerves. Small, but significant, changes in D1II were detected in #72 
nerves compared to wild type. More pronounced changes were observed in D2II, which was 
markedly and significantly increased in #72 nerves compared to wild type, particularly in the 
retinal region of the nerve, where it was almost 3 times the corresponding wild type value. WT 
RR: wild type retinal region. Wild type: N=12, #72: N=24; WT CR: wild type chiasmal region. 
Homo RR: #72 retinal region. Homo CR: #72 chiasmal region. Stars indicate p values: *p < 0.05; 
**p < 0.01. ***p < 0.001; ****p < 0.0001. 
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5.4.3.3 The contribution of the fast diffusion component to the total diffusion 
was increased in #72 optic nerves 
 
With alteration in white matter, changes in diffusivity might not just be 
restricted to changes within the two components of fast and slow diffusion, but 
the relative contribution of the fast (α) and slow (β) components could also 
change. Particularly where the measured diffusivity itself remained unchanged, 
pathological changes could potentially still be detected by determining changes 
in the contribution of the slow and fast diffusion components, independent from 
the diffusion rate.  
 
The contribution of the fast diffusion to total diffusion was significantly 
increased in retinal and chiasmal portions of the #72 mouse optic nerve 
compared to the wild type mouse optic nerve in both the parallel and 
perpendicular orientation (Figure 69). Conversely, the opposite, was true for the 
slow diffusion contribution. Results are summarised in Table 7 and Table 8.  
 
Within the #72 nerve, the contribution of the parallel fast diffusion to the total 
diffusion was significantly greater in the retinal region than in the chiasmal 
region. Since (α + β = 100%), the contribution of slow diffusion, reflects the 
opposite changes.  
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Figure 69. The contribution of fast diffusion (α) was increased in the #72 
optic nerve.  
Graphs representing mean (+ s.e.m) percentage contribution of fast or slow diffusion to total 
diffusion. A significant increase in the contribution of the perpendicular and parallel fast 
diffusion component (α) was present in the #72 nerve compared to the wild type nerve. Within 
the #72 nerve, α was significantly elevated in the retinal region compared to the chiasmal 
region, in the parallel direction. The contribution of the slow diffusion component (β) 
consequently demonstrated the same, but inverted changes. Wild type: N=12, #72: N=24; WT RR: 
wild type retinal region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo 
CR: #72 chiasmal region. Stars indicate p values: **p < 0.01. ***p < 0.001; ****p < 0.0001. 
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5.4.4 Histological examination of optic nerves confirmed the spatially 
distinct regions of silent demyelination and active inflammatory 
demyelination in the scanned regions of 72 mouse optic nerves 
 
5.4.4.1 Virtually complete demyelination was present in the #72 optic nerve 
 
Electron microscopic evaluation showed a virtually complete demyelination in 
the tissue immediately adjacent to the two scan regions, the retinal and the 
chiasmal portion of the #72 optic nerve. The demyelination appeared similar in 
both regions, which was in agreement with previously published results (Edgar et 
al., 2010). The wild type optic nerve appeared highly myelinated as expected at 
P120 (Figure 70). 
 
5.4.4.2 Marked increase in cell density in the chiasmal part of the #72 mouse 
optic nerve 
 
Quantification of DAPI stained nuclei showed a significant increase in total cell 
density in the chiasmal portion of the #72 optic nerve, compared to both the 
corresponding region of the wild type nerve and to the retinal region of the #72 
nerve (Figure 71). 
 
5.4.4.3 Inflammatory cells contributed to the increased cell density in the 
#72 mouse optic nerve chiasmal region 
 
Immunohistochemical staining with an antibody to CD45, a pan-leukocyte 
marker, revealed a marked increase in numbers of CD45 +ve cells in the 
chiasmal region of the #72 nerve. Quantification of CD45 +ve cell density 
confirmed that the chiasmal region of the #72 nerve contained significantly more 
cells than the same region of the wild type nerve. In contrast, CD45 +ve cell 
density in the retinal region of the #72 nerve was slightly, but significantly, 
reduced compared to wild type (Figure 72). 
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5.4.4.4 An astrocytic response was pronounced in the #72 mouse optic nerve  
 
To examine the status of astrocytes, optic nerve sections were stained with an 
antibody to GFAP. In both regions of the #72 mouse optic nerve there was a 
significant increase in the area occupied by GFAP +ve astrocytic processes 
compared to the same regions of the wild type nerve.  The extent of GFAP 
immunoreactivity was similar in retinal and chiasmal regions of the #72 nerve. 
(Figure 73). 
 
5.4.4.5 Oligodendrocyte densities were mildly reduced in the #72 mouse 
optic nerve 
 
An antibody to APC (clone CC1) was used to identify mature oligodendrocytes. 
Oligodendroglial density was significantly reduced in the #72 optic nerve, 
compared to the wild type nerve. The #72 retinal section demonstrated the 
lowest oligodendrocyte cell density (Figure 74). However, despite that fact that 
the #72 nerve was virtually completely demyelinated a remarkable number of 
mature oligodendrocytes were still present.  
 
5.4.4.6 Oligodendrocyte precursor cells were present in the #72 mouse optic 
nerve 
 
To examine OPCs, an antibody to NG2 was used. Although completely 
demyelinated the #72 optic nerve contained NG2 positive cells, the density of 
which was significantly increased in the chiasmal region of the #72 optic nerve, 
compared to the same region in the wild type nerve (Figure 75). Since NG2 is not 
completely OPC specific and may bind to a subset of microglial cells, the 
increase in NG2 cell density may not only represent an increase in OPCs. 
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Figure 70. The #72 mouse optic nerve was almost completely demyelinated 
at P120.  
Electron micrographs of wild type (A, B) and #72 (C, D) retinal and chiasmal optic nerve regions. 
The wild type optic nerve was highly myelinated in both sections (A, B). This was in contrast to 
the #72 optic nerve, where there was a complete absence of myelin  in both regions (C, D, 
x6700, scale bar 2µm). Artefacts, such as mitochondrial swellings (asterisk), were probably due 
to suboptimal fixation for EM processing. Graph of mean axonal density (+s.e.m) showed that 
axonal density was significantly decreased in the retinal region of the #72 optic nerves compared 
to same region in the wild type (E). No such difference was found between #72 and wild type 
nerves in the chiasmal region. Wild type: N=3, #72: N=5; WT RR: wild type retinal region. WT CR: 
wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: #72 chiasmal region. Stars 
indicate p values: **p < 0.01.  
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Figure 71. Cell density was markedly increased in the #72 chiasmal section 
of optic nerve.  
Micrographs of DAPI-stained 10µm-thick transverse sections of retinal and chiasmal regions of 
P120 #72 and wild type mouse optic nerves (A – D, x400, scale bar 50µm).  A marked increase in 
cellular density was seen in the #72 chiasmal region of optic nerve (D). Graph of mean cell 
density (+ s.e.m.) in retinal and chiasmal regions of wild type and #72 optic nerve (E). The cell 
density was significantly increased in the #72 chiasmal region compared to the corresponding 
region in the wild type and also compared to the retinal region of the #72 nerve. Conversely, cell 
density was very slightly, but significantly, reduced in the retinal region of the #72 nerve 
compared to the same region in the wild type nerve. Wild type: N=6, #72: N=12; WT RR: wild 
type retinal region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: 
#72 chiasmal region. Stars indicate p values: *p < 0.05; ****p < 0.0001.  
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Figure 72. The density of CD45 +ve microglia/macrophages was increased in 
the chiasmal portion of the #72 mouse optic nerve.  
Micrographs of CD45-stained 10µm-thick transverse sections of retinal and chiasmal regions of 
P120 #72 and wild type mouse optic nerves (A - D, x400, scale bar 50µm).  Lipofuscin granules 
were prominent in the #72 mouse nerve and were seen as fluorescent granules in C (arrows). The 
processes of the CD45+ cells in the #72 chiasmal region (H) appeared thickened compared to 
those in the wild type (E, F) and the #72 retinal region (G), suggesting that the cells were 
‘activated’.  Graph showing the mean (+s.e.m.) CD45 +ve cell density in retinal and chiasmal 
regions of wild type and #72 nerves (I). The density of CD45 +ve cells was significantly increased 
in the #72 nerve compared to the wild type, most markedly so in the chiasmal region, in which 
there was an approximately 10 fold increase in cell density compared to the control. WT RR: wild 
type retinal region. Wild type: N=6, #72: N=12; WT CR: wild type chiasmal region. Homo RR: #72 
retinal region. Homo CR: #72 chiasmal region. Stars indicate p values: ****p < 0.0001.  
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Figure 73. The #72 mouse optic nerve was characterised by a marked 
astrocytosis. 
Micrographs of GFAP-stained 10µm-thick transverse sections of retinal and chiasmal regions of 
P120 wild type and #72 mouse optic nerves (A – D, x400, scale bar: 50µm). Astrocytes appeared 
more numerous and processes appeared enlarged in the #72 (G, H) compared to the wild type 
optic nerve (E, F). Graph showing the mean area (+s.e.m.) occupied by GFAP immunoreactivity 
in retinal and chiasmal regions of wild type and #72 optic nerves (I).  The area occupied by GFAP 
immunoreactivity was significantly increased in both regions of the #72 optic nerve compared to 
the same regions in the wild type nerve. There was no significant difference between the two 
regions of the #72 mouse optic nerve. Wild type: N=6, #72: N=12; WT RR: wild type retinal 
region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: #72 chiasmal 
region. Stars indicate p values: ****p < 0.0001.  
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Figure 74. Mature oligodendrocyte cell density was reduced in #72 mouse 
optic nerve.  
Micrographs of APC-stained 10µm-thick transverse sections of retinal and chiasmal regions of 
P120 wild type and #72 mouse optic nerves (A - H, x400, scale bar 50µm). (I) Graph showing the 
mean density (+s.e.m.) of APC +ve cells in retinal and chiasmal regions of wild type and #72 
optic nerves.  Oligodendrocyte cell density was significantly reduced in the #72 optic nerve 
compared to the wild type optic nerve, most markedly in the retinal region. Wild type: N=6, #72: 
N=12; WT RR: wild type retinal region. WT CR: wild type chiasmal region. Homo RR: #72 retinal 
region. Homo CR: #72 chiasmal region. Stars indicate p values: *p < 0.05; **p < 0.01; ****p < 
0.0001. 
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Figure 75. Oligodendrocyte precursor cell density was elevated in the 
inflamed demyelinated chiasmal region of #72 optic nerve. 
Micrographs of retinal and chiasmal regions of P120 wild type and #72 mouse optic nerves (A – D, 
x400, scale bar 50µm) using NG2 as a marker for OPCs. The morphology of the NG2+ cells 
appeared similar in both wild type regions (E, F) and in the #72 retinal region (G), whereas cell 
processes appeared more prominent in the inflamed and demyelinated #72 chiasmal region (H). 
Graph showing the mean density (+s.e.m.) of NG2 +ve cells in retinal and chiasmal regions of 
wild type and #72 optic nerves (I). The NG2+ cell density was significantly increased in the #72 
chiasmal region of the optic nerve compared to the corresponding region of the wild type nerve 
and to the retinal regions of the #72 nerve. Wild type: N=6, #72: N=12; WT RR: wild type retinal 
region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: #72 chiasmal 
region. Stars indicate p values: ***p < 0.001. 
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In quantifying axonal and cellular densities, I confirmed and extended previous 
work (Edgar et al., 2010) which showed that at P120, the optic nerve of the #72 
mouse comprises a rostral, completely demyelinated, non-inflamed region and a 
caudal, demyelinating, inflamed region. Tables summarising the DWI data in 
relation to the histological findings are presented in Table 1, Table 2, Table 3, 
Table 4 and Table 5.  
  
248 
 
 
 Myelin 
Inflam-
mation 
ADCII 
x10-6mm2/s 
ΔADCII 
(%) 
ADC┴ 
x10-6mm2/s 
ΔADC┴ 
(%) 
MD 
x10-6mm2/s 
FA 
ΔFA 
(%) 
WT 
RR 
Yes No 
611.56 
(±28.43) 
+60.9 
110.08 
(±10.31) 
+120.6 
278.4 
(±41.22) 
0.79 
(±0.02) 
-10 
#72 
RR 
No No 
984.12 
(±20.14) 
244.42 
(±16.53) 
496.3 
(±42.98) 
0.71 
(±0.02) 
WT 
CR 
Yes No 
662.01 
(±32.22) 
+12.3 
106.23 
(±12.06) 
+115 
290.1 
(±45.94) 
0.82 
(±0.02) 
-24 
#72 
CR 
No Yes 
743.58 
(±29.19) 
228.35 
(±9.46) 
401.8 
(±30.56) 
0.62 
(±0.02) 
 
Table 5. Summary of diffusion parameters, calculated from two b-values 
only.  
(94.6 and 1135.3 s/mm2 in the parallel direction and 68.4 and 1118.4 s/mm2 in the perpendicular 
direction). ADCII and ADC┴ are mean values of all optic nerves measured in this study. Standard 
error of mean (s.e.m.) is in brackets below the values. Wild type: N=12, #72: N=24. 
 
 
 Myelin 
Inflam-
mation 
ADCII 
x10-6mm2/s 
ΔADCII 
(%) 
ADC┴ 
x10-6mm2/s 
ΔADC┴ 
(%) 
MD 
x10-6mm2/s 
FA 
ΔFA 
(%) 
#72 
RR 
No No 
984.12 
(±20.14) 
-24.4 
244.42 
(±16.53) 
-6.6 
496.3 
(±42.98) 
0.71 
(±0.02) 
-12.7 
#72 
CR 
No Yes 
743.58 
(±29.19) 
228.35 
(±9.46) 
401.8 
(±30.56) 
0.62 
(±0.02) 
 
Table 6. Summary of #72 diffusion parameters calculated from two b-
values only.  
Standard error of mean (s.e.m.) is in brackets below the mean value. Wild type: N=12, #72: 
N=24. 
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 Myelin 
Inflam-
mation 
D1┴ 
x10-6mm2/s 
ΔD1┴  
(%) 
D2┴ 
x10-6mm2/s 
ΔD2┴  
(%) 
WT 
ret 
Yes No 
609.4 
(±55.49) 
+1.5 
32.29 
(±4.16) 
+197.12 
#72 
ret 
No No 
618.7 
(±59.71) 
95.94 
(±8.85) 
WT 
ch 
Yes No 
690.8 
(±110.4) 
-13.94 
37.53 
(±4.66) 
+121.53 
#72 
ch 
No Yes 
594.5 
(±64.71) 
83.14 
(±8.35) 
 
Table 7. Summary of the mean perpendicular fast (D1┴) and slow (D2┴) 
diffusion values including the percentage of diffusion changes (ΔD1┴ and 
ΔD2┴) between the wild type and the #72 optic nerves.  
Standard error of mean (s.e.m.) is in brackets below the mean value. Wild type: N=12, #72: 
N=24. 
 
 
 Myelin 
Inflam-
mation 
D1┴ 
x10-6mm2/s 
ΔD1┴  
(%) 
D2┴ 
x10-6mm2/s 
ΔD2┴  
(%) 
#72 
ret 
No No 
618.7 
(±59.71) 
-3.9 
95.94 
(±8.85) 
-13.3 
#72 
ch 
No Yes 
594.5 
(±64.71) 
83.14 
(±8.35) 
 
Table 8. Summary of the mean perpendicular fast (D1┴) and slow (D2┴) 
diffusion values in #72 optic nerves.  
Standard error of mean (s.e.m.) is in brackets below the mean value. Wild type: N=12, #72: 
N=24. 
  
250 
 
 
 Myelin 
Inflam-
mation 
D1II 
x10-6mm2/s 
ΔD1II 
(%) 
D2II 
x10-6mm2/s 
ΔD2II 
(%) 
WT 
ret 
Yes No 
1082 
(±53.72) 
+12.8 
87.08 
(±10.86) 
+143.8 
#72 
ret 
No No 
1220 
(±26.63) 
212.3 
(±14.23) 
WT 
ch 
Yes No 
1169 
(±42.89) 
-9.1 
92.42 
(±8.831) 
+50 
#72 
ch 
No Yes 
1062 
(±27.93) 
138.6 
(±7.84) 
 
Table 9. Summary of the mean parallel fast (D1II)  and slow (D2II) diffusion 
values including the percentage of diffusion changes (ΔD1II and ΔD2II) between 
the wild type and the #72 optic nerves. 
Standard error of mean (s.e.m.) is in brackets below the mean value. Wild type: N=12, #72: 
N=24. 
 
 
 Myelin 
Inflam-
mation 
D1II 
x10-6mm2/s 
ΔD1II 
(%) 
D2II 
x10-6mm2/s 
ΔD2II 
(%) 
#72 
ret 
No No 
1220 
(±26.63) 
-13 
212.3 
(±14.23) 
-34.7 
#72 
ch 
No Yes 
1062 
(±27.93) 
138.6 
(±7.84) 
 
Table 10. Summary of the mean perpendicular fast (D1II) and slow (D2II) 
diffusion values in #72 optic nerves.  
Standard error of mean (s.e.m.) is in brackets below the mean value. Wild type: N=12, #72: 
N=24. 
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 Myelin 
Inflam-
mation 
α┴ 
(%) 
β┴ 
(%) 
Δ┴ 
(%) 
αII 
(%) 
βII 
(%) 
ΔII 
(%) 
WT 
RR 
Yes No 
25 
(±3) 
75 
(±3) 
±16 
68 
(±2) 
32 
(±2) 
±19 
#72 
RR 
No No 
41 
(±3) 
59 
(±3) 
87 
(±1) 
13 
(±1) 
WT 
CR 
Yes No 
19 
(±2) 
81 
(±2) 
±24 
69 
(±2) 
31 
(±2) 
±9 
#72 
CR 
No Yes 
43 
(±3) 
57 
(±3) 
78 
(±2) 
22 
(±2) 
 
Table 11. Summary of the contribution of fast and slow diffusion (in %) in 
the perpendicular and parallel direction.  
Standard error of mean (s.e.m.) is in brackets below the value. In the perpendicular direction 
the slow diffusion (β┴) is the main type of diffusion. This is in contrast to the parallel direction, 
where the fast diffusion (αII) is the prominent type of diffusion. Wild type: N=12, #72: N=24. 
 
 
 Myelin 
Inflam-
mation 
α┴ 
(%) 
β┴ 
(%) 
Δ┴ 
(%) 
αII 
(%) 
βII 
(%) 
ΔII 
(%) 
#72 
RR 
No No 
41 
(±3) 
59 
(±3) 
±3.9 
87 
(±1) 
13 
(±1) 
±30.8 
#72 
CR 
No Yes 
43 
(±3) 
57 
(±3) 
78 
(±2) 
22 
(±2) 
 
Table 12. Summary of the contribution of fast and slow diffusion (in %) in 
the #72 optic nerves.  
Standard error of mean (s.e.m.) is in brackets below the value. Wild type: N=12, #72: N=24. 
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5.5 Discussion 
 
In this study I took advantage of the simple anatomy and stereotypic pattern of 
demyelination and inflammation in the #72 mouse optic nerve to assess the 
sensitivity of high resolution DW MRI and DW MRI with increasing b-values, to 
distinguish complete demyelination from inflammatory demyelination. 
 
The purpose built coil and sampling container proved useful for the application 
of DW MRI to fixed and excised mouse optic nerves. Preliminary studies were 
undertaken to show that nerves could be accurately positioned within the coil 
and that results of multiple scans of wild type nerves showed that the technique 
provided highly reproducible data. Despite the fact that such high resolution 
scanning is currently not feasible in vivo, the data demonstrate proof-of-
principle of the potential of high resolution DW MRI with multiple increasing b-
values to distinguish between different types of white matter lesions.  
  
I showed that both conventional DW MRI and DW MRI with increasing b-values 
detected differences in diffusion parameters in the #72 nerves compared to wild 
type as well as between rostral and caudal regions of the #72 nerves. 
Histological analyses confirmed that the #72 nerve comprised a rostral, 
completely demyelinated region and a caudal, inflammatory demyelinating 
region. The demyelinated nerve was also characterised by a marked astrocytosis 
and contained both mature oligodendrocytes and NG2 +ve cells. Assessment of 
axonal integrity proved difficult due to tissue fixation being suboptimal for EM 
evaluation. The use of multiple increasing b-values proved to be more sensitive 
than conventional two b-value DW MRI in detecting the diffusion changes 
between inflammatory and non-inflammatory demyelination. In the standard 
approach the diffusion changes between the non-inflammatory and the 
inflammatory demyelinated region in percentages were -24.4 % in the ADCII 
direction and -6.6 % in the ADC┴ compared to the slow diffusion changes 
measured with multiple b-values where the changes were -34.7 % in the D2II 
direction and -13.3 % in the D2┴ direction (Table 6 versus Table 8 and Table 10). 
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5.5.1 Distinct changes in parallel and perpendicular fast and slow 
diffusion become apparent 
 
Using DW MRI with increasing b-values, similar changes as in standard DW MRI of 
the #72 nerve compared to wild type nerve and also between the two regions of 
the #72 nerve were found. These changes were most marked in the slow 
diffusion component (D2II and D2┴). Only very minor changes were evident in the 
fast parallel diffusion component (D1II) and no changes were observed in fast 
perpendicular diffusion component (D1┴). Thus the slow diffusion component 
appeared more sensitive to the histological changes in optic nerves. Changes in 
the slow diffusion component were more pronounced compared with changes 
observed using only two b-values but did not reveal more specific information in 
regard of diffusivity changes related to histological background.  
 
5.5.2 The basis of anisotropic diffusion and the relation of diffusion 
changes to white matter disease 
 
The strictly organised arrangement of axons is believed to be the main 
contributor to the anisotropic diffusion of water molecules in white matter 
(reviewed in Beaulieu, 2002;Beaulieu, 2009) The organised fibre tract structure 
forms the basis for the ability of diffusion tensor imaging to detect and trace 
nerve fibre bundles (Moseley et al., 1990a).  However, studies correlating DTI 
parameters with histological measures have further demonstrated its value as a 
tool for assessing white matter integrity  (Budde et al., 2008;Harsan et al., 
2006;Harsan et al., 2008;Song et al., 2002;Song et al., 2005).  Indeed, a number 
of studies, particularly from the Song laboratory at Washington University St. 
Louis, Missouri USA, have provided evidence that pathological changes in specific 
white matter elements can be deduced from calculation of the diffusion 
coefficient perpendicular and parallel to the nerve fibre bundles.   
 
For example, it has been shown that dys- or demyelination increases the 
perpendicular diffusion coefficient and reduces fractional anisotropy (Song et 
al., 2002;Song et al., 2005).  Remyelination reverses the changes, emphasising 
the influence of the myelin sheath on perpendicular diffusivity (Harsan et al., 
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2006). Axonal pathology on the other hand has been shown in several studies, to 
correlate with reduced parallel diffusion and also leads to decreased FA and MD 
values (Budde et al., 2008;Budde et al., 2009;DeBoy et al., 2007;Feng et al., 
2009;Kim et al., 2006).  
 
However most of the correlative DTI studies have only examined the status of 
myelin and axons and failed to take account of other white matter elements. 
Therefore the possibility that changes in the density and morphology of other 
cell types could influence the DTI measures has largely been neglected. Recent 
studies have shown an increased parallel diffusion in the presence of mild axonal 
pathology after demyelination (Harsan et al., 2007;Ruest et al., 2011) and yet 
others have shown a temporal reduction of parallel and perpendicular diffusion 
in the presence of mild axonal pathology, with a return to initial values despite 
more severe axonal damage after demyelination (Xie et al., 2010).  
 
While the increase in perpendicular (radial) diffusion is generally accepted to be 
related to demyelination and may be altered by cell density (Xie et al., 2010), 
the increase in parallel (axial) diffusion in the presence of mild axonal injury 
(Harsan et al., 2007;Ruest et al., 2011) is more difficult to explain. One study 
(Harsan et al., 2007) suggested that the increase in astrocytes, which was 
present in the jimpy mouse model of PMD, correlated with increased parallel 
diffusion, whereas a different study (Ruest et al., 2011) suggested that a 
combination of increased axonal density and astrocytosis could contribute.  
 
Nevertheless, all of the three more comprehensive studies (Harsan et al., 
2007;Ruest et al., 2011;Xie et al., 2010) show that, especially for parallel 
diffusivity, there is at the moment no clear explanation for the observed 
diffusion changes. Tissue and cellular changes besides demyelination and 
axonopathy are most likely responsible for the variation in results reported in 
the literature. 
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5.5.3 Changes in “conventional” DW MRI parameters distinguish lesion 
types in the optic nerve  
 
5.5.3.1 Fractional anisotropy and mean diffusion changes in #72 optic nerve 
 
I found that fractional anisotropy, which is a measure of diffusion directionality, 
was reduced in the #72 optic nerve compared to the wild type. This has also 
been shown in other studies (Harsan et al., 2006;Ono et al., 1995) where a 
significant reduction of FA values has been found following demyelination 
(Harsan et al., 2006;Ono et al., 1995; reviewed in Beaulieu, 2009). 
 
FA provides a measure of the relationship between parallel and perpendicular 
diffusion, such that it is highest (closest to one) when diffusion in one particular 
direction is markedly greater than in another and lowest (closest to zero) when 
diffusion in all directions is of similar magnitude (Equation 8). Generally, a 
reduction in FA in white matter is associated with either a reduction in diffusion 
in the parallel direction or an increase in diffusion in the perpendicular direction 
(reviewed in Beaulieu, 2002;Beaulieu, 2009).  
 
In contrast, in the current study, a reduction FA was associated with increases in 
both parallel and perpendicular diffusion. This can be explained by the fact that 
the increase in the perpendicular diffusion in the #72 mouse nerves was 
relatively greater than the increase in the parallel direction (Table 5). 
 
With respect to whether DWI could distinguish complete demyelination from 
inflammatory demyelination, FA was also significantly reduced in the inflamed 
region of the #72 nerve compared to the non-inflamed region (see Table 6).  
Examination of perpendicular and parallel diffusions (of which FA is a function) 
showed that this was due to a disproportionately high parallel diffusion in the 
non-inflamed nerve (Table 5). This was somewhat surprising because increased 
parallel diffusion is not commonly observed in relation to demyelination, 
although it has been recently described (Harsan et al., 2007;Ruest et al., 2011). 
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A significant increase in mean diffusivity (MD) in the #72 optic nerve was most 
pronounced in the retinal region. This reflects the observed increase in both 
parallel and perpendicular diffusion in the #72 optic nerve. Again, loss of myelin 
causes an increase in MD (reviewed in Beaulieu, 2009)  
 
5.5.3.2 Perpendicular diffusion changes were associated with the loss of 
myelin integrity 
 
Although significantly different to the wild type, there were no significant 
changes in the perpendicular diffusion between the retinal and the chiasmal 
region of the #72 optic nerve. This implies that the differences (compared to 
wild type) are probably mainly caused by demyelination, the extent of which 
was similar in both regions. This is in agreement with other studies (Harsan et 
al., 2006;Harsan et al., 2008;Klawiter et al., 2011;Nair et al., 2005;Ruest et al., 
2011;Song et al., 2002;Song et al., 2005;Xie et al., 2010). Surprisingly, the 
inflammation in the chiasmal section of #72 optic nerves did not seem to alter 
perpendicular diffusion. This was somewhat unexpected, since increased cell 
density has been suggested to decrease perpendicular diffusion (Xie et al., 
2010).  
 
Diffusion in tissue, which is a combination of intracellular as well as 
extracellular diffusion, is considered to be mainly restricted by the cell 
membrane (Beaulieu, 2009). Since axons, which are believed to be the main 
structure influencing diffusion, are densely packed (in the current study at least 
500,000 axons mm-2), the perpendicular diffusing water molecule will be 
confronted with a minimum of one cell membrane within the average distance of 
an axonal diameter, which in the optic nerve is around 1µm (Edgar et al., 2010). 
A decrease in axonal density, which may be caused by enlargement of the extra-
axonal space, could also lead to facilitated extra-axonal perpendicular diffusion. 
There was a reduced axonal density in the #72 optic nerve when compared to 
the wild type retinal region which may explain the prominent increase.  
 
So why should an increase in cell density not affect perpendicular diffusion? 
Given the size of microglia, which in the non-activated state is approximately 10 
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- 20µm and considerably larger after activation, the cell is 10 – 20 times larger 
than the average axonal cross-section. If the assumption is correct that the cell 
membrane is the main barrier to diffusion (Beaulieu, 2009) the distance between 
two cell membranes of a microglial cell would be 10 – 20µm. This is in contrast 
to the axons, where on average every 1µm at least one cell membrane occurs. 
Additional cell membranes from inflammatory cells would only add one more 
obstacle every tenth to twentieth axon and only minimally influence 
perpendicular diffusion. Therefore, the perpendicular diffusion is most likely 
governed by the density of axonal membrane and, since most of the axons are 
myelinated in the optic nerve (Edgar et al., 2010), modified by myelin sheath. 
 
In contrast to the finding of the current study, (Xie et al., 2010) suggested that 
inflammation reduces perpendicular diffusion. However, in their model (in 
contrast to the model used in my study) the corpus callosum was not completely 
demyelinated at the time point where elevated microglial cell density was 
observed by (Xie et al, 2010). The remaining intact myelin sheaths could 
potentially still influence the diffusion. Therefore it is questionable if the 
reduced perpendicular diffusion observed by (Xie et al., 2010) is due to 
increased cell density or if the remaining intact myelin sheaths are still 
numerous enough to prevent perpendicular diffusion to increase. 
 
5.5.3.3 Diffusion parallel to optic nerve fibres is altered in association with 
loss of myelin integrity and changes in cell density 
 
The marked increase in parallel diffusivity, especially in the non-inflamed 
demyelinated retinal region was unexpected. Only a small number of studies 
have recently demonstrated increased parallel diffusion in models of dys- and 
demyelinated tissue, with relatively mild axonal changes and increased axonal 
density (Ruest et al., 2011;Harsan et al., 2007). 
 
In the parallel diffusion direction, water molecules diffuse in and along axons, 
where virtually no membranes other than myelin restrict diffusion. With 
demyelination, a component of the extra-axonal diffusion barrier will disappear 
and could facilitate the extra-axonal diffusion alongside axons, resulting in an 
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increase in bulk parallel diffusion as was observed when comparing the #72 with 
the wild type nerve. However, in the presence of inflammation, multiple cell 
membranes could potentially restrict the previously relatively unrestricted 
extra-axonal parallel diffusion and reduce the bulk parallel diffusivity, leading to 
the differences in parallel diffusion observed in the #72 chiasmal region 
compared to the #72 retinal region.  
 
From an intraaxonal point of view, changes in extra-axonal structures will most 
likely have little if any impact on intraaxonal diffusion. However, studies have 
shown that with axonal swellings or transection of axons, parallel diffusion is 
reduced (Budde et al., 2008;Budde et al., 2009). The presence of axonal 
swellings in the chiasmal region of the #72 optic nerve has been described in the 
previous study by (Edgar et al., 2010). Despite the relatively low number of 
axonal swellings, the difference between the retinal and the chiasmal #72 optic 
nerve may reflect this. 
  
Since the ultrastructural evaluation of the #72 optic nerve showed a similar 
degree of demyelination in both regions accompanied by only mild axonal 
changes (Edgar et al., 2010) and unaltered axonal numbers, other 
histopathological changes besides demyelination and axonal pathology may 
influence additionally parallel diffusion (diffusion #72 retinal region > chiasmal 
region, Table 5). Along the entire optic nerve there is a marked astrogliosis. 
Astrocytes have been proposed to alter diffusion values in both parallel and 
perpendicular direction (Harsan et al., 2007). Two proposal have been made: 
that hypertrophic astrocytic processes align along axons and facilitate 
intracellular diffusion parallel to the axons (Skoff, 1976) and an increase in 
aquaporin 4, a transmembranous water channel expressed on astrocytes, 
facilitate fast transmembranous water transport (reviewed in Nicchia et al., 
2004;Harsan et al., 2007). Whereas the astrocytosis in the #72 mouse nerve may 
explain an increase in parallel and also in the perpendicular diffusivity compared 
to the wild type, the parallel diffusion differences within the #72 optic nerve 
appears not to be influenced by the astroglial population, since the astrogliosis 
is similar in the retinal region compared to the chiasmal region. 
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Finally the study by (Ruest et al., 2011) also demonstrated an increase in 
perpendicular and parallel diffusivity in #72 corpus callosum at P120. These 
results are in agreement to the findings of the current study. Additionally when 
comparing the histological data from (Ruest et al., 2011) to Chapter 3 and the 
chiasmal region of #72 optic nerve, all three regions appears histologically 
similar.  
 
5.5.4 Multiexponential signal decay becomes apparent after applying 
multiple increasing high b-values to the DWI 
 
The DTI sequences normally uses two b-values, b ~ 0 and b ~ 1000 s/mm2. By 
applying multiple increasing b-values to the sequence, the signal decay versus b-
value becomes multiexponential. It is believed that different types of water 
diffusion within the tissue are responsible for the generation of the 
multiexponential signal decay (reviewed in Beaulieu, 2002). The distinct types of 
diffusion detected using multiple increasing high b-values are believed to be 
influenced by various micro anatomical structures such as microtubules, cells 
nuclei, cell membranes and myelin sheaths (reviewed in Beaulieu, 2002). 
Therefore, potentially novel information about tissue architecture, which is 
excluded in scans only using b - value up to 1500 s/mm2, may come to light.  
 
In the current study, where I extended the diffusion experiment by applying 
multiple increasing b-values, particular diffusion aberrations were detected 
when compared to standard monoexponential analysis.  By applying multiple b-
values ranging from 68.4 to 6304.6 s/mm2 to the parallel and perpendicular DWI 
sequence in relation to the optic nerve fibres, a non-monoexponential signal 
decay became apparent.  This finding was consistent with findings in other DWI 
studies of white matter, using a similar range of b-values, in which the signal 
decay curve appears to change around the b-value of 2000 s/mm2 (Mulkern et 
al., 2000;Ronen et al., 2006). 
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5.5.4.1 Biexponential analysis of the signal decay curve allowed the 
distinction of a fast and slow diffusion component 
 
Analysis of the signal decay curve in this study showed that curve fitting was 
accurate when using a biexponential fitting routine. The biexponential 
characteristic of the curve allowed separation of the data into two distinct 
diffusion components, a fast and a slow diffusion component.  The fast diffusion 
component is assumed to be mainly under axonal influence whereas the slow 
diffusion component is assumed to be influenced by extra-axonal structures such 
as myelin sheaths and glial cells (reviewed in Beaulieu and Allen, 1994;Beaulieu, 
2002). 
 
5.5.4.2 The slow diffusion components were sensitive to detect 
histopathological changes in demyelinated optic nerve  
 
When comparing the percental changes of ADC┴ and ADCII between the two 
regions in the #72 optic nerve (Table 2) with the percental changes in the slow 
diffusion compartment in both ┴ and II direction (Table 8 and Table 10), a clear 
augmentation of the diffusion changes were detected. This shows the clear 
advantage of the high resolution DW MRI with multiple b–values to enhance the 
sensitivity to detect specific histopathological changes such as inflammation 
besides demyelination.  
 
5.5.4.3 The fast and slow diffusion components provided information beyond 
diffusion rate 
 
The distinction of two different components also allowed the analysis of 
diffusion changes not only by differences in diffusion but also by changes in 
diffusion characteristics. The contribution of fast (α) and slow (β) diffusion 
components to overall diffusion showed that in the perpendicular direction the 
slow diffusion (β┴) and in the parallel direction the fast diffusion (αII) were most 
prominent α┴ and αII were significantly increased in the homozygote optic nerve 
compared to the wild type, suggesting that the contribution of the fast diffusion 
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is increased after demyelination. The increase in α was more significantly 
elevated in the non-inflamed retinal region compared to the inflamed chiasmal 
region, demonstrating that inflammatory cells could influence diffusion 
characteristics. The calculation of α and β provided further information about 
tissue related changes in diffusion characteristics, because D1┴ was similar in 
wild type and #72 optic nerves but still there were significant changes in the 
diffusion characteristics. By calculating α and β additional information about 
diffusion changes were gained, which was especially of importance when 
diffusivity within each component remained unchanged.   
 
The general increase in α in both directions in the #72 mouse nerves may also 
provide an explanation why “standard” DW MRI also detects the changes caused 
by demyelination and inflammation. Standard DW MRI values are a mixture of 
slow and fast diffusion. If changes in contribution of the fast or slow diffusion 
component occur within the range of a b-value of 1500 s/mm2, the changes will 
also be detected in standard DW MRI as it appeared to be in my study. 
 
I used the Student’s t-test in this experiment, since the plan was not to compare 
all measurements with each other. Therefore, in order not to run inappropriate 
comparisons, I separately compared the results from the two different sections 
within the same optic nerve and the results from the same section between wild 
type and #72 optic nerve (see 5.3.13 Statistics). Multiple comparison tests, 
however, which are more conservative tests with less probability of making a 
type I error, would have been more appropriate for this experiment. The use of 
one way ANOVA with post-hoc tests (e.g. Bonferroni’s multiple comparison test) 
may have been a better choice to analyse this experiment. In my opinion, 
however, using the one way ANOVA with multiple comparisons would not have 
made any changes in the results and interpretation of this experiment. 
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5.6 Conclusion 
 
I have shown in this study specific diffusion parameter changes in both 
“classical” and modified DW MRI experiment, linked to demyelination and 
inflammation in the optic nerve. The potential of DW MRI to distinguish between 
two crucial lesion types in demyelinating disease, namely acute inflammatory 
demyelination and chronic silent demyelination was demonstrated. 
However, the DW MRI parameter differences were relatively small and unless 
specific numerical values can be assigned to specific white matter lesion type, it 
will remain difficult to distinguish lesion types in vivo in the absence of a 
comparator. 
 
The biexponential signal decay allowed me to analyse two distinct diffusion 
components, the slow and the fast diffusion component. In this study I 
demonstrated that demyelination was associated with an increase in the slow 
diffusion coefficient parallel and perpendicular to the optic nerve fibre tracts.  
Demyelination without inflammation appeared to further increase the parallel 
slow diffusion coefficient suggesting that inflammation had a modulatory effect 
on slow diffusion along the parallel direction. Furthermore the changes in the 
contribution of fast and slow diffusion probably signify a general effect on 
diffusion characteristics after demyelination and inflammation. 
 
These new findings are important in context with in vivo diagnosis and 
monitoring of demyelinating diseases. I have shown, that standard diffusion 
weighted imaging distinguishes normal and demyelinated white matter lesions 
(confirming the results published by other investigators). I also showed that it is 
possible to distinguish between demyelination accompanied by inflammation and 
chronic demyelination when high resolution DWI is used. Using multiple 
increasing b-values, I showed that diffusion changes could mainly be attributed 
to the slow diffusion component. Using this method, the presumptive extra-
axonal influence especially on slow parallel diffusion became more apparent, 
demonstrating DWI with multiple b-values is a sensitive molecular probe capable 
of exploring changes in the extra-axonal space. However there are still some 
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technical issues restricting the DWI MRI with multiple increasing b-values to be 
used in clinical settings. 
 
Considering the results from the current study, “standard” DW MRI also 
differentiates distinct lesion types, and may be used in clinical settings as an in 
vivo tool to identify white matter lesion type.  
 
The possibility to distinguish these two specific white matter lesion types may be 
of importance for the MS research community and patients suffering from MS in 
giving the opportunity to diagnose demyelination non-invasively in vivo, to 
monitor lesion development more accurately, to asses therapeutic success and 
allow accurate determination of the long term prognosis.   
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6 Final discussion and future experiments 
 
Data presented in this study provided insight into the development of 
intracranial demyelination and remyelination failure in the homozygous Plp1 
gene overexpressing mouse, line #72. The study demonstrated that, following 
initial myelination, there follows spontaneously, a progressive, non-remitting 
demyelination that eventually leads to a virtually complete absence of myelin 
sheaths.  
 
In vitro and in vivo studies (i.e. what was done in Chapter 3 The development of 
the phenotype and pathology of the homozygote #72 corpus callosum and 
Chapter 4 An evaluation of cell intrinsic and cell extrinsic factors that contribute 
to remyelination failure) were undertaken to evaluate the role of OPC intrinsic 
and OPC extrinsic factors in the pathogenesis.  The data provided evidence that 
remyelination failure may be due to an age related impairment of differentiation 
of OPCs. This, in line with evidence that increasing age plays a major role in 
diminishing the efficacy of the repair process (Shen et al., 2008) suggests that 
final OPC differentiation during the complex remyelination process is probably 
the most vulnerable step. Despite the fact that exogenous, neonatal derived 
neurospheres were able to myelinate axons in the adult #72 mouse brain, factors 
were present in demyelinated CNS that have previously been shown to be 
inhibitory to remyelination. Therefore a combination of OPC intrinsic and 
extrinsic factors is most likely leading to remyelination failure in the adult #72.  
 
The transplantation of multipotent neurospheres into neonates provided 
evidence that early introduction of these cells has the potential to replace the 
endogenous, genetically defective oligodendroglia during post natal 
development, to form normal myelin sheath around axons and to stably 
integrate into the CNS, possibly indefinitely. These findings would support the 
development of an approved therapeutic strategy to rescue or ameliorate severe 
forms of PMD by neonatal neuronal stem cell application into the CNS.  
 
The results presented also showed that the #72 mouse with its highly 
reproducible and stereotypic optic nerve pathology with a spatially distinct 
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inflamed demyelinated region and a non-inflamed demyelinated region is 
valuable as a model to evaluate the potential of novel DW MRI techniques to 
function as a molecular probe, able to distinguish white matter changes. The 
aim of this section is to bring together results from the phenotypic study, the 
evaluation of the OPC intrinsic and extrinsic compartments, the cell transplant 
and the DW MRI study in order to suggest future work and discuss some of the 
points raised in the thesis.  
 
6.1 The #72 mouse as a model for chronic demyelination 
 
Although complete demyelination was present in the #72 mouse at the end stage 
of the disease and coincided with clinical signs, OPCs were still present. The 
lesion development in #72 mice is comparable, in some respects, to the situation 
described in chronic demyelinated MS lesions, where, despite the presence of 
OPCs, remyelination fails (Chang et al., 2002). Nevertheless, although Plp1 is not 
expressed in OPCs they still harbour the genetic defect, which may also have an 
effect on normal OPC function. The failed remyelination is thought to lead to a 
progressive axonal loss, which is considered to be the primary reason underlying 
permanent disability in MS patients (Bjartmar and Trapp, 2003).  
 
There is a growing interest in investigating OPC response in relation to the 
remyelination process, mainly with the aim to find possible ways to enhance the 
myelin repair mechanism and to prevent the development of irreversible axonal 
damage. However, animal models with chronic demyelination are relatively rare. 
Chronic EAE models have been described but require manipulation of the 
immune system to induce disease (Swanborg, 1995). Also it is difficult to 
evaluate the direct effect of therapeutic interventions on OPCs in EAE models, 
because putative effects could be mediated through a treatment related 
immuno-modulatory effect and not by direct enhancement of OPC proliferation 
and differentiation.  
 
This point of view was taken into consideration in a recent study by (Huang et 
al., 2011) investigating the remyelination enhancing effect of systemically 
applied retinoic acid, a metabolite of vitamin A. The investigators argued 
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against the use of the EAE model because of potential modulatory effects of the 
therapeutic substance on the immune mediated process.  
 
Furthermore any remyelination enhancing therapies investigated in a 
systemically induced chronic demyelination using a toxin as for example 
cuprizone (Torkildsen et al., 2008) must also be interpreted with caution, since 
chronic intoxication may also have not only adverse effects on oligodendrocytes 
but also on all other cells in the CNS.  
 
Bearing in mind the caveat that OPCs in the #72 mouse harbour a genetic 
abnormality,  data presented in this thesis suggest the chronically demyelinated 
(as defined earlier) #72 mouse may represent a useful tool for testing myelin 
enhancing therapies. With respect to this aspiration, this model has a number of 
strengths. First, demyelination occurs spontaneously, obviating surgical or 
immunological intervention. Secondly, the background in which the reparative 
process should take place is less complex than in the EAE model, making the 
interpretation more straightforward. Thirdly, the stereotypic temporal and 
spatial progression of demyelination in this model facilitates the assessment of 
effect.  
 
6.2 In vitro systems to investigate cell intrinsic pathways 
 
The integrity of the OPC is an important prerequisite for successful repair and 
any disturbance to OPC intrinsic properties could result in remyelination failure. 
Although it has been shown that Plp1 gene overexpression in oligodendrocytes 
leads to a sequestration of PLP to endosomes, lysosomes and autophagosomes, 
which results in an impaired intracellular transport of myelin proteins to the 
myelin sheath, the effect on OPCs is not understood (Karim et al., 2007;Karim et 
al., 2010). PLP/DM20 has not been identified in adult OPCs to date, but there is 
evidence that OPCs transiently express Dm20 mRNA and DM20 protein during 
embryonic development and it has been suggested that DM20 plays a role in 
normal glial development (Dickinson et al., 1996). Interestingly, overexpression 
of DM20 leads to late onset CNS demyelination with astrocytosis and a 
lymphocytic infiltration (Mastronardi et al., 1993) similar to the pathology seen 
267 
in adult hemizygote #72 mice (Anderson et al., 1998). In the #72 mouse Dm20 
will most likely also be overexpressed. It is not known if adult #72 OPCs express 
DM20, which could potentially impair adult cell function.  Clarification of the 
role of DM20 may render novel information in the development of Plp1 gene 
overexpression mediated adult demyelination pathology. 
 
In vitro studies provide an elegant way to address questions regarding cell 
intrinsic properties, in the absence of confounding extrinsic (environmental) 
factors. One confounding factor in the cell culture experiment that I performed 
was contamination by microglia. Although a co-culture system was utilised, 
where wild type and #72 adult OPCs were exposed to the same environment, 
microglia might secrete substances such as free radicals to which the #72 OPCs 
could potentially be more susceptible than the wild type. The magnetic cell 
sorter technique, as described in (Windrem et al., 2008), could provide a 
relatively simple solution to avoid unwanted cell contamination. However, adult 
OPCs are relatively sparse and my initial attempts to use a magnetic cell sorting 
system failed. For the same reason, FACS sorting of adult, corpus callosum 
derived OPCs is impractical.   
 
Most of the published work on cultured OPCs used neonatal animals as a source 
(Dietrich et al., 2006;Huang et al., 2011;Pang et al., 2005;Syed et al., 2008). 
The OPC yield from neonatal mouse is considerably higher than from the adult. If 
a higher yield of adult OPCs could be obtained, experiments involving immuno-
precipitation, western blot quantification and protein turnover could potentially 
provide more detailed information about protein-protein interaction and protein 
integrity during OPC differentiation. Also, after successful purification of 
sufficient number of OPCs in vitro, microarrays (DNA, RNA, protein and cytokine 
arrays) could be applied to screen for candidate molecules that could explain 
the OPC differentiation block observed in the #72 mouse.   
 
The results of this study should help inform hypotheses regarding putative OPC 
intrinsic factors that could influence remyelination failure in the #72 mouse. 
Candidates identified using microarray could then be verified using a cell culture 
model of myelination such as a myelinating culture (Thomson et al., 2006) or a 
brain tissue culture system (Zhang et al., 2011). These systems can be 
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manipulated (i) pharmacologically (ii) using RNA interference and (iii) by 
transfection, to examine the consequence for myelination and/or remyelination 
of the up- or down-regulation of specific gene products, providing a relatively 
inexpensive, high-throughput screen.  
 
Recently the regulatory role of specific microRNA during (re)myelination, miR-
219 and miR-338, by suppressing OPC differentiation inhibitors, has shown a 
further cell intrinsic (re)myelination control mechanism (Zhao et al., 2010). The 
role of microRNA in Plp1 gene overexpression has not been elucidated so far and 
would definitively be warranted to be further explored in the #72 mouse.  
 
More insight into the OPC function may be gained from culture of brain slices 
(Zhang et al., 2011). The advantage of tissue culture compared to cell culture is 
the inclusion of the OPC extrinsic compartment including oligodendrocytes, 
axons, astroglia and microglia. Tissue culture also allows the possibility to 
evaluate myelination and monitor remyelination after demyelination and may 
provide the opportunity to test remyelination enhancing substances. I obtained 
preliminary results from #72 brain slice cultures containing the corpus callosum 
and the brain stem (data not shown). The development of corpus callosum slices 
was satisfactory but some unexpected axonal damage appeared after 
lysolecithin induced demyelination, making the interpretation of (re)myelination 
difficult. However, complement induced demyelination appeared to be more 
successful (in collaboration with Dr. Ariel Arthur from the Linington lab, 
University of Glasgow) and may offer an opportunity to evaluate the 
remyelination dynamics and capacity on #72 brain slices. A further advantage of 
tissue culture is the high throughput of relatively large quantities of tissue which 
can be used for morphometric analysis or for microarray screening before, 
during and after demyelination.  
 
A major drawback with the culture technique is that so far adult brain slices do 
not survive in culture for prolonged periods and the method appears only to 
work when using neonatal tissue. In my case neonatal tissue does not mimic the 
chronically demyelinated CNS and results obtained in context with the 
remyelination process in slice culture may not be extrapolated to the adult 
situation in vivo.  
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6.3 Evaluation of OPC extrinsic changes in relation to 
remyelination failure 
 
6.3.1 The role of the microglial/macrophage response in the 
pathogenesis of remyelination failure in the #72 mouse 
 
The role of the profound microglial/macrophage response in the #72 mouse is 
also of interest in the development of the demyelination and remyelination 
failure pathology. 
 
The role of the inflammatory response in myelination and remyelination is in 
general controversial. There is evidence that acute inflammation is beneficial 
for the remyelination process (Foote and Blakemore, 2005a). On the other hand, 
excessive inflammation most likely generates a hostile environment for cells to 
survive. In the adult and neonate #72 the inflammation appeared not to injure 
transplanted neuronal stem cells, despite the fact that the inflammatory 
response probably contributes to the progression of demyelination, as 
demonstrated in another Plp1 overexpressing line (Ip et al., 2006;Ip et al., 
2007).  
 
The intravenous application of neuronal stem cells may represent an alternative, 
less invasive way to promote repair (Pluchino et al., 2003). On the other hand 
even this approach renders difficulties in interpretation since another study has 
shown an indirect disease modulating effect in EAE without tissue integration of 
the systemically applied stem cells (Einstein et al., 2006). Just recently the 
beneficial effect of macrophages in globoid cell leukodystrophy was 
demonstrated (Kondo et al., 2011) and further experiments aimed directly at 
reducing the inflammatory response, using for example corticosteroid or 
minocycline, may also help to determine if the inflammation in the #72 corpus 
callosum promotes or inhibits (re)myelination. 
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6.3.2 The extracellular matrix – impact on myelin repair and beyond 
 
It is possible that accumulation of hyaluronan contributes to the remyelination 
failure in the #72 mouse. Further evaluation of the role of hyaluronan in the #72 
corpus callosum needs to be addressed by for example quantitative 
measurement of hyaluronan using western blot techniques and a metabolic and 
secretory assessment of the astrocytic population, the cell population 
predominantly responsible for hyaluronan synthesis in the CNS. The effect of 
hyaluronan on remyelination inhibition could also be evaluated in vivo by 
injecting hyaluronidase into the adult #72 corpus callosum with subsequent 
evaluation of the (re)myelination response. The entire group of 
glycosaminoglycans are of interest, especially chondroitin sulphate 
proteoglycan, which has been shown to interfere with axonal regeneration after 
trauma (Massey et al., 2006;Garcia-Alias et al., 2009). ABC chondroitinase, 
which breaks down glycosaminoglycans, enhanced axonal growth leading to 
improved recovery if applied in combination with task specific rehabilitation 
exercises (Wang et al., 2011). Since trauma not only causes axonal damage, but 
also damages the myelin sheath, it may be of interest to evaluate the extent, 
and the clinical impact, of myelin repair following trauma. Based on the 
negative influence of hyaluronan on myelin sheath repair, it may also be of 
interest to investigate if hyaluronan has a negative impact on axonal 
regeneration after trauma.  
 
6.4 Axonal pathology as a consequence of Plp1 gene 
overexpression 
 
Data from this study and a previous study by (Edgar et al., 2010) demonstrated a 
progressive development of axonal swellings in the #72 mouse. In the optic nerve 
it has been shown that the presence of axonal swellings correlated with the 
microglial/macrophage response. This also seems to be the case in the corpus 
callosum, where an increasing microglial/macrophage response was 
accompanied by the presence of axonal swellings. In the optic nerve, it has been 
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demonstrated that some of these swellings occur on otherwise intact axons 
(Edgar et al., 2011). 
 
In the study by (Edgar et al., 2010) there was virtually no axonal pathology 
present in the chronic demyelinated retinal region of the optic nerve. This is in 
contrast to MS lesions where a progressive axonal degeneration due to long term 
demyelination is believed to be the main cause of permanent disability after 
demyelination. Interestingly activation of microglia has been suggested to 
mediate axonal pathology in EAE, with the main evidence for this being a 
reduction in axonal injury in mice treated with minocycline (Howell et al., 
2010). Treating the #72 mice with minocycline could render further insight into 
the development of axonal pathology in relation to microglial activation 
associated with spontaneous demyelination. However, reducing the 
inflammatory cell response would most likely also lead to reduced 
demyelination, which could lead to a decrease in axonal damage. This makes it 
difficult to dissect the single components possibly involved in axonal pathology. 
 
6.5 The use of stem cells in long term myelin repair 
 
This study demonstrated the proof-of-concept that early intracranial 
transplantation of multipotent neuronal stem cells potentially can replace the 
defective endogenous oligodendrocyte population. While I showed that 
neurospheres survive, integrate, myelinate and form an apparently stable 
population of oligodendrocytes after transplantation into neonate #72 mouse 
brains, the procedure did not rescue the phenotype despite the quite 
remarkable sizes of these patches of remyelination. Also the fate of transplanted 
cells other than myelin forming oligodendrocytes, which is unknown at present, 
could provide more insight into the distribution of the transplanted cells and to 
monitor if the transplanted cells also replace the genetically defective OPC 
population in the subventricular zone. One possible method to address this 
would be to transplant neuronal stem cells permanently expressing a fluorescent 
marker (such as GFP) into neonate mice. The fate of the transplanted cells could 
be characterised after constructing a #72 chimera, in particular to investigate if 
the transplanted cells produce a continuous OPC niche in the CNS. 
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6.6 Diffusion weighted imaging in myelin disorders 
 
DW MRI is increasingly being used to evaluate white matter changes in vivo, non-
invasively (Budde et al., 2009;Harsan et al., 2006;Harsan et al., 2008;Song et 
al., 2002;Song et al., 2005). The modification of DW MRI by adding multiple 
increasing b-values, as in this study, showed that it enhances the sensitivity to 
detect demyelination and inflammation. Using multiple increasing b-values may 
therefore improve the diagnostic accuracy of DW MRI for the detection of 
specific white matter lesions. An experiment using multiple higher b-values has 
recently been performed in shaking pups in vivo (Wu et al., 2011). Although the 
study did not investigate the pathological changes as detailed and not the same 
diffusion parameters were calculated as I did, Wu et al. showed that from a 
technical point of view, DW MRI with multiple increasing b-values is possible in 
vivo. A further step would involve the performance of similar experiments in 
vivo in order to verify the changes seen in my experiment using fixed tissue and 
in order to rule out any fixation related influence.  
 
At the moment I have not evaluated the role of axonal changes in DW MRI with 
multiple increasing high b-values in detail. To further analyse the influence of 
changes in axonal integrity on diffusion, the experiments undertaken in this 
study could be repeated in wild type and #72 mice, subsequent to optic nerve 
crush.  
 
6.7 The use of demyelinating models in investigating psychiatric 
disorders 
 
Changes in myelin integrity recently demonstrated in psychiatric disorders such 
as schizophrenia, point to a potential central role of myelin integrity and 
distribution in the development of these diseases (reviewed in Davis et al., 
2003). Schizophrenia is a severe psychiatric disorder where an impaired 
connectivity between brain regions is regarded as the main abnormality 
(reviewed in Davis et al., 2003). Interestingly, in certain demyelinating 
disorders, such as metachromatic leukodystrophy (MLD) and to a much lesser 
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extent multiple sclerosis (MS), patients may also develop schizophrenic-like 
symptoms (reviewed in Davis et al., 2003), emphasising the role of myelin in 
cognitive (dys)function.  
Two month old heterozygote 4e mice (another Plp1 overexpressing line), where 
mild demyelination of major white matter tracts in the spinal cord, brainstem 
and corpus callosum was present, were reported to develop schizophrenic-like 
behavioural changes (Tanaka et al., 2009). The increased awareness of the 
myelin related changes in the pathogenesis of schizophrenia, and the need for 
models involving spontaneous demyelination in order to study these disorders, 
means that the #72 model may also be useful for studying the influence of 
spontaneous demyelination on schizophrenic-like symptoms. 
 
6.8 Summary  
 
In short, the Plp1 gene overexpressing #72 mouse, a model of PMD, is useful for 
future investigation into the development and treatment of chronic 
demyelination and remyelination failure. Novel stem cell transplantation 
strategies for white matter diseases that progress into debilitating chronic 
demyelination can furthermore be evaluated using the #72 model. Additionally 
the #72 model has raised relevant questions about the influence of Plp1 gene 
overexpression on adult OPC function and integrity. Due to the endogenous 
mediated microglial changes, the model also allows us to investigate the role of 
microglial activation in demyelination and remyelination pathology and on the 
effect on axonal integrity. This study has also shown that standard and modified 
DW MRI with multiple b-values may serve as a molecular probe to evaluate 
myelin pathology and may become an important technique in diagnostic imaging 
to distinguish lesion type in MS.  
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7 Appendix 
 
7.1 Fixatives 
 
7.1.1 Periodate lysine paraformaldehyde  
Preparation of ingredients for 1000ml of PLP fixative 
Buffered lysine solution: 
  13.7g lysine monohydrate in 375ml distilled water 
  1.8g sodium hydrogen phosphate in 100ml distilled water 
  Mix the two solutions to give 475ml buffer, pH7.4 
  
10% paraformaldehyde: 
  20g paraformaldehyde in 250ml distilled water 
  Heat to 65  C 
   Add a few drops of 1M NaOH until solution clears 
   Allow to cool under running water 
   Filter solution  
The two solutions can be stored at 4  C separately overnight if necessary.  
Immediately before use of PLP fixative, the two solutions were mixed and made 
up to a final volume of 1 litre using 0.1M phosphate buffer. 2.14g sodium 
periodate was added and allowed to dissolve. Ready PLP fix cannot be stored 
overnight. 
 
7.1.2 4% Paraformaldehyde in PBS 
For 500ml of fixative 
25 g paraformaldehyde made up to 500 ml with PBS 
Heat to 65  C 
Add a few drops of 5m NaOH until solution clears 
Cool solution under running water 
Filter solution  
Store at 4  C 
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7.1.3 Karnovsky’s modified fixative (paraformaldehyde / 
glutaraldehyde 4% / 5%) 
 
Preparation of ingredients for 500ml of fixative 
 8% paraformaldehyde 
  20g paraformaldehyde in 250ml distilled water 
  Heat to 65  C 
  Add a few drops of 1M NaOH until solution clears 
  Cool solution under running water 
  Filter solution 
  0.08M cacodylate buffer 
  17.1224g sodium cacodylate in 1 litre of distilled water 
  Adjust pH to 7.2 
 25% glutaraldehyde 
  
For 500ml Karnovsky’s modified fixative mix 
250ml 8% paraformaldehyde 
 100ml 25% glutaraldehyde 
 150ml 0.08M cacodylate buffer 
 250mg Calcium chloride 
Filter the solution, adjust to pH 7.2 and store at 4  C 
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7.2 Tissue Processing 
 
7.2.1 Resin processing 
 
Perfusion fixed tissue was passed through the following protocol before 
embedding in resin: 
Via
l 
Solution Time Temp Comments 
1 Na-cacodylate buffer1 50 min 4°C 
 
2 
1% Osmium tetroxide (OsO4) 
in 
cacodylate buffer 
2 hrs. 
Room 
Temperatur
e 
(RT) 
toxic, add 
vial just 
shortly 
before 
needed, 
remove after 
use & pour 
into corn oil 
3 Na-cacodylate buffer 30 min RT 
 
4 50% Ethanol 5 min RT 
 
5 50% Ethanol 10 min RT 
 
6 70% Ethanol 5 min RT 
 
7 70% Ethanol 10 min RT 
 
8 80% Ethanol 5 min RT 
 
9 80% Ethanol 10 min RT 
 
10 90% Ethanol 5 min RT 
 
11 90% Ethanol 10 min RT 
 
12 100% Ethanol 5 min RT 
add vial just 
shortly 
before 
needed, fill 
to 20ml 
(evaporation
) 
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Via
l 
Solution Time Temp Comments 
13 100% Ethanol 10 min RT 
add vial just 
shortly 
before 
needed, fill 
to 20ml 
(evaporation
) 
14 Propylene oxide 15 min RT 
add vial just 
shortly 
before 
needed, fill 
to 20ml 
(evaporation
) 
15 Propylene oxide 15 min RT 
add vial just 
shortly 
before 
needed, fill 
to 20ml 
(evaporation
) 
16 
1:2 araldite2:propylene oxide 
change to fresh vial same slot 
1:1 araldite:propylene oxide 
13 hrs. &     
6 hrs. 
RT 
 
17 2:1 araldite:propylene oxide 18 hrs. RT 
 
18 araldite 
4 hrs. 15 
min 
RT 
 
After the procedure, processed tissue samples were placed in resin filled silicon 
moulds and left to polymerise for 24 hours at 60  C. 
 
1Isotonic cacodylate buffer 
16.05g  sodium cacodylate 
3.8g   sodium chloride 
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0.055g  calcium chloride 
0.102g  magnesium chloride 
Dissolve in 1 litre distilled water and adjust pH to 7.2 
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2Araldite Resin 
30g  araldite (CY212)     resin 
25.2g  dodecanyl succinic anhydride   hardener 
1.2ml  2,4,6-tri-diethylaminomethyl-phenol  accelerator 
1.0ml  di-butyl phthalate     plasticiser 
 
7.3 Staining protocols 
 
7.3.1 Immunohistochemistry using methanol for cell membrane 
penetration 
1 PBS 10 min RT 
2 Methanol -20  C 10 min freezer 
3 PBS 10 min RT 
4 block with PBS 
containing 10% 
normal goat serum 1 hr. RT 
5 remove excess and 
apply primary 
antibody in 
PBS/10% NGS 12 hrs. fridge 
6 PBS x3 3x10 min RT 
7 apply secondary 
antibody in 
PBS/10% NGS 1 hr. RT 
8 PBS x3 3x10 min RT 
9 DAPI in PBS 
(1:1500)  1 min RT 
10 PBS 5 min RT 
11 running water 5 min RT 
12 coverslip with 
glycine in PBS   RT 
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7.3.2 Immunohistochemistry using Triton-X 100 for cell membrane 
penetration 
1 PBS 10 min RT 
2 
block with PBS 
containing 10% 
normal goat serum 
and 0.5% Triton-X 
100 
1 hr. RT 
3 
remove excess and 
apply primary 
antibody in 
PBS/10% NGS 0.5% 
Triton-X 
12 hrs. Fridge 
4 PBS x3 3x10 min RT 
5 
apply secondary 
antibody in 
PBS/10% NGS and 
0.5% Triton-X 
1 hr. RT 
6 PBS x3 3x10 min RT 
7 
DAPI in PBS 
(1:1500) 
1 min RT 
8 PBS 5 min RT 
9 running water 5 min RT 
10 
cover with coverslip 
containing glycine 
in PBS 
 
RT 
 
7.3.3 X-gal staining  
 
Either freshly perfused and cryoprotected 1mm thick brain samples or 10 and 
20µm thick mounted cryosections were post fixed for 10 minutes on ice in 4% 
paraformaldehyde. The samples were then washed twice for 10 minutes on ice 
using fresh 2mM MgCl2/PBS solution followed by a 10 minute treatment with a 
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detergent solution containing 1mM MgCl2 (Sigma), 0.01% sodium desoxycholate 
(Sigma) 0.02% NP40. The samples were then immersed or covered for three 
hours at room temperature with the X-gal staining solution containing 20mM 
K3Fe(CN)6, 20mM K4Fe(CN)6 3H2O, 2mM MgCl2, 0.01% sodium desoxycholate, 
0.02% NP40 and X-gal at a final concentration of 1 mg/ml in PBS pH 7.4. Finally 
the samples were washed three times for 10 minutes in PBS and once in water 
for five minutes 
 
7.3.4 Staining for electron microscopy 
 
1 
saturated uranyl 
acetate in 50% 
ethanol 
15 min RT 
2 50% ethanol Rinse RT 
3 50% ethanol Rinse RT 
4 distilled water Rinse RT 
5 distilled water Rinse RT 
6 air dry 
  
7 
Reynolds’s lead 
citrate1 (Sodium 
hydroxide 
moistened 
chamber) 
10 min RT 
8 
1M sodium 
hydroxide 
Rinse RT 
9 
1M sodium 
hydroxide 
Rinse RT 
10 
1M sodium 
hydroxide 
Rinse RT 
11 distilled water 
several 
rinses 
RT 
 
1Reynold’s lead citrate (1.2mM lead citrate, 1.8mM sodium citrate, pH12) 1.33g 
lead citrate dissolved in 15ml distilled water for 1 min. Shake vigorously 1.76g 
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sodium citrate dissolved in 15ml distilled water for 1 min. Shake vigorously. 
Combine the solutions and equilibrate over 30 minutes with occasional shaking. 
Clear with 1M NaOH. Make up a final volume of 50ml adding distilled water. 
 
7.4 Staining solutions 
 
7.4.1 Methylene blue / azur II 
 
1% methylene blue 
1% azur II 
1% borax 
In distilled water. Filter before use. 
 
7.5 Media for cell culture 
 
7.5.1 Differentiation media with insulin (50 ml) 
 
48.85 ml DMEM (Gibco 31885-023) containing 2.5 ml Penicillin/ Streptomycin 
(Gibco, 15070-022) per 500ml DMEM 
0.583 ml 30% glucose (Sigma, G-7021) 
0.25ml of 10µM hydrocortisone (Sigma, H-0396) 
0.25 ml N1 mix  
1 ml insulin (human, recombinant, Sigma I-2767) 
50µl biotin (Sigma, B-4501) 
 
7.5.2 N1 mix (25ml) 
 
In PBS with a final concentration of  
1 mg/ml transferrin (Sigma, T-2252) 
16.11 mg/ml putrescine (Sigma, P-7505) 
4µM progesterone (Sigma P-0130) 
6µM selenium (Sigma, S-9133) 
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7.5.3 Neurosphere media (50 ml) 
 
250 ml NS medium contains  
38 ml sterile distilled water  
5 ml 10x DMEM/F12 (GIBCO, 21700-026) 
5 ml N1 mix   
1 ml 30% Glucose 
0.75ml 7.5% NaHCO3 (Sigma, S-5761)  
0.25ml 1M HEPES (Sigma, H-9136) 
0.5ml L-Glutamine (Gibco, 25030-081) 
0.5ml Penicilline/Streptomycine  
0.125ml 4% bovine serum albumin (Sigma, A-3059).   
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8 Abbreviations 
APC:   Adenomatous polyposis coli 
ATP:    Adenosine Triphosphate 
BDNF:   Brain derived neurotrophic factor 
bHLH:   Basic helix-loop-helix 
BrdU:   5-bromo-2-deoxyuridine 
cAMP:   Cyclic adenosine monophosphate 
CASPR:  Contactin associated protein 
CDK:    Cyclin-dependent kinase 
CFP:   Cyan fluorescence protein  
CNP:   2’-3’-cyclic nucleotide-3’-phosphodiesterase 
CNS:    Central Nervous System 
CO2:   Carbon dioxide 
D2:    Deiodinase 2 
DAPI:    4’6-diamidino-2-phenylindol 
DMEM:  Dulbecco’s modified Eagle’s medium 
DNA:   Deoxyribonucleic acid 
DNase:  Deoxyribonuclease  
DTI:    Diffusion Tensor Imaging 
DW MRI:   Diffusion weighted MRI 
EAE:    Experimental autoimmune encephalitis  
EGF:    Epidermal growth factor  
EM:    Electron Microscopy 
FGF:   Fibroblast growth factor 
FISH:    Fluorescence in situ hybridisation  
FITC:   Fluorescein isothiocyanate 
GalC:    Galactocerebrosides 
GFAP:   Glial fibrillary acidic protein 
GFP:    Green fluorescence protein 
Golli-MBP:   Gene of oligodendrocyte lineage myelin basic protein 
HABP:    Hyaluronan binding protein 
HDAC:   Histone deacetylase 
HIFBS:   Heat inactivated foetal bovine serum  
HMW:    High molecular weight 
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IGF-1:   Insulin growth factor 1  
IGFBP-2:   Insulin-like growth factor binding protein 2  
IGFR-1:   Insulin-like growth factor receptor 1 
IL6:    Interleukin 6 
iNOS:   Inducible nitric oxide synthase  
IPL:    Intraperiod line 
LINGO1:  Leucine rich repeat and Ig domain containing 1 
LMW:    Low molecular weight 
MAG:    Myelin associated protein 
MBP:    Myelin basic protein 
md rat:   Myelin deficient rat 
MDL:    Major dense line 
MHCII:   Major histocompatibility complex II 
microRNA:   Micro ribonucleic acid  
MOBP:   Myelin associated oligodendrocytic basic protein 
MOG:    Myelin/oligodendrocyte protein 
MRI:    Magnetic Resonance Imaging 
mRNA:  Messenger ribonucleic acid 
MRS:    Magnetic resonance spectroscopy 
MS:    Multiple Sclerosis 
MTC:    Monocarboxylase transporters 
MTI:    Magnetisation transfer imaging 
NAA:    N-acteylaspartate  
NF155:   Neurofascin 155 
NG2:    Neuronal/glial 2 
NGS:    Normal goat serum 
NO2:   Nitrogen dioxide 
NRG1:   Neuregulin 1 
NRG1-III:  Neuregulin 1 – III 
NS:    Neurosphere  
NTIS :   Non-thyroidal illness syndrome 
O2:   Oxygen 
OCT:    Optimal cutting temperature compound 
Olig1:   Oligodendrocyte transcription factor 1 
Olig2:   Oligodendrocyte transcription factor 2 
286 
OMpg:   Oligodendrocyte myelin glycoprotein 
OPC:    Oligodendrocyte Precursor Cell 
OSP:    Oligodendrocyte specific protein 
P120:    120 days post-partum 
PBS:   Phosphate buffered saline 
PDGF:   Platelet derived growth factor 
PDGFRα:   Platelet derived growth factor receptor α 
PLP fixative:  Periodate – lysine – paraformaldehyde 
PLP/DM20:   Proteolipidprotein 
Plp1 gene:   Proteolipidprotein 1 gene (mouse) 
PLP1:    Proteolipidprotein gene 1 (human) 
PMD:    Pelizaeus – Merzbacher – Disease 
PNS:    Peripheral Nervous System 
PSA NCAM:   Polisialylated acid form of neuronal cell adhesion molecule 
r.p.m:   Rounds per minute 
Rb:    Retinoblastoma 
SPG2:   X-linked hereditary spastic paraplegia 
T3:   Thriiodothyronine   
T4:   Thyroxin  
Tcf4:   Transcription factor 4 
TGF-β:  Transforming growth factor β 
TGFβ-1:   Transforming growth factor β1 
Thy1:   Thymocyte differentiation antigen 1 
TLR-2:   Toll-like receptor 2 
TMEV:    Theiler’s murine encephalomyelitis virus  
TNFα:   Tumour necrosis factor α 
TRH:    Thyroid releasing hormone 
UPR:    Unfolded protein response 
UV:    Ultra violet  
X-ALD:   X-linked adrenoleukodystrophy 
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